Professor David Goldstein

Butow P; Tattersall MHN; Clayton J; Goldstein D, 2013, 'Breaking bad news and truth disclosure in Australia', in New Challenges in Communication with Cancer Patients, pp. 377 - 387, http://dx.doi.org/10.1007/978-1-4614-3369-9_31

Erovic BM; Rotstein L; Goldstein DP, 2013, 'Surgical Management for Tertiary Hyperparathyroidism', in Encyclopedia of Otolaryngology, Head and Neck Surgery, Springer Berlin Heidelberg, pp. 2693 - 2698, http://dx.doi.org/10.1007/978-3-642-23499-6_770

Cohen MA; Goldstein DP; Gullane PJ, 2013, 'Salvage Surgery for Head and Neck Cancer', in Encyclopedia of Otolaryngology, Head and Neck Surgery, Springer Berlin Heidelberg, pp. 2352 - 2358, http://dx.doi.org/10.1007/978-3-642-23499-6_29

Erovic BM; Rotstein L; Sawka AM; Goldstein DP, 2013, 'Thyroid Nodules, Evaluation', in Encyclopedia of Otolaryngology, Head and Neck Surgery, Springer Berlin Heidelberg, pp. 2766 - 2777, http://dx.doi.org/10.1007/978-3-642-23499-6_174

Goldstein DA; Birnbaum AD; Tessler HH, 2011, 'Fuchs' Heterochromic Iridocyclitis', in Cornea, Elsevier, pp. 1307 - 1310, http://dx.doi.org/10.1016/b978-0-323-06387-6.00117-3

Goldstein D; Jones R; Smalley RV; Borden EC, 2010, 'Interferon Therapy and Cancer', in Oldham RK (ed.), Cancer Biotherapy: Principles and Practice, Springer, New York, pp. 277 - 302, http://dx.doi.org/10.1007/978-90-481-2289-9_9

Goldstein DA; Pyatetsky D, 2010, 'Rétinopathies herpétiques nécrosantes', in Les Uvéites, Elsevier, pp. 273 - 281, http://dx.doi.org/10.1016/b978-2-294-71107-7.50022-6

Shrime MG; Goldstein DP; Irish JC; Gullane PJ, 2009, 'Complications of Lip Surgery', in Complications in Head and Neck Surgery, Elsevier, pp. 251 - 256, http://dx.doi.org/10.1016/b978-141604220-4.50026-2

Goldstein DA; Tessler HH, 2009, 'Episcleritis and Scleritis', in Ophthalmology, Elsevier, pp. 255 - 261, http://dx.doi.org/10.1016/b978-0-323-04332-8.00035-4

LAI WW; GOLDSTEIN DA; TESSLER HH, 2006, 'Posterior Scleritis', in Retinal Imaging, Elsevier, pp. 303 - 306, http://dx.doi.org/10.1016/b978-0-323-02346-7.50036-3

Yip D; Karapetis C; Strickland A; Steer C; Goldstein D; Harper P, 2000, 'Chemotherapy and radiotherapy for pancreatic cancer', in , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd002093

Smalley RV; Goldstein D; Borden EC, 1998, 'Interferons: Therapy in Cancer', in Principles of Cancer Biotherapy, Springer Netherlands, pp. 266 - 283, http://dx.doi.org/10.1007/978-94-009-0029-5_11

Cicinelli MV; Miller V; Marchese A; Zaguia F; Miserocchi E; Goldstein DA, 2022, 'Outer Retinal Disruption in Early-Onset Birdshot Chorioretinopathy.', Ophthalmol Retina, http://dx.doi.org/10.1016/j.oret.2022.04.024

Ciulla TA; Kapik B; Barakat MR; Khurana RN; Nguyen QD; Grewal DS; Albini T; Cunningham ET; Goldstein DA, 2022, 'Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema', American Journal of Ophthalmology, vol. 237, pp. 310 - 324, http://dx.doi.org/10.1016/j.ajo.2021.10.024

Singer LP; Parazin B; Coughlin MW; Bloom JS; Crellin-Quick A; Goldstein DA; Van Der Walt S, 2022, 'HEALPix Alchemy: Fast All-Sky Geometry and Image Arithmetic in a Relational Database for Multimessenger Astronomy Brokers', Astronomical Journal, vol. 163, http://dx.doi.org/10.3847/1538-3881/ac5ab8

Grasl S; Janik S; Faisal M; Grasl MC; Pammer J; Weinreb I; Fischer G; Kim J; Hosni A; de Almeida JR; Goldstein DP; Erovic BM, 2022, 'Influence of Grading on Management and Outcome in Mucoepidermoid Carcinoma of the Parotid-A Multi-institutional Analysis.', Laryngoscope, http://dx.doi.org/10.1002/lary.30135

Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, vol. 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y

Id Said B; Ailles L; Karamboulas C; Meens J; Huang SH; Xu W; Keshavarzi S; Bratman SV; Cho BCJ; Giuliani M; Hahn E; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; de Almeida JR; Chepeha DB; Irish JC; Goldstein DP; Hope A; Hosni A, 2022, 'Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.', JAMA Otolaryngol Head Neck Surg, vol. 148, pp. 342 - 349, http://dx.doi.org/10.1001/jamaoto.2022.0003

Cheng EY; Kim JH; Grose EM; Philteos J; Levin M; de Almeida J; Goldstein D, 2022, 'Clinicopathological Predictors of Survival for Parotid Mucoepidermoid Carcinoma: A Systematic Review.', Otolaryngol Head Neck Surg, pp. 1945998221086845, http://dx.doi.org/10.1177/01945998221086845

Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA, 2022, 'Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.', J Clin Oncol, vol. 40, pp. 866 - 875, http://dx.doi.org/10.1200/JCO.21.01961

Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C, 2022, 'Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: A scoping review', Personalized Medicine, vol. 19, pp. 139 - 153, http://dx.doi.org/10.2217/pme-2021-0096

Noltes ME; Cottrell J; Madani A; Rotstein L; Gomez-Hernandez K; Devon K; Boggild MK; Goldstein DP; Wong EM; Brouwers AH; Kruijff S; Eskander A; Monteiro E; Pasternak JD, 2022, 'Quality Indicators for the Diagnosis and Management of Primary Hyperparathyroidism.', JAMA Otolaryngol Head Neck Surg, vol. 148, pp. 209 - 219, http://dx.doi.org/10.1001/jamaoto.2021.3858

Foo T; Goldstein D; Segelov E; Shapiro J; Pavlakis N; Desai J; Yip D; Zalcberg J; Price TJ; Nagrial A; Chantrill L; Burge M; Karapetis CS; Tebbutt N; Roy AC, 2022, 'The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours', Targeted Oncology, vol. 17, pp. 95 - 110, http://dx.doi.org/10.1007/s11523-022-00869-y

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2022, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, vol. 105, pp. 452 - 459, http://dx.doi.org/10.1016/j.pec.2021.05.018

Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2022, 'Corrigendum to “Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy” [Gait Posture 89 (2021) 178–185](S0966636221002514)(10.1016/j.gaitpost.2021.07.010)', Gait and Posture, vol. 92, pp. 1, http://dx.doi.org/10.1016/j.gaitpost.2021.11.006

Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G, 2022, 'Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice', Pain, vol. 163, pp. 110 - 124, http://dx.doi.org/10.1097/j.pain.0000000000002384

Nguyen M; Segelov E; Goldstein D; Pavlakis N; Shapiro J; Price TJ; Nagrial A; Chantrill L; Leong T; Chen J; Burge M; Karapetis CS; Chau I; Lordick F; Renouf D; Tebbutt N; Roy AC, 2022, 'Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, vol. 22, pp. 39 - 51, http://dx.doi.org/10.1080/14737140.2022.2002689

Siu DHW; Ali A; Tjokrowidjaja A; De Silva M; Lee J; Clingan PR; Aghmesheh M; Brungs D; Mapagu C; Goldstein D; O'Neill S; Liauw WS; Sjoquist KM; Thomas D; Pavlakis N; Clarke SJ; Diakos C; Chantrill LA, 2022, 'Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers', Asia-Pacific Journal of Clinical Oncology, http://dx.doi.org/10.1111/ajco.13745

Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM, 2022, 'Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients', Patient Education and Counseling, http://dx.doi.org/10.1016/j.pec.2022.01.011

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-022-07024-3

Siu J; Griffiths R; Noel CW; Austin PC; Pasternak J; Urbach D; Monteiro E; Goldstein DP; Irish JC; Sawka AM; Eskander A, 2022, 'Surgical Case Volume has an Impact on Outcomes for Patients with Lateral Neck Disease in Thyroid Cancer.', Ann Surg Oncol, vol. 29, pp. 1141 - 1150, http://dx.doi.org/10.1245/s10434-021-10923-0

Noel CW; Kwinter A; Mifsud M; Ringash J; Waldron J; Chepeha DB; Irish JC; Martino R; Gomes A; Aziza E; de Almeida JR; Goldstein DP, 2022, 'Quantifying Neck Fibrosis and Its Functional Implications: Development of the Neck Fibrosis Scale.', Laryngoscope, vol. 132, pp. 1015 - 1021, http://dx.doi.org/10.1002/lary.29897

Horowitz G; De Almeida JR; Berania I; Goldstein DP; Köhler HF; Kowalski LP; Matos LL; Brenner-Ullman A; Fliss DM; Muhanna N; Halpern D; Nard-Carmel N; Ungar OJ; Warshavsky A, 2022, 'Achieving negative resection margins in oral cavity cancer with masticator space involvement-Is it feasible? International collaborative study.', Head Neck, vol. 44, pp. 453 - 459, http://dx.doi.org/10.1002/hed.26943

Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Gooden E; Brown DH; Eskander A; Zahedi A; Chung J; Su J; Xu W; Ihekire O; Jones JM; Gafni A; Baxter NN; Goldstein DP; Canadian Active Surveillance Study Group (Greater Toronto Area) , 2022, 'A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.', Thyroid, vol. 32, pp. 255 - 262, http://dx.doi.org/10.1089/thy.2021.0485

H L Chan H; Sahovaler A; Daly MJ; Ferrari M; Franz L; Gualtieri T; Tzelnick S; Eu D; Manojlovic-Kolarski M; Berania I; Orzell S; de Almeida JR; Goldstein DP; Nicolai P; Gilbert RW; Irish JC, 2022, 'Projected cutting guides using an augmented reality system to improve surgical margins in maxillectomies: A preclinical study.', Oral Oncol, vol. 127, pp. 105775, http://dx.doi.org/10.1016/j.oraloncology.2022.105775

Blasco MA; Noel CW; Truong T; Huang SH; Goldstein DP; Irish JC; Gilbert R; Hosni A; Hope A; O'Sullivan B; Waldron J; Perez-Ordonez B; Weinreb I; Smith SM; Bartlett E; Yu E; de Almeida JR, 2022, 'Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer.', Head Neck, vol. 44, pp. 1422 - 1429, http://dx.doi.org/10.1002/hed.27036

Sahovaler A; Lee JJW; Xu W; Su S; Hosni A; Bayley A; Goldstein DP; de Almeida JR, 2021, 'Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study.', J Otolaryngol Head Neck Surg, vol. 50, pp. 71, http://dx.doi.org/10.1186/s40463-021-00551-9

Lundy J; Harris M; Zalcberg J; Zimet A; Goldstein D; Gebski V; Borsaru A; Desmond C; Swan M; Jenkins BJ; Croagh D, 2021, 'EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy', Frontiers in Oncology, vol. 11, http://dx.doi.org/10.3389/fonc.2021.770022

Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, vol. 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0

Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer', Scientific Reports, vol. 11, pp. 1786, http://dx.doi.org/10.1038/s41598-021-81398-y

Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D, 2021, 'AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer', BMC Cancer, vol. 21, http://dx.doi.org/10.1186/s12885-021-08666-y

Chiang JCB; Goldstein D; Tavakoli A; Trinh T; Klisser J; Lewis CR; Friedlander M; Naduvilath TJ; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel', Scientific Reports, vol. 11, http://dx.doi.org/10.1038/s41598-021-02439-0

Zazuli Z; de Jong C; Xu W; Vijverberg SJH; Masereeuw R; Patel D; Mirshams M; Khan K; Cheng D; Ordonez-Perez B; Huang S; Spreafico A; Hansen AR; Goldstein DP; de Almeida JR; Bratman SV; Hope A; Knox JJ; Wong RKS; Darling GE; Kitchlu A; van Haarlem SWA; van der Meer F; van Lindert ASR; Ten Heuvel A; Brouwer J; Ross CJD; Carleton BC; Egberts TCG; Herder GJM; Deneer VHM; Maitland-van der Zee AH; Liu G, 2021, 'Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.', J Pers Med, vol. 11, http://dx.doi.org/10.3390/jpm11111233

Yu A; Street D; Viney R; Goodall S; Pearce A; Haywood P; Haas M; Battaglini E; Goldstein D; Timmins H; Park SB, 2021, 'Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences', Supportive Care in Cancer, vol. 29, pp. 6379 - 6387, http://dx.doi.org/10.1007/s00520-021-06196-8

Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho-Oncology, vol. 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764

O'Sullivan B; Huang SH; Hahn E; Gullane P; Irish J; Su J; Tong L; de Almeida J; Gilbert RW; Brown D; Witterick I; Vescan A; Montero E; Gentili F; Catton C; Chung P; Chepeha DB; Goldstein D; Xu W; Hosni A, 2021, 'High Local Control Following Pre-Operative Radiotherapy for Adult Deep Soft Tissue Sarcoma of the Head and Neck', International journal of radiation oncology, biology, physics, vol. 111, pp. S41 - S42, http://dx.doi.org/10.1016/j.ijrobp.2021.07.117

Jacinto JKM; Huang SH; Su J; Kim J; O'Sullivan B; Ringash J; Cho J; Hope AJ; Bratman S; Giuliani M; Hosni A; Hahn E; Spreafico A; Hansen A; Goldstein D; Tong L; Perez-Ordonez B; Weinreb I; Xu W; Waldron J, 2021, 'Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma', International journal of radiation oncology, biology, physics, vol. 111, pp. e384 - e385, http://dx.doi.org/10.1016/j.ijrobp.2021.07.1125

Id Said B; Ailles L; Huang SH; Xu W; Keshavarzi S; Bratman SV; Cho J; Giuliani ME; Hahn E; Kim J; O'Sullivan B; Ringash JG; Waldron JN; Spreafico A; de Almeida J; Chepeha DB; Irish J; Goldstein D; Hope AJ; Hosni A, 2021, 'Patient-Derived Xenograft Engraftment Predicts Oral Cavity Cancer Outcomes', International journal of radiation oncology, biology, physics, vol. 111, pp. e391 - e392, http://dx.doi.org/10.1016/j.ijrobp.2021.07.1140

Aughton K; Elander NO; Evans A; Jackson R; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; Carter R; Cunningham D; Tebbutt NC; Goldstein D; Shannon J; Glimelius B; Hackert T; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Palmer DH; Büchler MW; Ghaneh P; Neoptolemos JP; Greenhalf W, 2021, 'HENT1 predicts benefit from gemcitabine in pancreatic cancer but only with low CDA mRNA', Cancers, vol. 13, http://dx.doi.org/10.3390/cancers13225758

Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M, 2021, 'The experiences and needs of australian medical oncologists in integrating comprehensive genomic profiling into clinical care: A nation-wide survey', Oncotarget, vol. 12, pp. 2169 - 2176, http://dx.doi.org/10.18632/ONCOTARGET.28076

Maharaj AD; Evans SM; Zalcberg JR; Ioannou LJ; Graco M; Croagh D; Pilgrim CHC; Dodson T; Goldstein D; Philip J; Kench JG; Merrett ND; Neale RE; White K; Evans P; Leong T, 2021, 'Barriers and enablers to the implementation of multidisciplinary team meetings: A qualitative study using the theoretical domains framework', BMJ Quality and Safety, vol. 30, pp. 792 - 803, http://dx.doi.org/10.1136/bmjqs-2020-011793

Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, vol. 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6

Clifford BK; Jones MD; Simar D; Barry BK; Goldstein D, 2021, 'The effect of exercise intensity on exercise-induced hypoalgesia in cancer survivors: A randomized crossover trial', Physiological Reports, vol. 9, pp. e15047, http://dx.doi.org/10.14814/phy2.15047

Shepherd EA; Herst BS; Parlitsis GJ; Shapiro MJ; Goldstein DA; Merrill PT, 2021, 'Multiple Evanescent White-Dot Syndrome in a 9-Year-Old Girl', Journal of VitreoRetinal Diseases, pp. 247412642110442 - 247412642110442, http://dx.doi.org/10.1177/24741264211044222

Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2021, 'Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy', Gait and Posture, vol. 89, pp. 178 - 185, http://dx.doi.org/10.1016/j.gaitpost.2021.07.010

Lees JG; Abdulla M; Barkl-Luke ME; Livni L; Keating BA; Hayes J; Fiore NT; Park SB; Moalem-Taylor G; Goldstein D, 2021, 'Effect of exercise on neuromuscular toxicity in oxaliplatin-treated mice', Muscle and Nerve, vol. 64, pp. 225 - 234, http://dx.doi.org/10.1002/mus.27329

Giraud P; Racadot S; Vernerey D; Goldstein D; Glimelius B; Van Houtte P; Gubanski M; Spry N; Van Laethem JL; Hammel P; Huguet F, 2021, 'Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, vol. 110, pp. 993 - 1002, http://dx.doi.org/10.1016/j.ijrobp.2021.01.055

Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; van Houtte P; Bonnetain F; Louvet C; Hammel P; Huguet F, 2021, 'Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, vol. 110, pp. 1022 - 1031, http://dx.doi.org/10.1016/j.ijrobp.2021.01.052

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, vol. 81, pp. 3461 - 3479, http://dx.doi.org/10.1158/0008-5472.CAN-20-2496

Chiang JCB; Goldstein D; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal nerve changes following treatment with neurotoxic anticancer drugs', Ocular Surface, vol. 21, pp. 221 - 237, http://dx.doi.org/10.1016/j.jtos.2021.06.007

Battaglini E; Goldstein D; Grimison P; McCullough S; Mendoza-Jones P; Park SB, 2021, 'Chemotherapy-induced peripheral neurotoxicity in cancer survivors: Predictors of long-term patient outcomes', JNCCN Journal of the National Comprehensive Cancer Network, vol. 19, pp. 821 - 828, http://dx.doi.org/10.6004/jnccn.2021.7026

Krasovitsky MS; Goldstein D, 2021, 'Destructive soft tissue metastases in advanced colorectal cancer: a case report', ANNALS OF PALLIATIVE MEDICINE, http://dx.doi.org/10.21037/apm-21-362

Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, vol. 31, http://dx.doi.org/10.17061/PHRP31122108

Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker T; Corley S; Wilkins MR; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Hgf/c-met inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer', Cancers, vol. 13, http://dx.doi.org/10.3390/cancers13112763

Oar A; Kneebone A; Lee M; Goldstein D; Sjoquist KM; Le H; Chu J; Barbour A; Gholamrezaei L; Lynam JF; Bece A; Bahamad S; Yip S; Espinoza D; Chantrill LA; Moore A; Lee D; Nguyen QN; Samra J; Mumford J, 2021, 'Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.', JOURNAL OF CLINICAL ONCOLOGY, vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS4172

Kokkinos J; Jensen A; Sharbeen G; McCarroll JA; Goldstein D; Haghighi KS; Phillips PA, 2021, 'Does the microenvironment hold the hidden key for functional precision medicine in pancreatic cancer?', Cancers, vol. 13, pp. 2427 - 2427, http://dx.doi.org/10.3390/cancers13102427

Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I, 2021, 'Family communication about genomic sequencing: A qualitative study with cancer patients and relatives', Patient Education and Counseling, vol. 104, pp. 944 - 952, http://dx.doi.org/10.1016/j.pec.2020.10.022

Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, vol. 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697

Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY, 2021, 'Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)^☆', Annals of Oncology, vol. 32, pp. 533 - 541, http://dx.doi.org/10.1016/j.annonc.2021.01.004

Trinh T; Park SB; Murray J; Pickering H; Lin CSY; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV, 2021, 'Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial', Supportive Care in Cancer, vol. 29, pp. 1103 - 1110, http://dx.doi.org/10.1007/s00520-020-05591-x

Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D, 2021, 'Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy', JAMA network open, vol. 4, pp. e2036695, http://dx.doi.org/10.1001/jamanetworkopen.2020.36695

McNamara MG; Bridgewater JA; Goyal L; Goldstein D; Shroff RT; Moehler MH; Lowery MA; Bekaii-Saab TS; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox JJ; Valle JW, 2021, 'Gender representation in authorship in later-phase systemic clinical trials in biliary tract cancer (BTC).', Journal of Clinical Oncology, vol. 39, pp. 348 - 348, http://dx.doi.org/10.1200/jco.2021.39.3_suppl.348

Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2021, 'Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications', Pancreatology, vol. 21, pp. 103 - 114, http://dx.doi.org/10.1016/j.pan.2020.11.022

Chiang JCB; Goldstein D; Trinh T; Au K; Mizrahi D; Muhlmann M; Crowe P; O’neill S; Edwards K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of sub-basal corneal nerve reduction following neurotoxic chemotherapy', Translational Vision Science and Technology, vol. 10, pp. 1 - 11, http://dx.doi.org/10.1167/tvst.10.1.24

Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2021, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-021-00988-x

Quinn CM; Porwal M; Meagher NS; Hettiaratchi A; Power C; Jonnaggadala J; McCullough S; Macmillan S; Tang K; Liauw W; Goldstein D; Zeps N; Crowe PJ, 2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, vol. 16, http://dx.doi.org/10.1177/11772719211005745

Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2021, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, http://dx.doi.org/10.1002/jgc4.1455

Lee J; Zaguia F; Minkus C; Koreishi AF; Birnbaum AD; Goldstein DA, 2021, 'The Role of Screening for Asymptomatic Ocular Inflammation in Sarcoidosis', Ocular Immunology and Inflammation, http://dx.doi.org/10.1080/09273948.2021.1976216

Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC; Kirk J; Young MA; Newson A; Jacobs C; Savard J, 2021, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics, Part A, http://dx.doi.org/10.1002/ajmg.a.62563

Maharaj AD; Evans SM; Ioannou LJ; Croagh D; Earnest A; Holland JF; Pilgrim CHC; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Burmeister EA; Evans PM; Hayes TM; Houli N; Knowles B; Leong T; Nikfarjam M; Philip J; Quinn M; Shapiro J; Smith MD; Spillane JB; Wong R; Zalcberg JR, 2021, 'The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer', HPB, http://dx.doi.org/10.1016/j.hpb.2021.11.005

Kokkinos J; Ignacio RM; Haghighi K; Kopecky C; Sharbeen G; Gonzales-Aloy E; Youkhana J; Butler L; Goldstein D; McCarroll J; Phillips P, 2021, 'Patient-derived pancreatic tumours in a dish: implications for real-time precision medicine', HPB, vol. 23, pp. S235 - S235, http://dx.doi.org/10.1016/j.hpb.2020.11.590

Cameron B; Webber K; Li H; Bennett BK; Boyle F; de Souza P; Wilcken N; Lynch J; Friedlander M; Goldstein D; Lloyd AR, 2021, 'Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study.', Brain Behav Immun Health, vol. 10, pp. 100189, http://dx.doi.org/10.1016/j.bbih.2020.100189

Blinman P; Martin A; Jefford M; Goldstein D; Boadle D; Morris M; Tebbutt N; Aiken C; Harkin A; Segelov E; Haydon A; Iveson T; Stockler MR, 2021, 'Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer.', JNCI Cancer Spectr, vol. 5, pp. pkaa107, http://dx.doi.org/10.1093/jncics/pkaa107

Tempero M; O'Reilly E; Van Cutsem E; Berlin J; Philip P; Goldstein D; Tabernero J; Borad M; Bachet J; Parner V; Tebbutt N; Chua Y; Corrie P; Harris M; Taieb J; Burge M; Kunzmann V; Zhang G; McGovern D; Marks H; Biankin A; Reni M, 2021, 'LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival', Annals of Oncology, vol. 32, pp. S226 - S226, http://dx.doi.org/10.1016/j.annonc.2021.06.009

Sahovaler A; Chan HHL; Gualtieri T; Daly M; Ferrari M; Vannelli C; Eu D; Manojlovic-Kolarski M; Orzell S; Taboni S; de Almeida JR; Goldstein DP; Deganello A; Nicolai P; Gilbert RW; Irish JC, 2021, 'Augmented Reality and Intraoperative Navigation in Sinonasal Malignancies: A Preclinical Study.', Front Oncol, vol. 11, pp. 723509, http://dx.doi.org/10.3389/fonc.2021.723509

Said BI; Laurie A; Karamboulas C; Meens J; Huang SH; Xu W; Keshavarzi S; Bratman SV; Cho BCJ; Giuliani M; Hahn E; Kim J; O’Sullivan B; Ringash J; Waldron J; Spreafico A; de Almeida JR; Chepeha DB; Irish JC; Goldstein DP; Hope A; Hosni A, 2021, '45: Patient-Derived Xenograft Engraftment Predicts Oral Cavity Cancer Outcomes', Radiotherapy and Oncology, vol. 163, pp. S22 - S22, http://dx.doi.org/10.1016/s0167-8140(21)08923-4

Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'Targeting hgf/c-met axis in pancreatic cancer', International Journal of Molecular Sciences, vol. 21, pp. 1 - 18, http://dx.doi.org/10.3390/ijms21239170

Maharaj AD; Evans SM; Zalcberg JR; Ioannou LJ; Graco M; Croagh D; Pilgrim CHC; Dodson T; Goldstein D; Philip J; Kench JG; Merrett ND; Neale RE; White K; Evans P; Leong T; Green SE, 2020, 'Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework', PLoS ONE, vol. 15, pp. e0243312, http://dx.doi.org/10.1371/journal.pone.0243312

McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; André T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater J; Valle JW, 2020, 'Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer', Journal of Hepatology, vol. 73, pp. 1109 - 1117, http://dx.doi.org/10.1016/j.jhep.2020.05.014

Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis', British Journal of Cancer, vol. 123, pp. 1466, http://dx.doi.org/10.1038/s41416-020-1004-6

McGahan W; Waterhouse MA; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Burmeister EA; Jordan SJ; Neale RE, 2020, 'Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: A population-based analysis', Pancreatology, vol. 20, pp. 1458 - 1464, http://dx.doi.org/10.1016/j.pan.2020.07.405

Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, 'Taxane-induced peripheral neuropathy: differences in patient report and objective assessment', Supportive Care in Cancer, vol. 28, pp. 4459 - 4466, http://dx.doi.org/10.1007/s00520-020-05299-y

Lees JG; White D; Keating BA; Barkl-Luke ME; Makker PGS; Goldstein D; Moalem-Taylor G, 2020, 'Oxaliplatin-induced haematological toxicity and splenomegaly in mice', PLoS ONE, vol. 15, pp. e0238164, http://dx.doi.org/10.1371/journal.pone.0238164

Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'An orthotopic resectional mouse model of pancreatic cancer', Journal of Visualized Experiments, vol. 2020, pp. 1 - 13, http://dx.doi.org/10.3791/61726

Li T; Timmins HC; King T; Kiernan MC; Goldstein D; Park SB, 2020, 'Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials', Hematological Oncology, vol. 38, pp. 229 - 243, http://dx.doi.org/10.1002/hon.2706

Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB, 2020, 'Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, vol. 131, pp. 1979 - 1985, http://dx.doi.org/10.1016/j.clinph.2020.02.028

Tran B; Vajdic CM; Webber K; Laaksonen MA; Stavrou EP; Tiller K; Suchy S; Bosco AM; Harris MF; Lloyd AR; Goldstein D, 2020, 'Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study', Cancer Epidemiology, vol. 67, pp. 101773 - 101773, http://dx.doi.org/10.1016/j.canep.2020.101773

Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D; Barbour A; Goldstein D; Samra JS; Harris M; Chua YJ; Yip S; Simes J; Hicks R; Coates A; Gurney H; Do V; Marschner I; Goldstone S; Yip S; Pavlakis N; Goldstein D; Aghmesheh M; Joubert W; Grimes D; Burge M; Bagia S; Jaber M; Bryant R; Nathanson L; Cavallucci D; Fawcett J; O’Rourke T; Jones R, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, vol. 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2

Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K, 2020, 'The impact of anticancer drugs on the ocular surface', Ocular Surface, vol. 18, pp. 403 - 417, http://dx.doi.org/10.1016/j.jtos.2020.03.008

Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G, 2020, 'Acute changes in nerve excitability following oxaliplatin treatment in mice', Journal of Neurophysiology, vol. 124, pp. 232 - 244, http://dx.doi.org/10.1152/jn.00260.2020

Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK, 2020, 'Nomogram for Estimating Overall Survival in Patients with Metastatic Pancreatic Cancer', Pancreas, vol. 49, pp. 744 - 750, http://dx.doi.org/10.1097/MPA.0000000000001563

Vadboncoeur J; Jampol LM; Goldstein DA, 2020, 'Acute Zonal Occult Outer Retinopathy (AZOOR): a case report of regression following intravitreal dexamethasone (Ozurdex) implant.', Retin Cases Brief Rep, http://dx.doi.org/10.1097/ICB.0000000000001009

Lim BT; Butow P; Sze ML; Girgis A; Jefford M; Goldstein D; Costa D, 2020, 'Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups', Asia-Pacific Journal of Clinical Oncology, vol. 16, pp. 115 - 122, http://dx.doi.org/10.1111/ajco.13290

Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; Van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG, 2020, 'Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant imatinib', JAMA Surgery, vol. 155, pp. e200397, http://dx.doi.org/10.1001/jamasurg.2020.0397

Butow P; Davies G; Napier C; Thomas DM; Bartley N; Goldstein D; Ballinger ML; Juraskova I; Schlub TE; Tucker K; Meiser B; Young M-A, 2020, 'Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.', Journal of Clinical Oncology, vol. 38, pp. 1541 - 1541, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1541

Reni M; Riess H; O'Reilly EM; Reeves JA; Chiorean E; George TJ; Scheithauer W; Pascal A; Lerch M; Brenner WS; Ko Y-J; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Biankin A; Tempero MA, 2020, 'Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial.', Journal of Clinical Oncology, vol. 38, pp. 4618 - 4618, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.4618

Battaglini E; Goldstein D; Park S, 2020, 'Determining the impact of chemotherapy-induced peripheral neuropathy: A survey of cancer survivors.', Journal of Clinical Oncology, vol. 38, pp. e24080 - e24080, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e24080

Butow P; Butow P; Davies G; Napier CE; Schlub T; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker B; Goldstein D; Thomas DM, 2020, 'Assessment of the Value of Tumor Variation Profiling Perceived by Patients with Cancer', JAMA Network Open, vol. 3, pp. e204721, http://dx.doi.org/10.1001/jamanetworkopen.2020.4721

Xu Z; Pang TCY; Liu AC; Pothula SP; Mekapogu AR; Perera CJ; Murakami T; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis', British Journal of Cancer, vol. 122, pp. 1486 - 1495, http://dx.doi.org/10.1038/s41416-020-0782-1

Oar A; Lee M; Le H; Hruby G; Dalfsen R; Pryor D; Lee D; Chu J; Holloway L; Briggs A; Barbour A; Chander S; Ng SP; Samra J; Shakeshaft J; Goldstein D; Nguyen N; Goodman KA; Chang DT; Kneebone A, 2020, 'Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)', Practical Radiation Oncology, vol. 10, pp. e136 - e146, http://dx.doi.org/10.1016/j.prro.2019.07.018

Kokkinos J; Ignacio RMC; Sharbeen G; Boyer C; Gonzales-Aloy E; Goldstein D; McCarroll JA; Phillips PA, 2020, 'Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs', Biomaterials, vol. 240, pp. 119742, http://dx.doi.org/10.1016/j.biomaterials.2019.119742

Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ, 2020, 'Who should access germline genome sequencing? A mixed methods study of patient views', Clinical Genetics, vol. 97, pp. 329 - 337, http://dx.doi.org/10.1111/cge.13664

Sahai V; Tabernero J; Van Cutsem E; Reni M; Tempero MA; O'Reilly EM; Berlin J; Riess H; Goldstein D; Li M; Lu B; Ferrara S; Philip PA, 2020, 'Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns.', Journal of Clinical Oncology, vol. 38, pp. 704 - 704, http://dx.doi.org/10.1200/jco.2020.38.4_suppl.704

Tjokrowidjaja A; Goldstein D; Hudson HM; Lord SJ; Gebski V; Clarke S; de Souza P; Motzer RJ; Lee CK, 2020, 'The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy', Acta Oncologica, vol. 59, pp. 20 - 27, http://dx.doi.org/10.1080/0284186X.2019.1656342

Timmins HC; Li T; Kiernan MC; Horvath LG; Goldstein D; Park SB, 2020, 'Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients', Journal of Pain, vol. 21, pp. 44 - 58, http://dx.doi.org/10.1016/j.jpain.2019.06.011

Wang X; Yeo RX; Hogg PJ; Goldstein D; Crowe P; Dilda PJ; Yang JL, 2020, 'The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas', Oncotarget, vol. 11, pp. 46 - 61, http://dx.doi.org/10.18632/oncotarget.27416

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, '1133 PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES.', Gastroenterology, vol. 158, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(20)31245-2

Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, '8. Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, vol. 131, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2019.11.041

Li T; Timmins HC; McCrary JM; Trinh T; Horvath LG; Friedlander ML; Kiernan MC; Goldstein D; Park SB, 2020, '5. Neurophysiological characteristics in the development and recovery of peripheral neuropathy in oxaliplatin and paxlitaxel treated patients', Clinical Neurophysiology, vol. 131, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.038

Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D, 2019, 'Chemotherapy-induced peripheral neuropathy—patient-reported outcomes compared with NCI-CTCAE grade', Supportive Care in Cancer, vol. 27, pp. 4771 - 4777, http://dx.doi.org/10.1007/s00520-019-04781-6

McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Friedlander M; Bosco A; Harrison M; Maier N; O'Neill S; Park SB, 2019, 'Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy', Journal of Pain and Symptom Management, vol. 58, pp. 1023 - 1032, http://dx.doi.org/10.1016/j.jpainsymman.2019.07.021

Vasista A; Stockler M; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Snow S; Burge M; Harris D; Jonker D; Chua YJ; Epstein R; Bonaventura A; Kiely B, 2019, 'Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer', Oncologist, vol. 24, pp. e1102 - e1107, http://dx.doi.org/10.1634/theoncologist.2018-0613

Tang M; Chen J; Goldstein D; Links M; Lord S; Marschner I; Simes RJ; Lee CK, 2019, 'Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer', Pancreas, vol. 48, pp. 1274 - 1284, http://dx.doi.org/10.1097/MPA.0000000000001429

McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB, 2019, 'Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, vol. 27, pp. 3849 - 3857, http://dx.doi.org/10.1007/s00520-019-04680-w

McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; Andre T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater JA; Valle JW, 2019, 'Impact of anatomic site of biliary tract tumour origin and conditional probability of survival (CS): Results from 15 prospective advanced first-line clinical trial', ANNALS OF ONCOLOGY, vol. 30, pp. 274 - 274, http://dx.doi.org/10.1093/annonc/mdz247.042

Lee B; Lipton L; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Burge M; Cooray P; Nagrial A; Tebbutt NC; Thomson B; Nikfarjam M; Harris M; Haydon A; Lawrence B; Tai DWM; Simons K; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2019, 'Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer', Annals of Oncology, vol. 30, pp. 1472 - 1478, http://dx.doi.org/10.1093/annonc/mdz200

Maharaj AD; Holland JF; Scarborough RO; Evans SM; Ioannou LJ; Brown W; Croagh DG; Pilgrim CHC; Kench JG; Lipton LR; Leong T; McNeil JJ; Nikfarjam M; Aly A; Burton PR; Cashin PA; Chu J; Duong CP; Evans P; Goldstein D; Haydon A; Hii MW; Knowles BPF; Merrett ND; Michael M; Neale RE; Philip J; Porter IWT; Smith M; Spillane J; Tagkalidis PP; Zalcberg JR, 2019, 'The Upper Gastrointestinal Cancer Registry (UGICR): A clinical quality registry to monitor and improve care in upper gastrointestinal cancers', BMJ Open, vol. 9, pp. e031434, http://dx.doi.org/10.1136/bmjopen-2019-031434

McCrary JM; Goldstein D; Wyld D; Henderson R; Lewis CR; Park SB, 2019, 'Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test', Journal of Cancer Survivorship, vol. 13, pp. 495 - 502, http://dx.doi.org/10.1007/s11764-019-00769-7

Best MC; Bartley N; Jacobs C; Juraskova I; Goldstein D; Newson AJ; Savard J; Meiser B; Ballinger M; Napier C; Thomas D; Biesecker B; Butow P; Tucker K; Schlub T; Vines R; Vines K; Kirk J; Young MA, 2019, 'Patient perspectives on molecular tumor profiling: "why wouldn't you?"', BMC Cancer, vol. 19, pp. 753, http://dx.doi.org/10.1186/s12885-019-5920-x

Reni M; Winter J; Tortora G; Pelzer U; Riess H; Chang H; O'Reilly E; Oh D; Diaz IA; Milella M; Bendell J; Garlipp B; Tempero M; Macarulla T; Van Cutsem E; Berlin J; Goldstein D; Lu B; Jeanes J; Philip P, 2019, 'Analysis of patient screening in the phase III, international, randomized, open-label APACT trial', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, pp. iv110, http://dx.doi.org/10.1093/annonc/mdz156

Reni M; Riess H; O'Reilly E; Santoro A; Park J; Bekaii-Saab T; Tempero M; Shan Y; Macarulla T; Van Cutsem E; Noel M; Berlin J; Biankin A; Dhani N; Frassineti G; Goldstein D; Romano A; Bruchec YL; Philip P, 2019, 'An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, pp. iv126, http://dx.doi.org/10.1093/annonc/mdz154

Kopplin LJ; Munk M; Baynham J; Rosenbaum JT; Suhler EB; Biggee K; Goldstein DA; Lin P, 2019, 'Association of Fundus Autofluorescence Findings and Outer Retinal Lesions on Optical Coherence Tomography With Visual Acuity in Birdshot Chorioretinopathy.', J Vitreoretin Dis, vol. 3, pp. 235 - 241, http://dx.doi.org/10.1177/2474126419850746

Thavaneswaran S; Napier C; Goldstein D; Meiser B; Butow P; Thomas DM; Ballinger ML; Best M, 2019, 'Medical oncologists’ experience with returning molecular tumor profiling to patients.', Journal of Clinical Oncology, vol. 37, pp. 10521 - 10521, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10521

Tempero MA; Reni M; Riess H; Pelzer U; O'Reilly EM; Winter JM; Oh D-Y; Li C-P; Tortora G; Chang H-M; Lopez CD; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Ferrara S; Li M; Lu BD; Biankin A, 2019, 'APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.', Journal of Clinical Oncology, vol. 37, pp. 4000 - 4000, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4000

Eng L; Hueniken K; Brown MC; Hope A; Giuliani ME; Selby P; Chan KK; Mittmann N; Xu W; Goldstein DP; Liu G; de Almeida JR, 2019, 'Impact of health behavior change on health utility (HU) and financial toxicity in head and neck cancer (HNC) survivors.', Journal of Clinical Oncology, vol. 37, pp. 11561 - 11561, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.11561

Lukovic J; Alfaraj F; Mierzwa ML; Nader Marta G; Xu W; Su J; Ynoe de Moraes F; Huang SH; Bratman SV; O'Sullivan B; Kim J; Ringash J; Waldron J; de Almeida JR; Goldstein DP; Rosko A; Spector ME; Kowalski LP; Hope A; Hosni A, 2019, 'Development and validation of a prediction-score model for distant metastases in major salivary gland carcinoma.', Journal of Clinical Oncology, vol. 37, pp. 6085 - 6085, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.6085

Nichols AC; Theurer J; Prisman E; Read NE; Berthelet E; Tran E; Kevin F; de Almeida JR; Hope A; Goldstein DP; Hier M; Sultanem K; Yoo J; Macneil SD; Winquist E; Hammond A; Venkatesan V; Kuruvilla S; Eapen L; Palma DA, 2019, 'A phase II randomized trial for early-stage squamous cell carcinoma of the oropharynx: Radiotherapy versus trans-oral robotic surgery (ORATOR).', Journal of Clinical Oncology, vol. 37, pp. 6006 - 6006, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.6006

Knox JJ; McNamara MG; Palmer DH; Evans TRJ; Goldstein D; Bridgewater JA; Valle JW, 2019, 'NUC-1031 in combination with cisplatin for first-line treatment of advanced biliary tract cancer.', Journal of Clinical Oncology, vol. 37, pp. TPS4156 - TPS4156, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps4156

Michael M; Wong R; Gill SS; Goldstein D; Ngan S; Heriot AG; Link E; Farrell M; Neeson PJ; Ramsay RG; Wilson K; Mitchell C; Tie J; Pavlakis N; Zalcberg JR; Segelov E, 2019, 'Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.', JOURNAL OF CLINICAL ONCOLOGY, vol. 37, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.TPS3622

Lim BT; Butow P; Mills J; Miller A; Pearce A; Goldstein D, 2019, 'Challenges and perceived unmet needs of Chinese migrants affected by cancer: Focus group findings', Journal of Psychosocial Oncology, vol. 37, pp. 383 - 397, http://dx.doi.org/10.1080/07347332.2018.1551261

Kaur R; Meiser B; Zilliacus E; Tim Wong WK; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Norris C; Goldstein D, 2019, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, vol. 27, pp. 1951 - 1960, http://dx.doi.org/10.1007/s00520-018-4507-4

Maharaj AD; Ioannou L; Croagh D; Zalcberg J; Neale RE; Goldstein D; Merrett N; Kench JG; White K; Pilgrim CHC; Chantrill L; Cosman P; Kneebone A; Lipton L; Nikfarjam M; Philip J; Sandroussi C; Tagkalidis P; Chye R; Haghighi KS; Samra J; Evans SM, 2019, 'Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus', HPB, vol. 21, pp. 444 - 455, http://dx.doi.org/10.1016/j.hpb.2018.08.016

Sonbol MB; Ahn DH; Goldstein D; Okusaka T; Tabernero J; Macarulla T; Reni M; Li CP; O'Neil B; Van Cutsem E; Bekaii-Saab T, 2019, 'CanStem111P trial: A Phase III study of napabucasin plus nab-paclitaxel with gemcitabine', Future Oncology, vol. 15, pp. 1295 - 1302, http://dx.doi.org/10.2217/fon-2018-0903

Sclafani F; Hesselberg G; Thompson SR; Truskett P; Haghighi K; Rao S; Goldstein D, 2019, 'Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review', Journal of Surgical Oncology, vol. 119, pp. 489 - 496, http://dx.doi.org/10.1002/jso.25320

Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP, 2019, 'The Impact of Positive Resection Margins on Survival and Recurrence following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma', Annals of Surgery, vol. 269, pp. 520 - 529, http://dx.doi.org/10.1097/SLA.0000000000002557

Livni L; Lees JG; Barkl-Luke ME; Goldstein D; Moalem-Taylor G, 2019, 'Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture', Neuroscience Letters, vol. 694, pp. 14 - 19, http://dx.doi.org/10.1016/j.neulet.2018.11.016

McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Menant J; Friedlander M; Lewis CR; Hertzberg M; O'Neill S; King T; Bosco A; Harrison M; Park SB, 2019, 'Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, pp. 949 - 955, http://dx.doi.org/10.6004/jnccn.2019.7290

Chua YJ; Pavlakis N; Sjoquist KM; Martin AJ; Tsobanis E; Yip S; Bang Y-J; Alcindor T; O’callaghan CJ; Bekaii-Saab TS; Grothey A; Chen L-T; Simes J; Zalcberg JR; Goldstein D; Komatsu Y; Machida N; Esaki T; Hara H; Shitara K, 2019, 'Randomised Phase 3 Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE II', Annals of Oncology, vol. 30, pp. vi137 - vi137, http://dx.doi.org/10.1093/annonc/mdz343.087

Tempero MA; Reni M; Riess H; O’Reilly EM; Krishnamurthi S; Österlund P; Ales-Diaz IC; Milella M; Siena S; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin JD; Li M; Ferrara S; Bruchec YL; McGovern D; Biankin A, 2019, 'Phase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancreatic adenocarcinoma (APACT): Subgroup analyses', Annals of Oncology, vol. 30, pp. v259 - v260, http://dx.doi.org/10.1093/annonc/mdz247.010

Li T; Timmins H; King T; Kiernan M; Goldstein D; Park S, 2019, 'Bortezomib Induced Peripheral Neuropathy: A Systematic Review of Phase III Trials', Clinical Lymphoma Myeloma and Leukemia, vol. 19, pp. e346 - e346, http://dx.doi.org/10.1016/j.clml.2019.09.571

Blumberg JM; Walker P; Johnson S; Johnson B; Yu E; Lacasse M-C; Lam DK; Rittenberg B; Yao CMKL; Chepeha D; de Almeida JR; Goldstein DP; Gilbert R, 2019, 'Mandibular reconstruction with the scapula tip free flap.', Head Neck, vol. 41, pp. 2353 - 2358, http://dx.doi.org/10.1002/hed.25702

Alhashemi A; Jones JM; Goldstein DP; Ezzat S; Sawka AM, 2019, 'Re: Quality of life and symptom impact of thyroid cancer: A cross-sectional survey of Canadian patients.', Surgery, vol. 166, pp. 948 - 949, http://dx.doi.org/10.1016/j.surg.2018.09.018

Palma D; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida J; Hope A; Goldstein D; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil D; Winquist E; Hammond A; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Nichols A, 2019, '88 Radiotherapy Versus Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Results of a Randomized Trial', Radiotherapy and Oncology, vol. 139, pp. S39 - S40, http://dx.doi.org/10.1016/s0167-8140(19)33379-1

Karamboulas C; Bruce JP; Hope AJ; Meens J; Huang SH; Erdmann N; Hyatt E; Pereira K; Goldstein DP; Weinreb I; Su J; O'Sullivan B; Tiedemann R; Liu F-F; Pugh TJ; Bratman SV; Xu W; Ailles L, 2018, 'Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.', Cell Rep, vol. 25, pp. 1318 - 1331.e4, http://dx.doi.org/10.1016/j.celrep.2018.10.004

Eng L; Liu S; Zhang Q; Farzanfar D; Milne R; Yeung S; Brown MC; Howell D; Xu W; Goldstein DP; Jones JM; Selby P; Evans WK; Giuliani ME; Liu G, 2018, 'Cancer patient (pt) attitudes and preferences towards smoking status assessment.', Journal of Clinical Oncology, vol. 36, pp. 177 - 177, http://dx.doi.org/10.1200/jco.2018.36.30_suppl.177

Kaur R; Meiser B; Ziliacus E; Wong WKT; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Norris C; Goldstein D, 2018, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-018-4507-4

Beesley VL; Janda M; Burmeister EA; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Wyld DK; Chan RJ; Young JM; Neale RE, 2018, 'Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes', Palliative and Supportive Care, vol. 16, pp. 534 - 543, http://dx.doi.org/10.1017/S1478951517000608

Tan SYS; O’Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM, 2018, 'Predictors of care for patients with cancer of unknown primary site in three Australian hospitals', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. e512 - e520, http://dx.doi.org/10.1111/ajco.12815

Thompson SR; Lee ISY; Carroll S; Bishop S; Douglas P; Lam F; Brown C; Williams J; Goldstein D, 2018, 'Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?', ANZ Journal of Surgery, vol. 88, pp. 870 - 875, http://dx.doi.org/10.1111/ans.14398

Dumbrava MI; Burmeister EA; Wyld D; Goldstein D; O'Connell DL; Beesley VL; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Waterhouse MA; Neale RE, 2018, 'Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. 326 - 336, http://dx.doi.org/10.1111/ajco.12862

Shitara K; Özgüroğlu M; Bang YJ; Di Bartolomeo M; Mandalà M; Ryu MH; Fornaro L; Olesiński T; Caglevic C; Chung HC; Muro K; Goekkurt E; Mansoor W; McDermott RS; Shacham-Shmueli E; Chen X; Mayo C; Kang SP; Ohtsu A; Fuchs CS; Lerzo G; O'Connor JM; Mendez GA; Lynam J; Tebbutt N; Wong M; Strickland A; Karapetis C; Goldstein D; Vasey P; Van Laethem JL; Van Cutsem E; Berry S; Vincent M; Muller B; Rey F; Zambrano A; Guerra J; Krogh M; Baeksgaard L; Yilmaz M; Elme A; Magi A; Auvinen P; Alanko T; Moehler M; Kunzmann V; Seufferlein T; Thuss-Patience P; Hoehler T; Haag G; Al-Batran SE; Castro H; Lopez K; Aguilar Vasquez M; Sandoval M; Lam KO; Cuffe S; Kelly C; Geva R; Hubert A; Beny A; Brenner B; Giuseppe A; Falcone A; Maiello E; Passalacqua R; Montesarchio V; Hara H; Chin K; Nishina T; Komatsu Y; Machida N; Hironaka S; Satoh T; Tamura T; Sugimoto N; Cho H; Omuro Y; Kato K; Goto M; Hyodo I; Yoshida K; Baba H; Esaki T; Furuse J; Wan Mohammed WZ; Hernandez Hernandez C; Casas Garcia J; Dominguez Andrade A; Clarke K; Hjortland G; Glenjen N; Kubiatowski T; Jacek J; Wojtukiewicz M; Lazarev S; Lancukhay Y, 2018, 'Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial', The Lancet, vol. 392, pp. 123 - 133, http://dx.doi.org/10.1016/S0140-6736(18)31257-1

Battaglini E; Park SB; Barnes EH; Goldstein D, 2018, 'A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy', Contemporary Clinical Trials, vol. 70, pp. 135 - 138, http://dx.doi.org/10.1016/j.cct.2018.04.011

Wang X; Goldstein D; Crowe PJ; Yang JL, 2018, 'Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines', International Journal of Oncology, vol. 52, pp. 2143 - 2154, http://dx.doi.org/10.3892/ijo.2018.4337

Bekaii-Saab T; Okusaka T; Goldstein D; O'Neill B; Tabernero J; Li C; Reni M; Jin B; Oh C; Borodyansky L; Van Cutsem E, 2018, 'CanStem111P trial: A Phase 3 Study of napabucasin (NAPA) plus nab-paclitaxel (nPTX) with gemcitabine (Gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC) - Trial in progress', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. v51 - v52, http://dx.doi.org/10.1093/annonc/mdy151.183

Chiorean EG; Von Hoff D; Wan Y; Margunato-Debay S; Botteman M; Goldstein D, 2018, 'Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer', Cancer Management and Research, vol. 10, pp. 1389 - 1396, http://dx.doi.org/10.2147/CMAR.S163475

Blinman PL; Martin AJ; Jefford M; Goldstein D; Boadle D; Morris MF; Tebbutt NC; Aiken C; Paul J; Segelov E; Haydon AM; Iveson T; Stockler MR, 2018, 'Patients’ preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?', Journal of Clinical Oncology, vol. 36, pp. 3602 - 3602, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.3602

Lee B; Lipton LR; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Cooray P; Nagrial A; Burge ME; Tebbutt NC; Nikfarjam M; Harris M; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2018, 'Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer.', JOURNAL OF CLINICAL ONCOLOGY, vol. 36, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.e16206

Martin AJ; Gibbs E; Sjoquist K; Pavlakis N; Simes J; Price T; Shannon J; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Kim JW; Goldstein D, 2018, 'Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma', Gastric Cancer, vol. 21, pp. 473 - 480, http://dx.doi.org/10.1007/s10120-017-0754-1

Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P, 2018, 'The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4366-x

Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CSY; Kiernan MC; Park SB, 2018, 'Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy', Muscle and Nerve, vol. 57, pp. 615 - 621, http://dx.doi.org/10.1002/mus.25968

Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Oláh A; Büchler MW; Greenhalf W, 2018, 'Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy', British Journal of Cancer, vol. 118, pp. 1084 - 1088, http://dx.doi.org/10.1038/s41416-018-0005-1

Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Oláh A; Büchler MW; Greenhalf W, 2018, 'Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer', British Journal of Cancer, vol. 118, pp. 947 - 954, http://dx.doi.org/10.1038/s41416-018-0004-2

Feather CE; Lees JG; Makker PGS; Goldstein D; Kwok JB; Moalem-Taylor G; Polly P, 2018, 'Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice', Muscle and Nerve, vol. 57, pp. 650 - 658, http://dx.doi.org/10.1002/mus.25966

Clifford BK; Mizrahi D; Sandler CX; Barry BK; Simar D; Wakefield CE; Goldstein D, 2018, 'Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review', Supportive Care in Cancer, vol. 26, pp. 685 - 700, http://dx.doi.org/10.1007/s00520-017-3964-5

ter Veer E; van Rijssen LB; Besselink MG; Mali RMA; Berlin JD; Boeck S; Bonnetain F; Chau I; Conroy T; Van Cutsem E; Deplanque G; Friess H; Glimelius B; Goldstein D; Herrmann R; Labianca R; Van Laethem JL; Macarulla T; van der Meer JHM; Neoptolemos JP; Okusaka T; O'Reilly EM; Pelzer U; Philip PA; van der Poel MJ; Reni M; Scheithauer W; Siveke JT; Verslype C; Busch OR; Wilmink JW; van Oijen MGH; van Laarhoven HWM, 2018, 'Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease', The Lancet Oncology, vol. 19, pp. e151 - e160, http://dx.doi.org/10.1016/S1470-2045(18)30098-6

Eng L; Liu SY; Zhang Q; Farzanfar D; Yeung S; Brown MC; Xu W; Howell D; Goldstein DP; Jones JM; Selby P; Giuliani ME; Liu G, 2018, 'Cancer patient interest and perceptions of health behavior change programs.', Journal of Clinical Oncology, vol. 36, pp. 98 - 98, http://dx.doi.org/10.1200/jco.2018.36.7_suppl.98

Eng L; Liu SY; Zhang Q; Farzanfar D; Milne R; Yeung S; Brown MC; Howell D; Xu W; Goldstein DP; Jones JM; Selby P; Evans WK; Giuliani ME; Liu G, 2018, 'Cancer patient attitudes and preferences towards smoking status assessment.', Journal of Clinical Oncology, vol. 36, pp. 110 - 110, http://dx.doi.org/10.1200/jco.2018.36.7_suppl.110

Tie J; Cohen JD; Wang Y; Li L; Christie M; Simons K; Elsaleh H; Kosmider S; Wong R; Yip D; Lee M; Tran B; Rangiah D; Burge M; Goldstein D; Singh M; Skinner I; Faragher I; Croxford M; Bampton C; Haydon A; Jones IT; S Karapetis C; Price T; Schaefer MJ; Ptak J; Dobbyn L; Silliman N; Kinde I; Tomasetti C; Papadopoulos N; Kinzler K; Volgestein B; Gibbs P, 2018, 'Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: A prospective biomarker study', Gut, vol. 68, pp. 663 - 671, http://dx.doi.org/10.1136/gutjnl-2017-315852

Payne M; Burmeister EA; Waterhouse M; Jordan SJ; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Beesley VL; Gooden H; Janda M; Neale RE, 2018, 'Biliary Stenting in Patients with Pancreatic Cancer: Results from a Population-Based Cohort Study', Pancreas, vol. 47, pp. 80 - 86, http://dx.doi.org/10.1097/MPA.0000000000000960

Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P, 2018, 'The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4366-x

Akerman A; Sharbeen G; Holst J; Youkhana J; McCarroll J; Goldstein D; Erkan M; Phillips P, 2018, 'Targeting a solute carrier to metabolically reprogram tumour-promoting stromal cells in pancreatic cancer', Pancreatology, vol. 18, pp. S156 - S156, http://dx.doi.org/10.1016/j.pan.2018.05.419

Pang T; Xu Z; Pothula S; Yang MH; Becker T; Goldstein D; Heeschen C; Pirola R; Wilson J; Apte MV, 2018, '517 - World-First Identification of Circulating Pancreatic Stellate Cells in Metastatic Pancreatic Cancer', Gastroenterology, vol. 154, pp. S - 114, http://dx.doi.org/10.1016/s0016-5085(18)30816-3

Timmins HC; Li T; Grimison P; Murray JE; Cox KM; Horvath LG; Lewis CR; Goldstein D; Kiernan MC; Park SB, 2018, '5. Neurophysiological dysfunction in chemotherapy-treated patients: Comparison of different platinum analogues', Clinical Neurophysiology, vol. 129, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.018

Noel CW; McMullen C; Yao C; Monteiro E; Goldstein DP; Eskander A; de Almeida JR, 2018, 'The fragility of statistically significant findings from randomized trials in head and neck surgery.', Laryngoscope, vol. 128, pp. 2094 - 2100, http://dx.doi.org/10.1002/lary.27183

Liu A; Botkin A; Murray C; Goldstein D; Hofer SOP; Solish N; Kitchen J; Chan A-W, 2018, 'Treatment for Lentigo Maligna of the Head and Neck: Survey of Practices in Ontario, Canada.', Dermatol Surg, vol. 44, pp. 918 - 923, http://dx.doi.org/10.1097/DSS.0000000000001498

Parente DN; Bongers PJ; Verzijl R; Rotstein LE; Asa SL; Kluijfhout WP; Devon KM; Goldstein DP; Mete O; Pasternak JD, 2018, 'Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Trading Six for a Risky Half Dozen: Reply.', World J Surg, vol. 42, pp. 2279, http://dx.doi.org/10.1007/s00268-018-4505-1

Sampson L; Papadakos J; Milne V; Le LW; Liu G; Abdelmutti N; Milne R; Goldstein DP; Eng L; Giuliani M, 2018, 'Preferences for the Provision of Smoking Cessation Education Among Cancer Patients.', J Cancer Educ, vol. 33, pp. 7 - 11, http://dx.doi.org/10.1007/s13187-016-1035-0

Eng L; Liu S; Farzanfar D; Alton D; Smith E; Mccartney A; Yeung S; Basgaran A; Balaratnam K; Mattina K; Harper C; Mohan R; Brown MC; Hope A; Bradbury P; Sacher A; Leighl N; Shepherd F; Bezjak A; Howell D; Jones J; Xu W; Goldstein D; Evans W; Selby P; Giuliani M; Liu G, 2018, 'MA18.07 Awareness of the Harms of Continued Smoking Among Lung Cancer (LC) Survivors', Journal of Thoracic Oncology, vol. 13, pp. S420 - S420, http://dx.doi.org/10.1016/j.jtho.2018.08.470

Horowitz G; Hosni A; Yu E; Xu W; Lu L; Au M; Dixon PR; Brown D; Chepeha DB; Gilbert RW; Goldstein DP; Gullane PJ; Irish JC; Bayley A; Cho J; Giuliani M; Huang SH; Hope A; Kim J; O'Sullivan B; Ringash J; Waldron J; Weinreb I; Perez-Ordonez B; Bratman SV; de Almeida JR, 2018, 'Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma.', Oral Oncol, vol. 82, pp. 162 - 167, http://dx.doi.org/10.1016/j.oraloncology.2018.05.023

McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, vol. 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y

Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ, 2017, 'Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, vol. 17, pp. 951 - 964, http://dx.doi.org/10.1080/14737140.2017.1369882

Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2017, 'Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review', Asia-Pacific Journal of Clinical Oncology, vol. 13, pp. e291 - e297, http://dx.doi.org/10.1111/ajco.12638

Lim BT; Butow P; Mills J; Miller A; Goldstein D, 2017, 'Information needs of the Chinese community affected by cancer: A systematic review', Psycho-Oncology, vol. 26, pp. 1433 - 1443, http://dx.doi.org/10.1002/pon.4347

Hyatt A; Lipson-Smith R; Schofield P; Gough K; Sze M; Aldridge L; Goldstein D; Jefford M; Bell ML; Butow P, 2017, 'Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients', Health Expectations, vol. 20, pp. 886 - 895, http://dx.doi.org/10.1111/hex.12529

Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Kissane D; Hale S; Perry A; Aranda SK; Goldstein D, 2017, 'Perspectives of oncology nurses and oncologists regarding barriers to working with patients from a minority background: systemic issues and working with interpreters.', European Journal of Cancer Care, vol. 27, pp. e12758, http://dx.doi.org/10.1111/ecc.12758

Cubillo Gracian A; Dean A; Munoz A; Hidalgo M; Pazo-Cid R; Martin M; Macarulla Mercade T; Lipton L; Harris M; Manzano-Mozo JL; Maurel J; Guillen-Ponce C; Tebbutt N; Cooray P; Sohal D; Zalupski M; Kolevska T; Stagg R; Goldstein D, 2017, 'YOSEMITE: A 3 arm double-blind randomized phase 2 study of gemcitabine, paclitaxel protein-bound particles for injectable suspension, and placebo (GAP) versus gemcitabine, paclitaxel protein-bound particles for injectable suspension and either 1 or 2 truncated courses of demcizumab (GAD)', ANNALS OF ONCOLOGY, vol. 28, http://dx.doi.org/10.1093/annonc/mdx369.004

Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, vol. 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009

Yang JL; Gupta RD; Goldstein D; Crowe PJ, 2017, 'Significance of phosphorylated epidermal growth factor receptor and its signal transducers in human soft tissue sarcoma', International Journal of Molecular Sciences, vol. 18, http://dx.doi.org/10.3390/ijms18061159

Pang TCY; Xu Z; Pothula S; Becker T; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2017, 'Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research', Carcinogenesis, vol. 38, pp. 588 - 591, http://dx.doi.org/10.1093/carcin/bgx030

Goldstein D; Von Hoff D; Chiorean E; Reni M; Tabernero J; Ramanathan R; Wilkerson J; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis C; Renschler M; McGovern D; Lee C, 2017, 'Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 28, pp. iii142 - iii144, http://dx.doi.org/10.1093/annonc/mdx262.016

Sjoquist KM; Pavlakis N; Martin AJ; Tsobanis E; Yip S; Bang Y-J; Alcindor T; O'Callaghan CJ; Shitara K; Bekaii-Saab TS; Grothey A; Chen L-T; Simes J; Zalcberg JR; Goldstein D, 2017, 'Integrate II: A randomised phase 3 double-blind placebo-controlled study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC)—An international study organized by the Australasian Gastrointestinal Trials Group (AGITG).', Journal of Clinical Oncology, vol. 35, pp. TPS4136 - TPS4136, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps4136

Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; Van Houtte P; Bonnetain F; Louvet C; Hammel P; Huguet F, 2017, 'Neutrophil count and efficacy of chemoradiation in patients with locally advanced unresectable pancreatic carcinoma: An ancillary study of in the LAP 07 trial.', Journal of Clinical Oncology, vol. 35, pp. 4120 - 4120, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4120

Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Aly A; Botteman M; Wilkersen J; Margunato-Debay S; Lu B; Louis CU; Renschler MF; McGovern DMT; Lee CK, 2017, 'Nomogram for predicting overall survival (OS) in patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) or Gem alone for metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, vol. 35, pp. 4109 - 4109, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4109

Lee B; Cohen J; Lipton LR; Tie J; Javed AA; Li L; Goldstein D; Cooray P; Nagrial A; Burge ME; Tebbutt NC; Nikfarjam M; Harris M; O'Broin-Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2017, 'Potential role of circulating tumor DNA (ctDNA) in the early diagnosis and post-operative management of localised pancreatic cancer.', Journal of Clinical Oncology, vol. 35, pp. 4101 - 4101, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4101

Tie J; Cohen J; Wang Y; Li L; Kinde I; Elsaleh H; Wong R; Kosmider S; Yip D; Lee M; Tran B; Burge ME; Goldstein D; Singh MS; Diaz LA; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2017, 'The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC).', Journal of Clinical Oncology, vol. 35, pp. 3521 - 3521, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3521

McNamara MG; Bridgewater J; Lopes A; Wasan H; Malka D; Jensen LH; Okusaka T; Knox JJ; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; Valle JW, 2017, 'Systemic therapy in younger and elderly patients with advanced biliary cancer: Sub-analysis of ABC-02 and twelve other prospective trials', BMC Cancer, vol. 17, http://dx.doi.org/10.1186/s12885-017-3266-9

Yao CM; Ziai H; Tsang G; Copeland A; Brown D; Irish JC; Gilbert RW; Goldstein DP; Gullane PJ; de Almeida JR, 2017, 'Surgical site infections following oral cavity cancer resection and reconstruction is a risk factor for plate exposure.', J Otolaryngol Head Neck Surg, vol. 46, pp. 30, http://dx.doi.org/10.1186/s40463-017-0206-2

Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, vol. 54, pp. 74 - 84, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015

Lees JG; Makker PGS; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy', European Journal of Cancer, vol. 73, pp. 22 - 29, http://dx.doi.org/10.1016/j.ejca.2016.12.006

Janda M; Neale RE; Klein K; O'Connell DL; Gooden H; Goldstein D; Merrett ND; Wyld DK; Rowlands IJ; Beesley VL, 2017, 'Anxiety, depression and quality of life in people with pancreatic cancer and their carers', Pancreatology, vol. 17, pp. 321 - 327, http://dx.doi.org/10.1016/j.pan.2017.01.008

Goldstein D; Lemech C; Valle J, 2017, 'New molecular and immunotherapeutic approaches in biliary cancer', ESMO Open, vol. 2, http://dx.doi.org/10.1136/esmoopen-2016-000152

Doctor Z; Kessler R; Chen HY; Farr B; Finley DA; Foley RJ; Goldstein DA; Holz DE; Kim AG; Morganson E; Sako M; Scolnic D; Smith M; Soares-Santos M; Spinka H; Abbott TMC; Abdalla FB; Allam S; Annis J; Bechtol K; Benoit-Lévy A; Bertin E; Brooks D; Buckley-Geer E; Burke DL; Rosell AC; Kind MC; Carretero J; Cunha CE; D'Andrea CB; Costa LND; Depoy DL; Desai S; Diehl HT; Drlica-Wagner A; Eifler TF; Frieman J; García-Bellido J; Gaztanaga E; Gerdes DW; Gruendl RA; Gschwend J; Gutierrez G; James DJ; Krause E; Kuehn K; Kuropatkin N; Lahav O; Li TS; Lima M; Maia MAG; March M; Marshall JL; Menanteau F; Miquel R; Neilsen E; Nichol RC; Nord B; Plazas AA; Romer AK; Sanchez E; Scarpine V; Schubnell M; Sevilla-Noarbe I; Smith RC; Sobreira F; Suchyta E; Swanson MEC; Tarle G; Walker AR; Wester W, 2017, 'A Search for Kilonovae in the Dark Energy Survey', Astrophysical Journal, vol. 837, http://dx.doi.org/10.3847/1538-4357/aa5d09

Tie SS; Martini P; Mudd D; Ostrovski F; Reed SL; Lidman C; Kochanek C; Davis TM; Sharp R; Uddin S; King A; Wester W; Tucker BE; Tucker DL; Buckley-Geer E; Carollo D; Childress M; Glazebrook K; Hinton SR; Lewis G; Macaulay E; O'Neill CR; Abbott TMC; Abdalla FB; Annis J; Benoit-Lévy A; Bertin E; Brooks D; Carnero Rosell A; Carrasco Kind M; Carretero J; Cunha CE; Da Costa LN; Depoy DL; Desai S; Doel P; Eifler TF; Evrard AE; Finley DA; Flaugher B; Fosalba P; Frieman J; García-Bellido J; Gaztanaga E; Gerdes DW; Goldstein DA; Gruen D; Gruendl RA; Gutierrez G; Honscheid K; James DJ; Kuehn K; Kuropatkin N; Lima M; Maia MAG; Marshall JL; Menanteau F; Miller CJ; Miquel R; Nichol RC; Nord B; Ogando R; Plazas AA; Romer AK; Sanchez E; Santiago B; Scarpine V; Schubnell M; Sevilla-Noarbe I; Smith RC; Soares-Santos M; Sobreira F; Suchyta E; Swanson MEC; Tarle G; Thomas D; Walker AR, 2017, 'A Study of Quasar Selection in the Supernova Fields of the Dark Energy Survey', Astronomical Journal, vol. 153, http://dx.doi.org/10.3847/1538-3881/aa5b8d

Eng L; Alton D; Che J; Song Y; Su J; Farzanfar D; Mohan R; Krys O; Yoannidis T; Milne R; Brown MC; Vennettilli A; Hope AJ; Howell D; Jones JM; Selby P; Xu W; Goldstein DP; Giuliani ME; Liu G, 2017, 'Awareness among patients with cancer of the harms of continued smoking.', Journal of Clinical Oncology, vol. 35, pp. 179 - 179, http://dx.doi.org/10.1200/jco.2017.35.5_suppl.179

Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Goldstein D; Hale S; Perry A; Aranda SK; Kissane DW, 2017, 'Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals', European Journal of Oncology Nursing, vol. 26, pp. 83 - 90, http://dx.doi.org/10.1016/j.ejon.2016.12.001

Chan DL; Sjoquist KM; Goldstein D; Price TJ; Martin AJ; Bang YJ; Kang YK; Pavlakis N, 2017, 'The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0172307

Tang M; Chen J; Goldstein D; Links M; Lord S; Marschner I; Simes J; Lee CK, 2017, 'Correlation of phase 2 trials (Ph2t) results with outcomes of phase 3 trials (Ph3t) of investigational agents (IA) in locally advanced and metastatic pancreas cancer (LAMPC).', JOURNAL OF CLINICAL ONCOLOGY, vol. 35, http://dx.doi.org/10.1200/JCO.2017.35.4_suppl.227

Ritchie GE; Fernando M; Goldstein D, 2017, 'Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review', Cancer Chemotherapy and Pharmacology, vol. 79, http://dx.doi.org/10.1007/s00280-016-3123-6

Makker PGS; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0170814

Kunzmann V; Ramanathan RK; Goldstein D; Liu H; Ferrara S; Lu B; Renschler MF; Von Hoff DD, 2017, 'Tumor reduction in primary andmetastatic pancreatic cancer lesions with nab-paclitaxel and gemcitabine: An exploratory analysis from a phase 3 study', Pancreas, vol. 46, pp. 203 - 208, http://dx.doi.org/10.1097/MPA.0000000000000742

Sharbeen G; Youkhana J; Mawson A; McCarroll J; Nunez A; Biankin A; Johns A; Goldstein D; Phillips P, 2017, 'MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity', Oncotarget, vol. 8, pp. 9216 - 9229, http://dx.doi.org/10.18632/oncotarget.13985

Tang M; Goldstein D, 2017, 'The role of chemotherapy in gastric cancer-related microangiopathic haemolytic anaemia', Journal of Gastrointestinal Oncology, vol. 8, pp. E10 - E15, http://dx.doi.org/10.21037/jgo.2016.11.14

Pothula SP; Xu Z; Goldstein D; Merrett N; Pirola RC; Wilson JS; Apte MV, 2017, 'Targeting the HGF/c-MET pathway: Stromal remodelling in pancreatic cancer', Oncotarget, vol. 8, pp. 76722 - 76739, http://dx.doi.org/10.18632/oncotarget.20822

Vitale AT; Cunningham ET; Merrill PT; Goldstein DA; Dacey MS, 2017, 'OZURDEX^® (Dexamethasone Intravitreal Implant) 0.7 mg for Use in Noninfectious Posterior Segment Uveitis: A Case-Based Discussion', Retina, vol. 37, pp. 1 - 16, http://dx.doi.org/10.1097/01.IAE.0000521752.50140.80

van Rijssen LB; ter Veer E; Besselink MG; Mali RMA; Berlin J; Boeck S; Bonnetain F; Conroy T; Deplanque G; Goldstein D; Glimelius B; Neoptolemos JP; Reni M; Scheithauer W; van der Meer J; Wilmink JW; van der Poel MJ; Busch OR; van Oijen MGH; van Laarhoven HWM, 2017, 'COnsensus statement on mandatory measurements in PAncreatic cancer trials for systemic treatment of unresectable disease (COMM-PACT)', Annals of Oncology, vol. 28, pp. v255 - v255, http://dx.doi.org/10.1093/annonc/mdx369.129

Yu C; Saeed O; Goldberg A; Farooq S; Fazelzad R; Goldstein D; Tsang R; Brierley J; Ezzat S; Thabane L; Sawka A, 2017, 'Second Primary Malignancy Risk in Thyroid Cancer Survivors Treated with Radioactive Iodine: An Updated Systematic Review and Meta-analysis', Canadian Journal of Diabetes, vol. 41, pp. S41 - S49, http://dx.doi.org/10.1016/j.jcjd.2017.08.126

Eng L; Liu S; Zhang Q; Farzanfar D; Yeung S; Brown CM; Xu W; Howell D; Goldstein DP; Jones JM; Selby P; Giuliani ME; Liu G, 2017, 'Cancer patient interest and perceptions of lifestyle behavior programs', Annals of Oncology, vol. 28, pp. v558 - v559, http://dx.doi.org/10.1093/annonc/mdx388.046

Casali PG; Le Cesne A; Poveda A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson I; Italiano A; Gelderblom H; Penel N; Kopp H-G; Goldstein D; Broto JM; Gronchi A; Wardelmann E; Marreaud S; Zalcberg J; Litière S; Blay J-Y, 2017, 'Time to definitive failure to the first tyrosine kinase inhibitor in localized gastrointestinal stromal tumors (GIST) treated with imatinib as an adjuvant: Final results of the EORTC STBSG, AGITG, UNICANCER, FSG, ISG, and GEIS randomized trial', Annals of Oncology, vol. 28, pp. v645 - v645, http://dx.doi.org/10.1093/annonc/mdx440.070

Chiu K; Huang SH; Hosni A; Tong L; Xu W; Lu L; Bayley A; Bratman S; Cho J; Giuliani ME; Kim JH; Ringash JG; Waldron JN; Spreafico A; Irish J; Gilbert RW; Gullane P; Goldstein D; O'Sullivan B; Hope AJ, 2017, 'Outcomes of Oral Cavity Cancer Patients Treated with Definitive Radiation Therapy', International Journal of Radiation Oncology*Biology*Physics, vol. 99, pp. E330 - E331, http://dx.doi.org/10.1016/j.ijrobp.2017.06.1390

Chiu K; Huang SH; Hosni A; Tong L; Xu W; Lu L; Bayley A; Bratman S; Cho J; Giuliani ME; Kim JH; Ringash JG; Waldron JN; Spreafico A; Irish J; Gilbert RW; Gullane P; Goldstein D; O'Sullivan B; Hope AJ, 2017, 'Potential Impact of the 8th edition UICC/AJCC Staging in Oral Cavity Cancer Patients Treated With Surgery and Post-Operative Intensity Modulated Radiation Therapy', International Journal of Radiation Oncology*Biology*Physics, vol. 99, pp. E329 - E330, http://dx.doi.org/10.1016/j.ijrobp.2017.06.1389

Kwan JY; Su J; Huang SH; Xu W; Yip K; Giuliani ME; Bayley A; Kim JH; Hope AJ; Ringash JG; Cho J; McNiven AL; Hansen A; Goldstein D; Aerts H; Waldron JN; Haibe-Kains B; O'Sullivan B; Bratman SV; Liu FF, 2017, 'A Radiomic Prognostic Index Refines Risk Models for Distant Metastasis in HPV-Related Oropharyngeal Cancer', International Journal of Radiation Oncology*Biology*Physics, vol. 99, pp. E603 - E603, http://dx.doi.org/10.1016/j.ijrobp.2017.06.2053

Vulpe H; Kwan JYY; McNiven A; Brierley JD; Tsang R; Chan B; Goldstein DP; Le LW; Hope A; Giuliani M, 2017, 'Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy.', Curr Oncol, vol. 24, pp. e226 - e232, http://dx.doi.org/10.3747/co.24.3551

Tsang GFZ; Zhang H; Yao C; Kolarski M; Gullane PJ; Irish JC; Brown DH; Chepeha DB; Goldstein DP; Gilbert RW; de Almeida JR, 2017, 'Hardware complications in oromandibular defects: Comparing scapular and fibular based free flap reconstructions.', Oral Oncol, vol. 71, pp. 163 - 168, http://dx.doi.org/10.1016/j.oraloncology.2017.06.020

Eskander A; Mifsud M; Irish J; Gullane P; Gilbert R; Brown D; de Almeida JR; Urbach DR; Goldstein DP, 2017, 'Overview of surgery for laryngeal and hypopharyngeal cancer in Ontario, 2003-2010.', Head Neck, vol. 39, pp. 1559 - 1567, http://dx.doi.org/10.1002/hed.24787

Bernstein JM; Irish JC; Brown DH; Goldstein D; Chung P; Razak ARA; Catton C; Gilbert RW; Gullane PJ; O'Sullivan B, 2017, 'Survival outcomes for cutaneous angiosarcoma of the scalp versus face.', Head Neck, vol. 39, pp. 1205 - 1211, http://dx.doi.org/10.1002/hed.24747

Bernstein JM; Daly MJ; Chan H; Qiu J; Goldstein D; Muhanna N; de Almeida JR; Irish JC, 2017, 'Accuracy and reproducibility of virtual cutting guides and 3D-navigation for osteotomies of the mandible and maxilla.', PLoS One, vol. 12, pp. e0173111, http://dx.doi.org/10.1371/journal.pone.0173111

Lee DJ; Xu JJ; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Rotstein LE; Goldstein DP; de Almeida JR, 2017, 'Determining Patient Preferences for Indeterminate Thyroid Nodules: Observation, Surgery or Molecular Tests.', World J Surg, vol. 41, pp. 1513 - 1520, http://dx.doi.org/10.1007/s00268-017-3887-9

Black HA; Leighton DJ; Cleary EM; Rose E; Stephenson L; Colville S; Ross D; Warner J; Porteous M; Gorrie GH; Swingler R; Goldstein D; Harms MB; Connick P; Pal S; Aitman TJ; Chandran S, 2017, 'Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.', Neurobiol Aging, vol. 51, pp. 178.e11 - 178.e20, http://dx.doi.org/10.1016/j.neurobiolaging.2016.12.013

Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Van Houtte PJ; Bonnetain F; Glimelius B; Louvet C; Hammel P; Huguet F, 2017, 'Neutrophils Predicting Tumor Local Control After Chemoradiation Therapy in Locally Advanced Pancreatic Carcinoma in the LAP 07 Trial', International Journal of Radiation Oncology*Biology*Physics, vol. 99, pp. S88 - S89, http://dx.doi.org/10.1016/j.ijrobp.2017.06.213

Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR, 2016, 'Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.', JAMA Otolaryngol Head Neck Surg, vol. 142, pp. 1208 - 1215, http://dx.doi.org/10.1001/jamaoto.2016.3083

Burmeister EA; O’Connell DL; Jordan SJ; Goldstein D; Merrett N; Wyld DK; Beesley VL; Gooden HM; Janda M; Neale RE, 2016, 'Factors associated with quality of care for patients with pancreatic cancer in Australia', Medical Journal of Australia, vol. 205, pp. 459 - 465, http://dx.doi.org/10.5694/mja16.00567

Yang JL; Lim HJ; Wang X; Crowe PJ; Goldstein D, 2016, 'Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines', Anticancer research, vol. 36, pp. 5765 - 5772, http://dx.doi.org/10.21873/anticanres.11160

Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA, 2016, 'Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge', Cancer Treatment Reviews, vol. 50, pp. 118 - 128, http://dx.doi.org/10.1016/j.ctrv.2016.09.005

Vickers MM; Lee C; Tu D; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2016, 'Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3', Pancreatology, vol. 16, pp. 1106 - 1112, http://dx.doi.org/10.1016/j.pan.2016.08.013

Chiorean EG; Von Hoff DD; Tabernero J; El-Maraghi R; Wee Ma W; Reni M; Harris M; Whorf R; Liu H; Shiansong Li J; Manax V; Romano A; Lu B; Goldstein D, 2016, 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.', Br J Cancer, vol. 115, pp. e13, http://dx.doi.org/10.1038/bjc.2016.306

Mohan R; Alton D; Su J; Song Y; Farzanfar D; Krys O; Yoannidis T; Milne R; Brown MC; Hope AJ; Howell D; Jones JM; Selby P; Xu W; Goldstein DP; Giuliani ME; Liu G; Eng L, 2016, 'Differences in perceptions of smoking and second-hand smoke (SHS) in palliative and nonpalliative patients with cancer.', Journal of Clinical Oncology, vol. 34, pp. 251 - 251, http://dx.doi.org/10.1200/jco.2016.34.26_suppl.251

Huguet F; Goldstein D; Hammel P, 2016, 'Radiation therapy deviations in trial of locally advanced pancreatic cancer: In Reply', JAMA - Journal of the American Medical Association, vol. 316, pp. 1409 - 1410, http://dx.doi.org/10.1001/jama.2016.9781

de Souza P; Chua W; Clarke S; Goldstein D; Lee C, 2016, 'Inflammatory Markers Have a Role in Renal Cell Carcinoma Prognosis', European Urology Focus, vol. 2, pp. 341 - 342, http://dx.doi.org/10.1016/j.euf.2016.04.007

Gormly KL; Coscia C; Wells T; Tebbutt N; Harvey JA; Wilson K; Schmoll HJ; Price T; Price T; Hruby G; Jeffery M; Karapetis C; Ng W; Singhal N; Burge M; Lynch R; Briscoe K; Begbie S; Gill S; Sebesan S; Goldstein D; Ng S; Asghari R; Blum R; Walpole E; Byard I, 2016, 'MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial', Journal of Medical Imaging and Radiation Oncology, vol. 60, pp. 607 - 615, http://dx.doi.org/10.1111/1754-9485.12493

Wang X; Goldstein D; Crowe PJ; Yang JL, 2016, 'Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: A review of the evidence', OncoTargets and Therapy, vol. 9, pp. 5461 - 5473, http://dx.doi.org/10.2147/OTT.S94745

Burmeister EA; Waterhouse M; Jordan SJ; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Beesley V; Gooden H; Janda M; Neale RE, 2016, 'Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study', Pancreatology, vol. 16, pp. 873 - 881, http://dx.doi.org/10.1016/j.pan.2016.06.010

Pavlakis N; Sjoquist KM; Martin AJ; Tsobanis E; Yip S; Kang YK; Bang YJ; Alcindor T; O'Callaghan CJ; Burnell MJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Wong M; Strickland A; Kim JW; Zalcberg JR; Simes J; Goldstein D, 2016, 'Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial', Journal of Clinical Oncology, vol. 34, pp. 2728 - 2735, http://dx.doi.org/10.1200/JCO.2015.65.1901

Beesley VL; Wockner LF; O’Rourke P; Janda M; Goldstein D; Gooden H; Merrett ND; O’Connell DL; Rowlands IJ; Wyld DK; Neale RE, 2016, 'Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study', Supportive Care in Cancer, vol. 24, pp. 3589 - 3599, http://dx.doi.org/10.1007/s00520-016-3212-4

Beesley V; Wockner L; O'Rourke P; Janda M; Merrett H; Goldstein D; Gooden H; Merrett N; O'Connell D; Rowlands I; Wyld D; Neale R, 2016, 'Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (Support Care Cancer, 10.1007/s00520-016-3212-4)', Supportive Care in Cancer, vol. 24, pp. 3601 - 3602, http://dx.doi.org/10.1007/s00520-016-3251-x

Waterhouse MA; Burmeister EA; O’Connell DL; Ballard EL; Jordan SJ; Merrett ND; Goldstein D; Wyld D; Janda M; Beesley VL; Payne ME; Gooden HM; Neale RE, 2016, 'Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study', Journal of Gastrointestinal Surgery, vol. 20, pp. 1471 - 1481, http://dx.doi.org/10.1007/s11605-016-3157-4

Ferraro D; Goldstein D; O'Connell RL; Zalcberg JR; Sjoquist KM; Tebbutt NC; Grimison P; McLachlan S; Lipton LL; Vasey P; Gebski VJ; Aiken C; Cronk M; Ng S; Karapetis CS; Shannon J; Do V; Marschner I; Friedlander M; Gurney H; Simes J; Hague W; O’Connell R; Gorzeman M; Pike R; Miranda K; Waring P; Lau D; Fox S; Liu Y; Wood T; Cocks C; Simmons K; McCourt J; Jefford M; Hobinchet A; Mirco B; Sagong J; Dudukovic S; Aghmesheh M; Parker S; Segelov E; Ratnayake L; Ranieri N; Varma S; Page J; Heyer E; Abdi E; Chorlton C; Wilkinson L; Marshall I, 2016, 'TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer', Cancer Chemotherapy and Pharmacology, vol. 78, pp. 361 - 367, http://dx.doi.org/10.1007/s00280-016-3089-4

Fox AR; Gordon LK; Heckenlively JR; Davis JL; Goldstein DA; Lowder CY; Nussenblatt RB; Butler NJ; Dalal M; Jayasundera T; Smith WM; Lee RW; Adamus G; Chan CC; Hooks JJ; Morgans CW; Detrick B; Sen HN, 2016, 'Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach', American Journal of Ophthalmology, vol. 168, pp. 183 - 190, http://dx.doi.org/10.1016/j.ajo.2016.05.013

Jampol LM; Goldstein DA, 2016, 'Zika Virus, Microcephaly, and Ocular Findings-Reply.', JAMA Ophthalmol, vol. 134, pp. 946, http://dx.doi.org/10.1001/jamaophthalmol.2016.1307

Vernerey D; Huguet F; Vienot A; Goldstein D; Paget-Bailly S; Van Laethem JL; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Benetkiewicz M; Louvet C; Hammel P; Bonnetain F, 2016, 'Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)', British Journal of Cancer, vol. 115, pp. 281 - 289, http://dx.doi.org/10.1038/bjc.2016.212

Chiorean EG; Von Hoff DD; Tabernero J; El-Maraghi R; Ma WW; Reni M; Harris M; Whorf R; Liu H; Li JS; Manax V; Romano A; Lu B; Goldstein D, 2016, 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer', British Journal of Cancer, vol. 115, pp. 188 - 194, http://dx.doi.org/10.1038/bjc.2016.185

Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: The AGITG Pancreatic Cancer Workshop consensus', Medical Journal of Australia, vol. 204, pp. 419 - 422.e1, http://dx.doi.org/10.5694/mja16.00061

Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus', MEDICAL JOURNAL OF AUSTRALIA, vol. 204, pp. 419 - +, http://dx.doi.org/10.5694/mja16.00061

Shaw JM; Shepherd HL; Durcinoska I; Butow PN; Liauw W; Goldstein D; Young JM, 2016, 'It’s all good on the surface: care coordination experiences of migrant cancer patients in Australia', Supportive Care in Cancer, vol. 24, pp. 2403 - 2410, http://dx.doi.org/10.1007/s00520-015-3043-8

Burmeister EA; Jordan SJ; O’Connell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Merrett ND; Wyld D; Neale RE; Cosman PH; Bullen A; Burge M; Eastgate M; Powell J; Deuble M; Pryor D; Whelan J; Algie L; Gupta S; Lynch SV; Burmeister BH; Slater K; Fletcher D; Van Hazel G; Raftopoulos S; Spry N; Agar M; Brecciaroli F; Caird S; Cameron D; Chan P; Chantrill L; Christie D; Chua YJ; Croese J; Cronk M; Gani J; Grimison P; Hruby G; Jefford M; Samra JS; Wysocki AP, 2016, 'Using a Delphi process to determine optimal care for patients with pancreatic cancer', Asia-Pacific Journal of Clinical Oncology, vol. 12, pp. 105 - 114, http://dx.doi.org/10.1111/ajco.12450

Scheithauer W; Ramanathan RK; Moore M; Macarulla T; Goldstein D; Hammel P; Kunzmann V; Liu H; McGovern D; Romano A; Von Hoff DD, 2016, 'Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: Phase III MPACT trial', Journal of Gastrointestinal Oncology, vol. 7, pp. 469 - 478, http://dx.doi.org/10.21037/jgo.2016.01.03

Barbour A; O'Rourke N; Chan H; Chua YJ; Kench J; Hicks RJ; Samra JS; Pavlakis N; Haghighi KS; Yip S; Donoghoe M; Friend C; Burge ME; Fawcett J; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2016, 'Initial survival outcomes for the AGITG GAP study - a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)', JOURNAL OF CLINICAL ONCOLOGY, vol. 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.4105

Hammel P; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Borbath I; Bouché O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2016, 'Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial', JAMA - Journal of the American Medical Association, vol. 315, pp. 1844 - 1853, http://dx.doi.org/10.1001/jama.2016.4324

He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study', ONCOLOGIST, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

Chiorean EG; Von Hoff DD; Reni M; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; McGovern D; Lu B; Ko A, 2016, 'CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Annals of Oncology, vol. 27, pp. 654 - 660, http://dx.doi.org/10.1093/annonc/mdw006

Ramanathan RK; Goldstein D; Korn RL; Arena F; Moore M; Siena S; Teixeira L; Tabernero J; Van Laethem JL; Liu H; McGovern D; Lu B; Von Hoff DD, 2016, 'Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas', Annals of Oncology, vol. 27, pp. 648 - 653, http://dx.doi.org/10.1093/annonc/mdw020

He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

Yao C; Kahane A; Goldstein D; Zadeh G; De Almeida J, 2016, 'Preferences and Utilities for Health States after Treatment of Olfactory Groove Meningioma: Endoscopic vs Open', Journal of Neurological Surgery Part B: Skull Base, vol. 77, http://dx.doi.org/10.1055/s-0036-1580033

Ma A; Daly M; Qiu J; Chan H; Goldstein D; Irish J; De Almeida J, 2016, 'Intraoperative Image Guidance in Transoral Robotic Surgery – A Pilot Study', Journal of Neurological Surgery Part B: Skull Base, vol. 77, http://dx.doi.org/10.1055/s-0036-1579938

McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B; MacKay J; Ngan SY, 2016, 'The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)', European Journal of Cancer, vol. 55, pp. 15 - 26, http://dx.doi.org/10.1016/j.ejca.2015.10.060

Chantrill L; Goldstein D, 2016, 'Pancreatic cancer', Cancer Forum, vol. 40, pp. 3 - 5

Wang X; Goldstein D; Crowe P; Yang M; Garrett K; Zeps N; Yang JL, 2016, 'Overcoming resistance of targeted egfr monotherapy by inhibition of stat3 escape pathway in soft tisue sarcoma', Oncotarget, vol. 7, pp. 21496 - 21509, http://dx.doi.org/10.18632/oncotarget.7452

Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV, 2016, 'Hepatocyte growth factor inhibition: A novel therapeutic approach in pancreatic cancer', British Journal of Cancer, vol. 114, pp. 269 - 280, http://dx.doi.org/10.1038/bjc.2015.478

Goldstein D; Chiorean EG; Tabernero J; El-Maraghi RH; Ma WW; Reni M; Harris M; Whorf RC; Coughlin S; Li J; Manax VG; Lu BD; Romano A; Von Hoff DD, 2016, 'Outcome of second-line treatment (2L Tx) following nab-paclitaxel (nab-P) + gemcitabine (G) or G alone for metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, vol. 34, pp. 333 - 333, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.333

Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im SA; Gupta S; Kang YK; Schöffski P; Schuette J; Soulières D; Blay JY; Goldstein D; Fly K; Huang X; Corsaro M; Lechuga MJ; Martini JF; Heinrich MC, 2016, 'Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial', BMC Cancer, vol. 16, http://dx.doi.org/10.1186/s12885-016-2051-5

Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2016, 'Key role of pancreatic stellate cells in pancreatic cancer', Cancer Letters, vol. 381, pp. 194 - 200, http://dx.doi.org/10.1016/j.canlet.2015.10.035

Goldstein D; Von Hoff DD; Moore M; Greeno E; Tortora G; Ramanathan RK; Macarulla T; Liu H; Pilot R; Ferrara S; Lu B, 2016, 'Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)', European Journal of Cancer, vol. 52, pp. 85 - 91, http://dx.doi.org/10.1016/j.ejca.2015.10.017

O’Callaghan C; Schofield P; Butow P; Nolte L; Price M; Tsintziras S; Sze M; Thein T; Yiu D; Mireskandari S; Goldstein D; Jefford M, 2016, '“I might not have cancer if you didn’t mention it”: a qualitative study on information needed by culturally diverse cancer survivors', Supportive Care in Cancer, vol. 24, pp. 409 - 418, http://dx.doi.org/10.1007/s00520-015-2811-9

Goldstein D; Rosenberg JE; Figlin RA; Townsend RR; McCann L; Carpenter C; Pandite L, 2016, 'Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?', European Journal of Cancer, vol. 53, pp. 96 - 104, http://dx.doi.org/10.1016/j.ejca.2015.10.006

Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; McNamara MG; Valle JW, 2016, 'Prognostic factors for progression-free and overall survival in advanced biliary tract cancer', Annals of Oncology, vol. 27, pp. 134 - 140, http://dx.doi.org/10.1093/annonc/mdv483

Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA, 2016, 'Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids', Neoplasia (United States), vol. 18, pp. 753 - 764, http://dx.doi.org/10.1016/j.neo.2016.10.011

Beesley VL; Janda M; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Rowlands IJ; Wyld D; Neale RE, 2016, 'A tsunami of unmet needs: Pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services', Psycho-Oncology, vol. 25, pp. 150 - 157, http://dx.doi.org/10.1002/pon.3887

McCarroll JA; Teo J; Boyer C; Youkhana J; Sagnella S; Duong H; Sharbeen G; Goldstein D; Davis T; Kavallaris M; Phillips P; Liu J, 2016, 'A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo.', Biomacromolecules, vol. 17, pp. 2337 - 2351, http://dx.doi.org/10.1021/acs.biomac.6b00185

Sharbeen G; Youkhana J; McCarroll J; Akerman A; Goldstein D; Phillips P, 2016, 'MutY-Homolog modulates pancreatic cancer cell survival and chemoresistance', Pancreatology, vol. 16, pp. S5 - S5, http://dx.doi.org/10.1016/j.pan.2016.05.024

Oar AJ; Wong W; Chen C; Haghighi KS; Thompson S; Goldstein D, 2016, 'Stereotactic body hypofractionated radiotherapy for inoperable pancreatic cancer, with or without metastases', HPB, vol. 18, pp. e359 - e359, http://dx.doi.org/10.1016/j.hpb.2016.02.932

Huang SHS; Bratman SV; Su J; Tong L; Kim J; Waldron J; Hansen A; Goldstein D; Bayley A; Cho J; Giuliani M; Hope A; Ringash J; Xu W; O'Sullivan B, 2016, '99: Prognostic Value of Pre-Treatment Serum Lactate Dehydrogenase in HPV-Related and HPV-Unrelated Oropharyngeal Cancer', Radiotherapy and Oncology, vol. 120, pp. S38 - S39, http://dx.doi.org/10.1016/s0167-8140(16)33498-3

Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME, 2016, 'Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.', Head Neck, vol. 38 Suppl 1, pp. E1102 - E1109, http://dx.doi.org/10.1002/hed.24166

Vulpe H; Kwan J; McNiven A; Brierley J; Tsang R; Chan B; Goldstein D; Le L; Hope A; Giuliani M, 2016, '220: Patterns of Recurrence After External Beam Radiotherapy for Anaplastic And Differentiated Thyroid Carcinoma', Radiotherapy and Oncology, vol. 120, pp. S80 - S80, http://dx.doi.org/10.1016/s0167-8140(16)33619-2

Sampson L; Papadakos J; Milne V; Le L; Liu G; Abdelmutti N; Milne R; Goldstein D; Eng L; Giuliani M, 2016, '7: Preferences for the Provision of Smoking Cessation Education Among Cancer Patients', Radiotherapy and Oncology, vol. 120, pp. S3 - S3, http://dx.doi.org/10.1016/s0167-8140(16)33406-5

Wang JR; Habbous S; Espin-Garcia O; Chen D; Huang SH; Simpson C; Xu W; Liu F-F; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Goldstein DP; Liu G, 2016, 'Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.', Head Neck, vol. 38, pp. 736 - 742, http://dx.doi.org/10.1002/hed.23947

Sawka AM; Ezzat S; Goldstein DP, 2016, 'Exploring the Life Impact of Treated Low-Risk Thyroid Cancer.', Endocr Pract, vol. 22, pp. 513 - 514, http://dx.doi.org/10.4158/1934-2403-22.4.513

Givi B; Eskander A; Awad MI; Kong Q; Montero PH; Palmer FL; Xu W; De Almeida JR; Lee N; O'Sullivan B; Irish JC; Gilbert R; Ganly I; Patel SG; Goldstein DP; Morris LGT, 2016, 'Impact of elective neck dissection on the outcome of oral squamous cell carcinomas arising in the maxillary alveolus and hard palate.', Head Neck, vol. 38 Suppl 1, pp. E1688 - E1694, http://dx.doi.org/10.1002/hed.24302

Fu TS; Monteiro E; Muhanna N; Goldstein DP; de Almeida JR, 2016, 'Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: A systematic review and individual participant data meta-analysis.', Head Neck, vol. 38 Suppl 1, pp. E2306 - E2316, http://dx.doi.org/10.1002/hed.24233

Eskander A; Goldstein DP; Irish JC, 2016, 'Health Services Research and Regionalization of Care-From Policy to Practice: the Ontario Experience in Head and Neck Cancer.', Curr Oncol Rep, vol. 18, pp. 19, http://dx.doi.org/10.1007/s11912-016-0500-6

Rishi A; Huang SH; Song Y; Waldron J; O’Sullivan B; Wells W; Ringash J; Sun A; Hope A; Chung P; Giuliani M; Goldstein D; Spreafico A; Tong L; Xu W; Bayley A, 2016, '93: Outcome of Radiotherapy for Aggressive forms of Basal Cell Carcinoma of the Head and Neck', Radiotherapy and Oncology, vol. 120, pp. S36 - S36, http://dx.doi.org/10.1016/s0167-8140(16)33492-2

de Almeida JR; Moskowitz AJ; Miles BA; Goldstein DP; Teng MS; Sikora AG; Gupta V; Posner M; Genden EM, 2016, 'Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis.', Head Neck, vol. 38, pp. 589 - 600, http://dx.doi.org/10.1002/hed.23930

Rathod S; Huang SH; Su J; Kim J; Waldron J; Bayley A; Cho J; Giuliani M; Hope A; Ringash J; Hansen A; Goldstein D; Tong L; Xu W; O'Sullivan B, 2016, '23: Impact of Tumour Volume and the Surrogate Effect of Lymph Node Location on the Risk of Distant Metastasis in Nasopharyngeal Cancer', Radiotherapy and Oncology, vol. 120, pp. S9 - S9, http://dx.doi.org/10.1016/s0167-8140(16)33422-3

Lee S; Cabanero M; Hyrcza M; Butler M; Liu F-F; Hansen A; Huang SH; Tsao M; Song Y; Xu W; Goldstein D; Weinreb I; Bratman S, 2016, '29: Computer-Assisted Image Analysis of an Oral Cavity Squamous Cell Carcinoma Tissue Microarray', Radiotherapy and Oncology, vol. 120, pp. S11 - S11, http://dx.doi.org/10.1016/s0167-8140(16)33428-4

Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; Van Der Graaf WTA; Zalcberg JR; Litière S; Blay JY, 2015, 'Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas', Journal of Clinical Oncology, vol. 33, pp. 4276 - 4283, http://dx.doi.org/10.1200/JCO.2015.62.4304

Donskov F; Michaelson MD; Puzanov I; Davis MP; Bjarnason GA; Motzer RJ; Goldstein D; Lin X; Cohen DP; Wiltshire R; Rini BI, 2015, 'Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients', British Journal of Cancer, vol. 113, pp. 1571 - 1580, http://dx.doi.org/10.1038/bjc.2015.368

Kessler R; Marriner J; Childress M; Covarrubias R; D'Andrea CB; Finley DA; Fischer J; Foley RJ; Goldstein D; Gupta RR; Kuehn K; Marcha M; Nichol RC; Papadopoulos A; Sako M; Scolnic D; Smith M; Sullivan M; Wester W; Yuan F; Abbott T; Abdalla FB; Allam S; Benoit-Levy A; Bernstein GM; Bertin E; Brooks D; Rosell AC; Kind MC; Castander FJ; Crocce M; Da Costa LN; Desai S; Diehl HT; Eifler TF; Neto AF; Flaugher B; Frieman J; Gerdes DW; Gruen D; Gruendl RA; Honscheid K; James DJ; Kuropatkin N; Li TS; Maia MAG; Marshall JL; Martini P; Miller CJ; Miquel R; Nord B; Ogando R; Plazas AA; Reil K; Romer AK; Roodman A; Sanchez E; Sevilla-Noarbe I; Smith RC; Soares-Santos M; Sobreira F; Tarle G; Thaler J; Thomas RC; Tucker D; Walker AR, 2015, 'THE DIFFERENCE IMAGING PIPELINE FOR THE TRANSIENT SEARCH IN THE DARK ENERGY SURVEY', ASTRONOMICAL JOURNAL, vol. 150, http://dx.doi.org/10.1088/0004-6256/150/6/172

Foreman A; de Almeida JR; Gilbert R; Goldstein DP, 2015, 'The Allen's test: revisiting the importance of bidirectional testing to determine candidacy and design of radial forearm free flap harvest in the era of trans radial endovascular access procedures.', J Otolaryngol Head Neck Surg, vol. 44, pp. 47, http://dx.doi.org/10.1186/s40463-015-0096-0

Chandrasegaram MD; Goldstein D; Simes J; Gebski V; Kench JG; Gill AJ; Samra JS; Merrett ND; Richardson AJ; Barbour AP; Fawcett J; Grimison PS; Christophi C; Padbury R; Haghighi KS; Chen JW; Nikfarjam M; O'Rourke N; Spry N, 2015, 'Meta-analysis of radical resection rates and margin assessment in pancreatic cancer', British Journal of Surgery, vol. 102, pp. 1459 - 1472, http://dx.doi.org/10.1002/bjs.9892

Erovic BM; Shah MD; Bruch G; Johnston M; Kim J; O'Sullivan B; Perez-Ordonez B; Weinreb I; Atenafu EG; de Almeida JR; Gullane PJ; Brown D; Gilbert RW; Irish JC; Goldstein DP, 2015, 'Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis.', J Otolaryngol Head Neck Surg, vol. 44, pp. 43, http://dx.doi.org/10.1186/s40463-015-0097-z

Sawka AM; Straus S; Rodin G; Heus L; Brierley JD; Tsang RW; Rotstein L; Ezzat S; Segal P; Gafni A; Thorpe KE; Goldstein DP, 2015, 'Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.', Cancer, vol. 121, pp. 3717 - 3726, http://dx.doi.org/10.1002/cncr.29548

Goldstein D; Fawcett J; Bridgewater J; Choti M; Wilson K; Gebski V; Aiken C; Eminton Z; Falk S; Stanton L; Primrose J, 2015, 'Feasibility of trials to assess safety and toxicity of peri-operative and post-operative adjuvant therapy for hepatic metastases from colorectal cancer', EUROPEAN JOURNAL OF CANCER, vol. 51, pp. S343 - S343, http://dx.doi.org/10.1016/S0959-8049(16)30967-4

Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial', BMC Cancer, vol. 15, http://dx.doi.org/10.1186/s12885-015-1498-0

Jaeger U; Trneny M; Melzer H; Praxmarer M; Nawarawong W; Yehuda DB; Goldstein D; Mihaljevic B; Ilhan O; Ballova V; Hedenus M; Hsiao LT; Au WY; Burgstaller S; Weidinger G; Keil F; Dittrich C; Skrabs C; Klingler A; Chott A; Fridrik MA; Greil R, 2015, 'Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: Results of the randomized NHL13 trial', Haematologica, vol. 100, pp. 955 - 963, http://dx.doi.org/10.3324/haematol.2015.125344

Apte MV; Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS, 2015, 'Pancreatic cancer: The microenvironment needs attention too!', Pancreatology, vol. 15, pp. S32 - S38, http://dx.doi.org/10.1016/j.pan.2015.02.013

Grewal DS; Goldstein DA; Khatana AK; Tanna AP, 2015, 'Bilateral Angle Closure Following Use of a Weight Loss Combination Agent Containing Topiramate', Journal of Glaucoma, vol. 24, pp. e132 - e136, http://dx.doi.org/10.1097/IJG.0000000000000157

Davis ID; Long A; Yip S; Espinoza D; Thompson JF; Kichenadasse G; Harrison M; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro J; Harvie R; Jovanovic L; Hudson AL; Nelson CC; Stockler MR; Martin A, 2015, 'EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma', Annals of Oncology, vol. 26, pp. 1118 - 1123, http://dx.doi.org/10.1093/annonc/mdv078

Mason M; Giuliani M; Huang SH; Xu W; Hope A; Kim J; Bayley A; Cho BCJ; Goldstein D; Jang RW; Ordonez BP; Wajstaub S; Waldron J; Dinniwell R; O'Sullivan B; Ringash J, 2015, 'Extra-pulmonary small cell carcinoma in the head and neck setting: The role of prophylactic cranial irradiation', ORAL ONCOLOGY, vol. 51, pp. E57 - E59, http://dx.doi.org/10.1016/j.oraloncology.2015.03.014

Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, vol. 33, pp. 9571 - 9571, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9571

Pantaleo MA; Lolli C; Nannini M; Astolfi A; Indio V; Saponara M; Urbini M; La Rovere S; Gill A; Goldstein D; Ceccarelli C; Santini D; Rossi G; Fiorentino M; Di Scioscio V; Fusaroli P; Mandrioli A; Gatto L; Catena F; Basso U; Ercolani G; Pinna AD; Biasco G, 2015, 'Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations', Genetics in Medicine, vol. 17, pp. 391 - 395, http://dx.doi.org/10.1038/gim.2014.115

Tebbutt N; Kotasek D; Burris HA; Schwartzberg LS; Hurwitz H; Stephenson J; Warner DJ; Chen L; Hsu CP; Goldstein D, 2015, 'Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, vol. 75, pp. 993 - 1004, http://dx.doi.org/10.1007/s00280-015-2694-y

Malalis JF; Goldstein DA, 2015, 'Advances in tuberculosisassociated uveitis', International Ophthalmology Clinics, vol. 55, pp. 37 - 46, http://dx.doi.org/10.1097/IIO.0000000000000065

Sharbeen G; McCarroll J; Goldstein D; Phillips PA, 2015, 'Exploiting Base Excision Repair to Improve Therapeutic Approaches for Pancreatic Cancer', Frontiers in Nutrition, vol. 2, pp. 10, http://dx.doi.org/10.3389/fnut.2015.00010

Sze M; Butow P; Bell M; Vaccaro L; Dong S; Eisenbruch M; Jefford M; Girgis A; King M; McGrane J; Ng W; Asghari R; Parente P; Liauw W; Goldstein D; Psycho-oncology Co-operative Research Group Culturally and Linguistically Diverse (CALD) TEAM , 2015, 'Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables', Oncologist, vol. 20, pp. 523 - 531, http://dx.doi.org/10.1634/theoncologist.2014-0274

Chan DL; Goldstein D; Zalcberg JR, 2015, 'Neuroendocrine tumours - Models for rare tumour management', Cancer Forum, vol. 39, pp. 13 - 16

Murphy C; Sabesan S; Steer C; Yates P; Booms A; Jones V; Simpson A; Clarke K; Eek R; Ashley D; Goldstein D; Packer C; Tuthill F; Boyce A; Underhill C, 2015, 'Oncology service initiatives and research in regional Australia', Australian Journal of Rural Health, vol. 23, pp. 40 - 48, http://dx.doi.org/10.1111/ajr.12173

Goldstein D; El-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L; Tortora G; Van Laethem JL; Young R; Penenberg DN; Lu B; Romano A; Von Hoff DD, 2015, 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: Long-term survival from a phase III trial', Journal of the National Cancer Institute, vol. 107, http://dx.doi.org/10.1093/jnci/dju413

Wang X; Batty KM; Crowe PJ; Goldstein D; Yang JL, 2015, 'The Potential of panHER Inhibition in Cancer', Frontiers in Oncology, vol. 5, http://dx.doi.org/10.3389/fonc.2015.00002

Pavlakis N; Sjoquist KM; Tsobanis E; Martin A; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Wong M; Kim JW; Simes J; Zalcberg JR; Goldstein D, 2015, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG), first results', JOURNAL OF CLINICAL ONCOLOGY, vol. 33, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.9

Kunzmann V; Ramanathan RK; Goldstein D; Penenberg DN; Ferrara S; Lu B; Von Hoff DD, 2015, 'Tumor reduction in pancreatic versus metastatic sites in a randomized phase III study (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.', Journal of Clinical Oncology, vol. 33, pp. 382 - 382, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.382

Vernerey D; Hammel P; Paget-Bailly S; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Louvet C; Bonnetain F, 2015, 'Prognosis model for overall survival in locally advanced unresecable pancreatic carcinoma: An ancillary study of the LAP 07 trial.', Journal of Clinical Oncology, vol. 33, pp. 235 - 235, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.235

Tabernero J; Gabrielachiorean E; Infante JR; Hingorani SR; Ganju V; Weekes C; Scheithauer W; Ramanathan RK; Goldstein D; Penenberg DN; Romano A; Ferrara S; Von Hoff DD, 2015, 'Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Oncologist, vol. 20, pp. 143 - 150, http://dx.doi.org/10.1634/theoncologist.2014-0394

McCarroll JA; Sharbeen G; Liu J; Youkhana J; Goldstein D; McCarthy N; Limbri LF; Dischl D; Ceyhan GO; Erkan M; Johns AL; Biankin AV; Kavallaris M; Phillips PA, 2015, 'βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer', Oncotarget, vol. 6, pp. 2235 - 2249, http://dx.doi.org/10.18632/oncotarget.2946

Vajdic CM; Goldstein D, 2015, 'Cancer of unknown primary site', Australian Family Physician, vol. 44, pp. 640 - 643

Burmeister EA; O'Connell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Wyld D; Neale RE, 2015, 'Describing patterns of care in pancreatic cancer a population-based study', Pancreas, vol. 44, pp. 1259 - 1265, http://dx.doi.org/10.1097/MPA.0000000000000384

Pavlakis N; Sjoquist KM; Tsobanis E; Martin AJ; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Kim JW; Yip S; Simes J; Zalcberg JR; Goldstein D, 2015, 'LBA-06 INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib (REG) in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG): Final overall and subgroup results', Annals of Oncology, vol. 26, pp. iv119 - iv119, http://dx.doi.org/10.1093/annonc/mdv262.06

Burmeister E; Jordan S; O'Connell D; Beesley V; Goldstein D; Gooden H; Janda M; Merrett N; Wyld D; Neale R, 2015, 'Determinants of attempted resection for patients with non-metastatic pancreatic cancer', Pancreatology, vol. 15, pp. S84 - S85, http://dx.doi.org/10.1016/j.pan.2015.05.312

Neale R; Waterhouse M; Burmeister E; Ballard E; O'Connell D; Beesley V; Goldstein D; Gooden H; Janda M; Jordan S; Merrett N; Payne M; Wyld D, 2015, 'Determinants of outcomes following resection for pancreatic cancer – An Australian population-based study', Pancreatology, vol. 15, pp. S85 - S85, http://dx.doi.org/10.1016/j.pan.2015.05.313

Neale R; Burmeister E; O'Connell D; Beesley V; Goldstein D; Gooden H; Janda M; Jordan S; Merrett N; Payne M; Wyld D, 2015, 'Describing patterns of care in pancreatic cancer – A population-based study', Pancreatology, vol. 15, pp. S83 - S83, http://dx.doi.org/10.1016/j.pan.2015.05.306

Tempero M; Cardin D; Biankin AV; Goldstein D; Moore M; O'Reilly E; Philip P; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'Tu1953 Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Resected Pancreatic Cancer in a Phase III Trial (APACT)', Gastroenterology, vol. 148, pp. S - 944, http://dx.doi.org/10.1016/s0016-5085(15)33220-0

Tempero M; Cardin D; Biankin A; Goldstein D; Moore M; O'Reilly E; Philip P; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'P-185 Randomized phase III trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant therapy for patients with resected pancreatic cancer: APACT', Annals of Oncology, vol. 26, pp. iv54 - iv54, http://dx.doi.org/10.1093/annonc/mdv233.185

Alhashemi A; Goldstein DP; Sawka AM, 2015, 'A Systematic Review of Primary Active Surveillance for Low Risk Papillary Thyroid Cancer', Canadian Journal of Diabetes, vol. 39, pp. 529 - 529, http://dx.doi.org/10.1016/j.jcjd.2015.09.016

Noel CW; Foreman A; Goldstein DP; de Almeida JR, 2015, 'Extent of neck dissection after transoral robotic surgical resection of oropharyngeal squamous cell carcinoma: Report of a case and potential indications for inclusion of level I in a selective neck dissection.', Head Neck, vol. 37, pp. E130 - E133, http://dx.doi.org/10.1002/hed.23935

Vernerey D; Goldstein D; Huguet F; Paget-Bailly S; Van Laethem J-L; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Louvet C; Hammel P; Bonnetain F, 2015, 'Prognostic score and nomogram to predict overall survival in locally advanced pancreatic cancer', Pancreatology, vol. 15, pp. S107 - S107, http://dx.doi.org/10.1016/j.pan.2015.05.383

Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff K-D; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG, 2015, 'Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.', Eur J Cancer, vol. 51, pp. 2768 - 2776, http://dx.doi.org/10.1016/j.ejca.2015.09.004

Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CSY; Krishnan AV; Lewis CR; Kiernan MC, 2014, 'Paclitaxel-induced neuropathy: Potential association of MAPT and GSK3B genotypes', BMC Cancer, vol. 14, http://dx.doi.org/10.1186/1471-2407-14-993

Jefford M; Nolte L; Tsintziras S; Butow P; Sze M; Yiu D; Schofield P; Goldstein D; Price M, 2014, 'HOW IS POST-TREATMENT SURVIVORSHIP CONCEPTUALISED BY PEOPLE FROM DIFFERENT CULTURAL GROUPS?', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 10, pp. 158 - 158, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700480&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, vol. 23, pp. 2819 - 2830, http://dx.doi.org/10.1007/s11136-014-0717-5

Wang X; Goldstein D; Crowe PJ; Yang JL, 2014, 'Impact of STAT3 inhibition on survival of osteosarcoma cell lines', Anticancer Research, vol. 34, pp. 6537 - 6545

McGrane J; Butow P; Sze M; Eisenbruch M; Goldstein D; King M, 2014, 'Assessing the Invariance of a Culturally Competent Multi-lingual Unmet Needs Survey for Immigrant and Australian-born Cancer Patients: A Rasch Analysis', PSYCHO-ONCOLOGY, vol. 23, pp. 153 - 153, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344003700220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vastert SJ; Bhat P; Goldstein DA, 2014, 'Pathophysiology of JIA-associated Uveitis', Ocular Immunology and Inflammation, vol. 22, pp. 414 - 423, http://dx.doi.org/10.3109/09273948.2014.926937

Bhat PV; Goldstein DA, 2014, 'Review of the latest local treatments for uveitis', Expert Review of Ophthalmology, vol. 9, pp. 401 - 412, http://dx.doi.org/10.1586/17469899.2014.956725

Hillman RJ; Garland SM; Gunathilake MPW; Stevens M; Kumaradevan N; Lemech C; Ward RL; Meagher A; McHugh L; Jin F; Carroll S; Goldstein D; Grulich AE; Tabrizi SN, 2014, 'Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers', International Journal of Cancer, vol. 135, pp. 996 - 1001, http://dx.doi.org/10.1002/ijc.28730

Vernerey D; Hammel P; Paget-Bailly S; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Moore M; André T; Mineur L; Chibaudel B; Louvet C; Bonnetain F, 2014, 'Prognosis Model for Overall Survival in Locally Advanced Pancreatic Cancer (LAPC): An Ancillary Study of the Lap 07 Trial', Annals of Oncology, vol. 25, pp. ii105, http://dx.doi.org/10.1093/annonc/mdu193.2

McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, http://dx.doi.org/10.1007/s11136-014-0717-5

Sears K; Broderick B; Goldstein D; Stockley D, 2014, 'The Development of a New Master’s of Science in Healthcare Quality Program', Collected Essays on Learning and Teaching, vol. 7, pp. 39 - 39, http://dx.doi.org/10.22329/celt.v7i1.3991

Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA).', Journal of Clinical Oncology, vol. 32, pp. TPS4162 - TPS4162, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.tps4162

Goldstein D; El-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Macarulla T; Teixeira L; Tortora G; Van Laethem JL; Penenberg DN; Lu B; Romano A; Von Hoff DD, 2014, 'Analyses of updated overall survival (OS) and prognostic effect of neutrophil-to-lymphocyte ratio (NLR) and CA 19-9 from the phase III MPACT study of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem for patients (pts) with metastatic pancreatic cancer (PC).', Journal of Clinical Oncology, vol. 32, pp. 4027 - 4027, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4027

Vernerey D; Hammel P; Paget-Bailly S; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Moore M; André T; Mineur L; Chibaudel B; Louvet C; Bonnetain F, 2014, 'Prognosis model for overall survival in locally advanced pancreatic cancer (LAPC): An ancillary study of the LAP 07 trial.', Journal of Clinical Oncology, vol. 32, pp. 4024 - 4024, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4024

Huguet F; Hammel P; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; Spry N; Paget-Bailly S; Bonnetain F; Louvet C, 2014, 'Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study.', Journal of Clinical Oncology, vol. 32, pp. 4001 - 4001, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4001

Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im S-A; Gupta S; Kang Y-K; Schoffski P; Schuette J; Soulieres D; Blay J-Y; Goldstein D; Fly KD; Huang X; Corsaro M; Lechuga M; Martini J-F; Heinrich MC, 2014, 'Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial.', JOURNAL OF CLINICAL ONCOLOGY, vol. 32, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.10549

Davis ID; Long A; Martin A; Espinoza D; Yip S; Thompson JF; Kichenadasse G; Harrison M; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro J; Stockler MR, 2014, 'EVERSUN: A PHASE 2 TRIAL OF EVEROLIMUS ALTERNATING WITH SUNITINIB AS FIRST-LINE THERAPY FOR ADVANCED RENAL CELL CARCINOMA (ANZUP TRIAL 0901)', EUROPEAN JOURNAL OF CANCER, vol. 50, pp. E68 - E69, http://dx.doi.org/10.1016/j.ejca.2014.03.255

Sawka AM; Brierley JD; Ezzat S; Goldstein DP, 2014, 'Managing newly diagnosed thyroid cancer.', CMAJ, vol. 186, pp. 269 - 275, http://dx.doi.org/10.1503/cmaj.121742

Valle JW; Palmer D; Jackson R; Cox T; Neoptolemos JP; Ghaneh P; Rawcliffe CL; Bassi C; Stocken DD; Cunningham D; O'Reilly D; Goldstein D; Robinson BA; Karapetis C; Scarfe A; Lacaine F; Sand J; Izbicki JR; Mayerle J; Dervenis C; Oláh A; Butturini G; Lind PA; Middleton MR; Anthoney A; Sumpter K; Carter R; Büchler MW, 2014, 'Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: Ongoing lessons from the ESPAC-3 study', Journal of Clinical Oncology, vol. 32, pp. 504 - 512, http://dx.doi.org/10.1200/JCO.2013.50.7657

Eng L; Su J; Qiu X; Palepu PR; Hon H; Fadhel E; Harland L; La Delfa A; Habbous S; Kashigar A; Cuffe S; Shepherd FA; Leighl NB; Pierre AF; Selby P; Goldstein DP; Xu W; Liu G, 2014, 'Second-hand smoke as a predictor of smoking cessation among lung cancer survivors.', J Clin Oncol, vol. 32, pp. 564 - 570, http://dx.doi.org/10.1200/JCO.2013.50.9695

Ramanathan RK; Von Hoff DD; Moore MJ; Teixeira L; Siena S; Tabernero J; Goldstein D; Wei X; Lu B, 2014, 'Analysis of metabolic response (MR) by positron emission tomography (PET) compared with tumor response by computed tomography (CT) from MPACT, a phase III trial comparing nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone for patients (pts) with metastatic adenocarcinoma of the pancreas.', Journal of Clinical Oncology, vol. 32, pp. 254 - 254, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.254

Goldstein D; El Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L; Tortora G; Van Laethem J-L; Young R; Wei X; Lu B; Romano A; Von Hoff DD, 2014, 'Updated survival from a randomized phase III trial (MPACT) of nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients (pts) with metastatic adenocarcinoma of the pancreas.', Journal of Clinical Oncology, vol. 32, pp. 178 - 178, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.178

Greenhalf W; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Lamb RF; Garner E; Campbell F; MacKey JR; Costello E; Moore MJ; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Halloran CM; Mayerle J; Oláh A; Jackson R; Rawcliffe CL; Scarpa A; Bassi C; Büchler MW, 2014, 'Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial', Journal of the National Cancer Institute, vol. 106, http://dx.doi.org/10.1093/jnci/djt347

Von Hoff DD; Goldstein D; Renschler MF, 2014, 'The authors reply', New England Journal of Medicine, vol. 370, pp. 479 - 480, http://dx.doi.org/10.1056/NEJMc1314761

McCarroll JA; Naim S; Sharbeen G; Russia N; Lee J; Kavallaris M; Goldstein D; Phillips PA, 2014, 'Role of pancreatic stellate cells in chemoresistance in pancreatic cancer', Frontiers in Physiology, vol. 5 APR, http://dx.doi.org/10.3389/fphys.2014.00141

Bennett BK; Goldstein D; Chen M; Davenport TA; Vollmer-Conna U; Scott EM; Hickie IB; Lloyd AR, 2014, 'Characterization of fatigue states in medicine and psychiatry by structured interview', Psychosomatic Medicine, vol. 76, pp. 379 - 388, http://dx.doi.org/10.1097/PSY.0000000000000061

Goldstein D; Bell ML; Butow P; Sze M; Vaccaro L; Dong S; Liauw W; Hui R; Tattersall M; Ng W; Asghari R; Steer C; Vardy J; Parente P; Harris M; Karanth NV; King M; Girgis A; Eisenbruch M; Jefford M, 2014, 'Immigrants' perceptions of the quality of their cancer care: An Australian comparative study, identifying potentially modifiable factors', Annals of Oncology, vol. 25, pp. 1643 - 1649, http://dx.doi.org/10.1093/annonc/mdu182

Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS, 2014, 'The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: Anti-angiogenic implications in pancreatic cancer', Carcinogenesis, vol. 35, http://dx.doi.org/10.1093/carcin/bgu122

Chan CC; Goldstein DA; Davis JL; Nida Sen H, 2014, 'Gender and Uveitis', Journal of Ophthalmology, vol. 2014, http://dx.doi.org/10.1155/2014/818070

Birnbaum AD; Fawzi AA; Rademaker A; Goldstein DA, 2014, 'Correlation between clinical signs and optical coherence tomography with enhanced depth imaging findings in patients with birdshot chorioretinopathy', JAMA Ophthalmology, vol. 132, pp. 929 - 935, http://dx.doi.org/10.1001/jamaophthalmol.2014.877

Goldstein DA, 2014, 'Achieving drug delivery via the suprachoroidal space: Use of the suprachoroidal space for drug delivery may achieve sustained delivery of therapeutics close to the source of retinal or choroidal pathology', Retina Today, vol. JUL/AUG, pp. 82 - 83

Rose-Nussbaumer J; Goldstein DA; Thorne JE; Arantes TE; Acharya NR; Shakoor A; Jeng BH; Yeh S; Rahman H; Vemulakonda GA; Flaxel CJ; West SK; Holland GN; Smith JR, 2014, 'Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL', Clinical and Experimental Ophthalmology, vol. 42, pp. 118 - 125, http://dx.doi.org/10.1111/ceo.12141

Bhat PV; Goldstein DA, 2014, 'Dexamethasone intravitreal implant (allergan) for the treatment of noninfectious uveitis', Expert Opinion on Orphan Drugs, vol. 2, pp. 301 - 310, http://dx.doi.org/10.1517/21678707.2014.893817

Gordon LK; Goldstein DA, 2014, 'Gender and uveitis in patients with multiple sclerosis', Journal of Ophthalmology, vol. 2014, http://dx.doi.org/10.1155/2014/565262

Takakura A; Tessler HH; Goldstein DA; Guex-Crosier Y; Chan CC; Brown DM; Thorne JE; Wang R; Cunningham ET, 2014, 'Viral retinitis following intraocular or periocular corticosteroid administration: A case series and comprehensive review of the literature', Ocular Immunology and Inflammation, vol. 22, pp. 175 - 182, http://dx.doi.org/10.3109/09273948.2013.866256

McCarroll J; Teo J; Boyer C; Goldstein D; Kavallaris M; Phillips PA, 2014, 'Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer', Frontiers in Physiology, vol. 5, pp. 1 - 10, http://dx.doi.org/10.3389/fphys.2014.00002

Murray JE; Pickering HR; Lin CS-Y; Goldstein D; Friedlander ML; Kiernan MC; Krishnan AV, 2014, '6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy', Clinical Neurophysiology, vol. 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.028

Tempero M; Cardin D; Biankin A; Goldstein D; Moore M; O’Reilly E; Philip P; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'APACT: A Phase III Trial of Nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) Versus Gem Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (PC)', American Journal of Gastroenterology, vol. 109, pp. S72 - S72, http://dx.doi.org/10.14309/00000434-201410002-00232

Tempero MA; Cardin D; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'Apact: a Phase III Trial of Nab-Paclitaxel (Nab-P) Plus Gemcitabine (Gem) Vs Gem Alone for Resected Pancreatic Cancer (Pc)', Annals of Oncology, vol. 25, pp. iv252 - iv252, http://dx.doi.org/10.1093/annonc/mdu334.131

Siena S; Lipton L; Letourneau R; Tjulandin SA; Guillen Ponce C; Schwarz M; Ramanathan RK; Macarulla T; Goldstein D; Romano A; Ferrara S; Penenberg D; Von Hoff DD, 2014, 'Regional Subanalysis of the Phase III Mpact Trial: Nab-Paclitaxel (Nab-P) Plus Gemcitabine (Gem) Vs Gem Alone for Patients (Pts) with Metastatic Pancreatic Cancer (Pc)', Annals of Oncology, vol. 25, pp. iv235 - iv235, http://dx.doi.org/10.1093/annonc/mdu334.76

Wong KM; Qiu X; Cheng D; Azad AK; Habbous S; Palepu P; Mirshams M; Patel D; Chen Z; Roberts H; Knox J; Marquez S; Wong R; Darling G; Waldron J; Goldstein D; Leighl N; Shepherd FA; Tsao M; Der S; Reisman D; Liu G, 2014, 'Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.', Cancer Med, vol. 3, pp. 426 - 433, http://dx.doi.org/10.1002/cam4.201

de Almeida JR; Byrd JK; Wu R; Stucken CL; Duvvuri U; Goldstein DP; Miles BA; Teng MS; Gupta V; Genden EM, 2014, 'A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review.', Laryngoscope, vol. 124, pp. 2096 - 2102, http://dx.doi.org/10.1002/lary.24712

Habbous S; Harland LTG; La Delfa A; Fadhel E; Xu W; Liu F-F; Goldstein D; Waldron J; Huang S-H; O'Sullivan B; Liu G, 2014, 'Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.', Head Neck, vol. 36, pp. 802 - 810, http://dx.doi.org/10.1002/hed.23360

Eskander A; Merdad M; Irish JC; Hall SF; Groome PA; Freeman JL; Urbach DR; Goldstein DP, 2014, 'Volume-outcome associations in head and neck cancer treatment: a systematic review and meta-analysis.', Head Neck, vol. 36, pp. 1820 - 1834, http://dx.doi.org/10.1002/hed.23498

Goldstein DP; Ringash J; Bissada E; Jaquet Y; Irish J; Chepeha D; Davis AM, 2014, 'Scoping review of the literature on shoulder impairments and disability after neck dissection.', Head Neck, vol. 36, pp. 299 - 308, http://dx.doi.org/10.1002/hed.23243

Huguet F; Hammel P; Vernerey D; Van Laethem J; Goldstein D; Glimelius B; Bonnetain F; Louvet C, 2014, 'Impact de la chimioradiothérapie sur le contrôle local et le temps sans traitement dans l’essai de phase III LAP07', Cancer/Radiothérapie, vol. 18, pp. 587 - 587, http://dx.doi.org/10.1016/j.canrad.2014.07.013

Weinreb I; Zhang L; Tirunagari LMS; Sung Y-S; Chen C-L; Perez-Ordonez B; Clarke BA; Skalova A; Chiosea SI; Seethala RR; Waggott D; Boutros PC; How C; Liu F-F; Irish JC; Goldstein DP; Gilbert R; Ud Din N; Assaad A; Hornick JL; Thompson LDR; Antonescu CR, 2014, 'Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.', Genes Chromosomes Cancer, vol. 53, pp. 845 - 856, http://dx.doi.org/10.1002/gcc.22195

McAlister ED; Goldstein DP; Rotstein LE, 2014, 'Redefining classification of central neck dissection in differentiated thyroid cancer.', Head Neck, vol. 36, pp. 286 - 290, http://dx.doi.org/10.1002/hed.23237

Eskander A; Irish J; Groome PA; Freeman J; Gullane P; Gilbert R; Hall SF; Urbach DR; Goldstein DP, 2014, 'Volume-outcome relationships for head and neck cancer surgery in a universal health care system.', Laryngoscope, vol. 124, pp. 2081 - 2088, http://dx.doi.org/10.1002/lary.24704

Huang S; Patel S; O'Sullivan B; Shen X; Xu W; Irish J; Gilbert R; Gullane P; Waldron J; Goldstein D; et al , 2014, 'Longer Survival in HPV-Related Head-and-Neck Cancer Patients Following Positive Postradiation Planned Neck Dissection', International Journal of Radiation Oncology*Biology*Physics, vol. 88, pp. 486 - 486, http://dx.doi.org/10.1016/j.ijrobp.2013.11.077

Goldstein DP; Ringash J; Bissada E; Jaquet Y; Irish J; Chepeha D; Davis AM, 2014, 'Evaluation of shoulder disability questionnaires used for the assessment of shoulder disability after neck dissection for head and neck cancer.', Head Neck, vol. 36, pp. 1453 - 1458, http://dx.doi.org/10.1002/hed.23490

Hammel P; Huguet F; Dewi V; Laethem J-LV; Goldstein D; Glimelius B; Artru P; Borbath Y; Bonnetain F; Louvet C, 2014, 'Impact of chemoradiotherapy (CRT) on local tumour control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study', Pancreatology, vol. 14, pp. S6 - S6, http://dx.doi.org/10.1016/j.pan.2014.05.398

Rey F; Huang SH; O’Sullivan B; Qiu X; Wei X; Chan B; Ringash J; Goldstein D; Kim J; Waldron JN, 2014, 'EP-1136: Definitive radiation therapy for advanced stage oral cavity squamous cell carcinoma (OCSCC)', Radiotherapy and Oncology, vol. 111, pp. S32 - S32, http://dx.doi.org/10.1016/s0167-8140(15)31254-8

Bell ML; Butow PN; Goldstein D, 2013, 'Informatively missing quality of life and unmet needs sex data for immigrant and Anglo-Australian cancer patients and survivors', Quality of Life Research, vol. 22, pp. 2757 - 2760, http://dx.doi.org/10.1007/s11136-013-0392-y

Couto C; Rossetti S; Schlaen A; Hurtado E; D'alessandro L; Goldstein DA, 2013, 'Chronic postoperative mycobacterium gordonae endophthalmitis in a patient with phakic intraocular lens', Ocular Immunology and Inflammation, vol. 21, pp. 491 - 494, http://dx.doi.org/10.3109/09273948.2013.824104

Huang SH; O'Sullivan B; Xu W; Zhao H; Chen D-D; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BCJ; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J, 2013, 'Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.', Int J Radiat Oncol Biol Phys, vol. 87, pp. 1078 - 1085, http://dx.doi.org/10.1016/j.ijrobp.2013.08.049

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204

Tan K; Goldstein D; Crowe P; Yang JL, 2013, 'Uncovering a key to the process of metastasis in human cancers: A review of critical regulators of anoikis', Journal of Cancer Research and Clinical Oncology, vol. 139, pp. 1795 - 1805, http://dx.doi.org/10.1007/s00432-013-1482-5

Ackland S; Goldstein D; McJannett M, 2013, 'Forty years of COSA - Contributions to oncology teaching and research', Cancer Forum, vol. 37, pp. 238 - 242

Vulpe H; Giuliani M; Goldstein D; Perez-Ordonez B; Dawson LA; Hope A, 2013, 'Long term control of a maxillary sinus mucoepidermoid carcinoma with low dose radiation therapy: a case report.', Radiat Oncol, vol. 8, pp. 251, http://dx.doi.org/10.1186/1748-717X-8-251

Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken NRC; Wyld DK; Abdi EA; Glasgow A; Beale PJ; Jefford M; Glare PA; Stockler MR, 2013, 'The median informs the message: Accuracy of individualized scenarios for survival time based on oncologists' estimates', Journal of Clinical Oncology, vol. 31, pp. 3565 - 3571, http://dx.doi.org/10.1200/JCO.2012.44.7821

Grimison P; Phillips F; Butow P; White K; Yip D; Sardelic F; Underhill C; Tse R; Simes R; Turley K; Raymond C; Goldstein D, 2013, 'Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals', Asia-Pacific Journal of Clinical Oncology, vol. 9, pp. 226 - 238, http://dx.doi.org/10.1111/ajco.12014

Chou A; Waddell N; Cowley MJ; Gill AJ; Chang DK; Patch AM; Nones K; Wu J; Pinese M; Johns AL; Miller DK; Kassahn KS; Nagrial AM; Wasan H; Goldstein D; Toon CW; Chin V; Chantrill L; Humphris J; Mead RS; Rooman I; Samra JS; Pajic M; Musgrove EA; Pearson JV; Morey AL; Grimmond SM; Biankin AV, 2013, 'Clinical and molecular characterization of HER2 amplified-pancreatic cancer', Genome Medicine, vol. 5, http://dx.doi.org/10.1186/gm482

Butow PN; Sze M; Eisenbruch M; Bell ML; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J; Hui R; Boyle F; Liauw W; Goldstein D, 2013, 'Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients', Patient Education and Counseling, vol. 92, pp. 246 - 252, http://dx.doi.org/10.1016/j.pec.2013.03.006

Shaw J; Butow P; Sze M; Young J; Goldstein D, 2013, 'Reducing disparity in outcomes for immigrants with cancer: A qualitative assessment of the feasibility and acceptability of a culturally targeted telephone-based supportive care intervention', Supportive Care in Cancer, vol. 21, pp. 2297 - 2301, http://dx.doi.org/10.1007/s00520-013-1786-7

Hu J; Goldstein DA; Leiderman YI; Malhotra V; Chau FY; Lin AY; Vajaranant TS, 2013, 'Epithelial downgrowth after ahmed implantation presenting as a peritubular fibrovascular membrane', Journal of Glaucoma, vol. 22, http://dx.doi.org/10.1097/IJG.0b013e318255d9ee

Rifkin LM; Birnbaum AD; Goldstein DA, 2013, 'TNF inhibition for ophthalmic indications: Current status and outlook', BioDrugs, vol. 27, pp. 347 - 357, http://dx.doi.org/10.1007/s40259-013-0022-9

Kashigar A; Habbous S; Eng L; Irish B; Bissada E; Irish J; Brown D; Gilbert R; Gullane P; Xu W; Huang S-H; Witterick I; Freeman J; O'Sullivan B; Waldron J; Liu G; Goldstein D, 2013, 'Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients.', Cancer, vol. 119, pp. 2701 - 2709, http://dx.doi.org/10.1002/cncr.28088

Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', J Clin Oncol, vol. 31, pp. LBA4003, http://dx.doi.org/10.1200/jco.2013.31.18_suppl.lba4003

Teo J; Erlich RB; Sagnella S; Dwarte T; Davis TP; Kavallaris M; McCarroll J; Boyer C; Duong HTT; Phillips P; Sharbeen G; Goldstein D, 2013, 'Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers', Molecular Pharmaceutics, vol. 10, pp. 2435 - 2444, http://dx.doi.org/10.1021/mp400049e

Patel SS; Saraiya NV; Tessler HH; Goldstein DA, 2013, 'Mycobacterial ocular inflammation: Delay in diagnosis and other factors impacting morbidity', JAMA Ophthalmology, vol. 131, pp. 752 - 758, http://dx.doi.org/10.1001/jamaophthalmol.2013.71

Webber K; Girgis A; Bennett BK; Bonaventura A; Boyle FM; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2013, 'The unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners (GPs).', Journal of Clinical Oncology, vol. 31, pp. 9602 - 9602, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9602

Pavlakis N; Goldstein D; Sjoquist KM; Martin A; Tsobanis E; Yip S; Shannon J; Burge ME; Cronk MF; Tebbutt NC; Strickland A; Lipton LR; Price TJ; Nott LM; Harris DL; Burnell MJ; Alcindor T; Bang Y-J; Kang Y-K; O'Callaghan CJ, 2013, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer (AOGC)—A study by the Australasian Gastrointestinal Trials Group (AGITG).', Journal of Clinical Oncology, vol. 31, pp. TPS4157 - TPS4157, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.tps4157

Hammel P; Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', Journal of Clinical Oncology, vol. 31, pp. LBA4003 - LBA4003, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.lba4003

Chiorean EG; Von Hoff DD; Ervin TJ; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; Ko A; Lu B, 2013, 'CA19-9 decrease at 8 weeks as a predictor of overall survival (OS) in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients with metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, vol. 31, pp. 4058 - 4058, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4058

Vickers MM; Tu D; Lee C; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H-J; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2013, 'Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.', Journal of Clinical Oncology, vol. 31, pp. 4053 - 4053, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4053

Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates.', Journal of Clinical Oncology, vol. 31, pp. 4005 - 4005, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4005

Eng L; Pringle D; Qiu X; Shen X; Niu C; Mahler M; Halytskyy O; Charow R; Lam C; Shani RM; Villeneuve J; Tiessen K; Brown MC; Alibhai SMH; Jones JM; Howell D; Goldstein DP; Xu W; Selby P; Liu G, 2013, 'The role of social exposure to smoking on smoking cessation in adult cancer survivors.', Journal of Clinical Oncology, vol. 31, pp. 9536 - 9536, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9536

Butow PN; Sze M; Eisenbruch M; Bell M; Aldridge L; Vardy JL; Hui R; Boyle F; Liauw WS; Goldstein D, 2013, 'Should culture affect practice? Prognostic discussions with immigrants.', Journal of Clinical Oncology, vol. 31, pp. 6556 - 6556, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.6556

Moore MJ; Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Hon JK; Biakhov MY; Hingorani SR; Ganju V; Weekes CD; Scheithauer W; Ramanathan RK; Tabernero J; Goldstein D; Wei X; Romano A, 2013, 'Prognostic factors (PFs) of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, vol. 31, pp. 4059 - 4059, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4059

Shinghal T; Bissada E; Chan HB; Wood RE; Atenafu EG; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Waldron J; Goldstein DP, 2013, 'Medial mandibulotomies: is there sufficient space in the midline to allow a mandibulotomy without compromising the dentition?', J Otolaryngol Head Neck Surg, vol. 42, pp. 32, http://dx.doi.org/10.1186/1916-0216-42-32

Suhler EB; Lowder CY; Goldstein DA; Giles T; Lauer AK; Kurz PA; Pasadhika S; Lee ST; De Saint Sardos A; Butler NJ; Tessler HH; Smith JR; Rosenbaum JT, 2013, 'Adalimumab therapy for refractory uveitis: Results of a multicentre, open-label, prospective trial', British Journal of Ophthalmology, vol. 97, pp. 481 - 486, http://dx.doi.org/10.1136/bjophthalmol-2012-302292

Ganly I; Goldstein D; Carlson DL; Patel SG; O'Sullivan B; Lee N; Gullane P; Shah JP, 2013, 'Long-term regional control and survival in patients with "low-risk," early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness.', Cancer, vol. 119, pp. 1168 - 1176, http://dx.doi.org/10.1002/cncr.27872

Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT)', JOURNAL OF CLINICAL ONCOLOGY, vol. 31, http://dx.doi.org/10.1200/jco.2013.31.4_suppl.lba148

Wang X; Goldstein D; Crowe P; Yang J, 2013, 'S3I-201, a novel STAT3 inhibitor, inhibits growth of human soft tissue sarcoma cell lines', World Journal of Cancer Research, http://dx.doi.org/10.1166/wjcr.2013.1005

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, vol. 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204

Von Hoff DD; Ervin T; Arena FP; Chiorean EG; Infante J; Moore M; Seay T; Tjulandin SA; Ma WW; Saleh MN; Harris M; Reni M; Dowden S; Laheru D; Bahary N; Ramanathan RK; Tabernero J; Hidalgo M; Goldstein D; Van Cutsem E; Wei X; Iglesias J; Renschler MF, 2013, 'Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine', New England Journal of Medicine, vol. 369, pp. 1691 - 1703, http://dx.doi.org/10.1056/NEJMoa1304369

Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N, 2013, 'Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer', International Journal of Radiation Oncology Biology Physics, vol. 85, pp. 157 - 162, http://dx.doi.org/10.1016/j.ijrobp.2012.03.003

Tan CJ; Yang JL; Crowe P; Goldstein D, 2013, 'Targeted therapy in soft tissue sarcoma-A novel direction in therapeutics', Chinese Clinical Oncology, vol. 2, http://dx.doi.org/10.3978/j.issn.2304-3865.2013.08.01

Butow PN; Bell M; Aldridge L; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-beri P; McGrane J, 2013, 'Unmet needs in immigrant cancer survivors: a cross-sectional population-based study', Supportive Care in Cancer, vol. 21, pp. 2509 - 2520, http://dx.doi.org/10.1007/s00520-013-1819-2

Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-beri P; Goldstein D, 2013, 'Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study', European Journal of Cancer, vol. 49, pp. 1948 - 1956, http://dx.doi.org/10.1016/j.ejca.2013.01.011

Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP, 2013, 'The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.', Thyroid, vol. 23, pp. 246 - 247, http://dx.doi.org/10.1089/thy.2012.0422

Yla-Kotola TM; Bartlett E; Goldstein DP; Armstrong K; Gilbert RW; Hofer SOP, 2013, 'Union and bone resorption of free fibular flaps in mandibular reconstruction.', J Reconstr Microsurg, vol. 29, pp. 427 - 432, http://dx.doi.org/10.1055/s-0033-1343953

Erovic BM; Goldstein DP; Kim D; Al Habeeb A; Waldron J; Ghazarian D; Irish JC, 2013, 'Sebaceous gland carcinoma of the head and neck: the Princess Margaret Hospital experience.', Head Neck, vol. 35, pp. 316 - 320, http://dx.doi.org/10.1002/hed.22964

Goldstein DP; Bachar GY; Lea J; Shrime MG; Patel RS; Gullane PJ; Brown DH; Gilbert RW; Kim J; Waldron J; Perez-Ordonez B; Davis AM; Cheng L; Xu W; Irish JC, 2013, 'Outcomes of squamous cell cancer of the oral tongue managed at the Princess Margaret Hospital.', Head Neck, vol. 35, pp. 632 - 641, http://dx.doi.org/10.1002/hed.23001

Tabernero J; Von Hoff D; Moore M; Ervin T; Arena F; Chiorean E; Infante J; Hingorani S; Ganju V; Weekes C; Scheithauer W; Ramanathan R; Goldstein D; Wei X; Romano A, 2013, 'Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: Influence of Prognostic Factors on Survival', Annals of Oncology, vol. 24, pp. iv11 - iv12, http://dx.doi.org/10.1093/annonc/mdt201.1

Haerle SK; Shiau C; Goldstein DP; Qiu X; Erovic BM; Ghazarian D; Xu W; Irish JC, 2013, 'Merkel cell carcinoma of the head and neck: potential histopathologic predictors.', Laryngoscope, vol. 123, pp. 3043 - 3048, http://dx.doi.org/10.1002/lary.24233

Misra S; Meiyappan S; Heus L; Freeman J; Rotstein L; Brierley JD; Tsang RW; Rodin G; Ezzat S; Goldstein DP; Sawka AM, 2013, 'Patients' experiences following local-regional recurrence of thyroid cancer: a qualitative study.', J Surg Oncol, vol. 108, pp. 47 - 51, http://dx.doi.org/10.1002/jso.23345

Huguet F; Hammel P; Goldstein D; Spry N; Van Laethem J-L; Van Houtte P; Glimelius B; Gubanski M; Bonnetain F; Racadot S, 2013, 'Étude de la relation entre le score d’assurance qualité de la radiothérapie, la toxicité et la survie dans l’essai de phase III LAP07 dans le cancer du pancréas localement évolué', Cancer/Radiothérapie, vol. 17, pp. 581 - 582, http://dx.doi.org/10.1016/j.canrad.2013.06.018

Wang SJ; Patel SG; Shah JP; Goldstein DP; Irish JC; Carvalho AL; Kowalski LP; Lockhart JL; Holland JM; Gross ND, 2013, 'An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy.', JAMA Otolaryngol Head Neck Surg, vol. 139, pp. 554 - 559, http://dx.doi.org/10.1001/jamaoto.2013.3001

Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; John Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ, 2013, 'Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure".', Oral Oncol, vol. 49, pp. e19, http://dx.doi.org/10.1016/j.oraloncology.2013.02.005

Habbous S; Chu KP; Harland LTG; La Delfa A; Fadhel E; Sun B; Xu W; Wong A; Howell D; Ringash J; Waldron J; O'Sullivan B; Goldstein D; Huang S-H; Liu G, 2013, 'Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.', Oral Oncol, vol. 49, pp. 407 - 412, http://dx.doi.org/10.1016/j.oraloncology.2012.11.010

Erovic BM; Al Habeeb A; Harris L; Goldstein DP; Kim D; Ghazarian D; Irish JC, 2013, 'Identification of novel target proteins in sebaceous gland carcinoma.', Head Neck, vol. 35, pp. 642 - 648, http://dx.doi.org/10.1002/hed.23021

Habbous S; Chu KP; Qiu X; La Delfa A; Harland LTG; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu F-F; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G, 2013, 'The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.', Cancer Epidemiol, vol. 37, pp. 820 - 829, http://dx.doi.org/10.1016/j.canep.2013.09.011

Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BCJ; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ, 2013, 'Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.', Oral Oncol, vol. 49, pp. 255 - 260, http://dx.doi.org/10.1016/j.oraloncology.2012.09.006

Eskander A; Devins GM; Freeman J; Wei AC; Rotstein L; Chauhan N; Sawka AM; Brown D; Irish J; Gilbert R; Gullane P; Higgins K; Enepekides D; Goldstein D, 2013, 'Waiting for thyroid surgery: a study of psychological morbidity and determinants of health associated with long wait times for thyroid surgery.', Laryngoscope, vol. 123, pp. 541 - 547, http://dx.doi.org/10.1002/lary.23503

Wang JR; Gramling SJB; Goldstein DP; Cheng D; Chen D; Azad AK; Tse A; Hon H; Chen Z; Mirshams M; Simpson C; Huang SH; Marquez S; O'Sullivan B; Liu F-F; Roberts H; Xu W; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Reisman DN; Liu G, 2013, 'Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk.', Carcinogenesis, vol. 34, pp. 1012 - 1017, http://dx.doi.org/10.1093/carcin/bgt008

Eskander A; Givi B; Gullane PJ; Irish J; Brown D; Gilbert RW; Hope A; Weinreb I; Xu W; Goldstein DP, 2013, 'Outcome predictors in squamous cell carcinoma of the maxillary alveolus and hard palate.', Laryngoscope, vol. 123, pp. 2453 - 2458, http://dx.doi.org/10.1002/lary.24079

Erovic BM; Goldstein DP; Kim D; Mete O; Brierley J; Tsang R; Freeman JL; Asa SL; Rotstein L; Irish JC, 2013, 'Parathyroid cancer: outcome analysis of 16 patients treated at the Princess Margaret Hospital.', Head Neck, vol. 35, pp. 35 - 39, http://dx.doi.org/10.1002/hed.22908

Huguet F; Racadot S; Goldstein D; Spry N; Van Laethem J; Van Houtte P; Glimelius B; Gubanski M; Bonnetain F; Hammel P, 2013, 'Investigation of Relation of Radiation Therapy Quality Assurance Scores (RTQASc) With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma (LAPC)', International Journal of Radiation Oncology*Biology*Physics, vol. 87, pp. S29 - S30, http://dx.doi.org/10.1016/j.ijrobp.2013.06.080

Reni M; Von Hoff D; Chiorean E; Ervin T; Arena F; Infante J; Bathini V; Clingan P; Kunzmann V; Ramanathan R; Tabernero J; Goldstein D; Ko A; Lu B, 2013, 'CA19-9 Decrease and Kinetics in a Randomized Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer', Annals of Oncology, vol. 24, pp. iv31 - iv31, http://dx.doi.org/10.1093/annonc/mdt202.19

Erovic BM; Al Habeeb A; Harris L; Goldstein DP; Ghazarian D; Irish JC, 2013, 'Significant overexpression of the Merkel cell polyomavirus (MCPyV) large T antigen in Merkel cell carcinoma.', Head Neck, vol. 35, pp. 184 - 189, http://dx.doi.org/10.1002/hed.22942

Hammel P; Huguet F; van Laethem J-L; Goldstein D; Glimelius B; Borbath I; Bouché O; Shannon J; André T; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study', Pancreatology, vol. 13, pp. S89 - S89, http://dx.doi.org/10.1016/j.pan.2013.04.312

Huang SH; O'Sullivan B; Xu W; Zhao H; Chen D; Chan K; Kim J; Bayley A; Goldstein D; Waldron J, 2013, 'OC-017: Temporal Regression and Regional Control Following Primary Radiotherapy for HPV(+) vs. HPV(-) Head & Neck Cancers', Radiotherapy and Oncology, vol. 106, pp. S5 - S6, http://dx.doi.org/10.1016/s0167-8140(15)34636-3

Huesgen E; Burgos R; Goldstein DA; Max B; Jarrett OD, 2012, 'Severe dyslipidaemia after the addition of raltegravir to a lopinavir/ritonavir-containing regimen', Antiviral Therapy, vol. 17, pp. 1385 - 1388, http://dx.doi.org/10.3851/IMP2182

Chiang E; Goldstein DA; Shapiro MJ; Mets MB, 2012, 'Branch retinal artery occlusion caused by toxoplasmosis in an adolescent', Case Reports in Ophthalmology, vol. 3, pp. 333 - 338, http://dx.doi.org/10.1159/000343262

Paparizos SC; Goldstein DA; Bouhenni RA; Steiner S; Dunmire JJ; Edward DP, 2012, 'Immunohistochemical evidence of specific iris involvement in blau syndrome', Ocular Immunology and Inflammation, vol. 20, pp. 471 - 474, http://dx.doi.org/10.3109/09273948.2012.726391

Eng L; Su J; Qiu X; Palepu PR; Hon H; Fadhel E; Harland L; La Delfa A; Habbous S; Kashigar A; Cuffe S; Leighl NB; Pierre A; Selby P; Goldstein DP; Liu G; Xu W, 2012, 'Developing a comprehensive smoking cessation program in patients with lung cancer: The role of social smoking environments.', Journal of Clinical Oncology, vol. 30, pp. 75 - 75, http://dx.doi.org/10.1200/jco.2012.30.34_suppl.75

Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, vol. 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269

Birnbaum AD; Jiang Y; Vasaiwala R; Tessler HH; Goldstein DA, 2012, 'Bilateral simultaneous-onset nongranulomatous acute anterior uveitis: Clinical presentation and etiology', Archives of Ophthalmology, vol. 130, pp. 1389 - 1394, http://dx.doi.org/10.1001/archophthalmol.2012.2006

Butow P; Aldridge L; Bell M; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; Goldstein D; King MT, 2012, 'Inferior quality of life and psychological well-being in immigrant cancer survivors', QUALITY OF LIFE RESEARCH, vol. 21, pp. 48 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209358900132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Orlin A; Chan RVP; Freund KB; Folk JC; Chau F; Goldstein DA, 2012, 'Diagnostic and therapeutic challenges', Retina, vol. 32, pp. 1988 - 1993, http://dx.doi.org/10.1097/IAE.0b013e318261895c

Steiner S; Goldstein DA, 2012, 'Imaging in the diagnosis and management of APMPPE', International Ophthalmology Clinics, vol. 52, pp. 211 - 219, http://dx.doi.org/10.1097/IIO.0b013e318265d45a

Fawzi AA; Pappuru RR; Sarraf D; Le PP; McCannel CA; Sobrin L; Goldstein DA; Honowitz S; Walsh AC; Sadda SR; Jampol LM; Eliott D, 2012, 'Acute macular neuroretinopathy: Long-term insights revealed by multimodal imaging', Retina, vol. 32, pp. 1500 - 1513, http://dx.doi.org/10.1097/IAE.0b013e318263d0c3

Sawka AM; Straus S; Rotstein L; Brierley JD; Tsang RW; Asa S; Segal P; Kelly C; Zahedi A; Freeman J; Solomon P; Anderson J; Thorpe KE; Gafni A; Rodin G; Goldstein DP, 2012, 'Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer.', J Clin Oncol, vol. 30, pp. 2906 - 2911, http://dx.doi.org/10.1200/JCO.2011.41.2734

Abbasian J; Martin TM; Patel S; Tessler HH; Goldstein DA, 2012, 'Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease', American Journal of Ophthalmology, vol. 154, pp. 72 - 77, http://dx.doi.org/10.1016/j.ajo.2012.01.016

Chow CC; Birnbaum A; Janowicz M; Goldstein DA, 2012, 'Lipemia retinalis as a presenting feature of hypertriglyceridemia associated with protease inhibitors in human immunodeficiency virus-infected patients', Retinal Cases and Brief Reports, vol. 6, pp. 294 - 297, http://dx.doi.org/10.1097/ICB.0b013e318234ccdd

Goldstein D; Sze M; Bell M; King M; Jefford M; Eisenbruch M; Girgis A; Vaccaro L; Butow PN, 2012, 'Disparities in quality-of-life outcomes in immigrant cancer patients.', Journal of Clinical Oncology, vol. 30, pp. e16507 - e16507, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e16507

Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study.', Journal of Clinical Oncology, vol. 30, pp. 9044 - 9044, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9044

Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken N; Wyld D; Beale PJ; Jefford M; Glasgow AL; Abdi EA; Glare PA; Stockler MR, 2012, 'Usefulness of medical oncologists’ estimates of survival time in people with advanced cancer.', Journal of Clinical Oncology, vol. 30, pp. 9087 - 9087, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9087

Chua YJ; Karapetis CS; Underhill C; Nott LM; Goldstein D; Cronk MF; Gebski V; Wong N; Sjoquist KM; Biankin AV, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', Journal of Clinical Oncology, vol. 30, pp. TPS4137 - TPS4137, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps4137

Fawcett J; Sjoquist KM; Padbury R; Christophi C; Tebbutt NC; Pilgrim CHC; Gebski V; Wong N; Aiken C; Goldstein D, 2012, 'ATTACHE: A phase III, multicenter, randomized comparison of chemotherapy given prior to and post surgical resection versus chemotherapy given post surgical resection for hepatic metastases from colorectal cancer.', Journal of Clinical Oncology, vol. 30, pp. TPS3643 - TPS3643, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps3643

Eng L; Su J; Palepu PR; Hon H; Fadhel E; Harland L; La Delfa A; Habbous S; Kashigar A; Cuffe S; Leighl NB; Pierre A; Goldstein DP; Liu G; Xu W, 2012, 'Social environment as a predictor of smoking cessation and recidivism in lung cancer survivors.', Journal of Clinical Oncology, vol. 30, pp. 9032 - 9032, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9032

Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; King M; Jefford M; Schofield P; Duggal-Beri P; Goldstein D, 2012, 'Cancer survivorship outcomes in immigrants.', Journal of Clinical Oncology, vol. 30, pp. 6111 - 6111, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.6111

Wong KM; Qiu X; Cheng D; Azad AK; Palepu PR; Mirshams M; Patel D; Chen Z; Roberts H; Knox JJ; Wong R; Darling GE; Waldron JN; Goldstein DP; Leighl NB; Shepherd FA; Tsao MS; Der S; Reisman D; Liu G, 2012, 'The effect of two BRM promoter variants on the risk of stage I/II upper aerodigestive tract cancers.', Journal of Clinical Oncology, vol. 30, pp. 10522 - 10522, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.10522

Sen HN; Drye LT; Goldstein DA; Larson TA; Merrill PT; Pavan PR; Sheppard JD; Burke A; Srivastava SK; Jabs DA, 2012, 'Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) trial', Ocular Immunology and Inflammation, vol. 20, pp. 104 - 112, http://dx.doi.org/10.3109/09273948.2011.647228

Cunningham ET; Goldstein DA; Zierhut M, 2012, 'Uveitis treatment trials-A cross-study perspective', Ocular Immunology and Inflammation, vol. 20, pp. 63 - 67, http://dx.doi.org/10.3109/09273948.2012.661297

Azad AK; Bairati I; Samson E; Cheng D; Cheng L; Mirshams M; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G, 2012, 'Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.', Cancer, vol. 118, pp. 1554 - 1565, http://dx.doi.org/10.1002/cncr.26446

Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Mark Jeffrey G; Tebbutt NC; Buck M; Lowenthal RM; Boland A; Gebski V; Zalcberg J; John Simes R, 2012, 'Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))', European Journal of Cancer, vol. 48, pp. 407, http://dx.doi.org/10.1016/j.ejca.2011.12.001

Grünwald V; Karakiewicz PI; Bavbek SE; Miller K; Machiels JP; Lee SH; Larkin J; Bono P; Rha SY; Castellano D; Blank CU; Knox JJ; Hawkins R; Anak O; Rosamilia M; Booth J; Pirotta N; Bodrogi I; Romedi M; Ferrandini S; Rondinon M; Pittman K; Goldstein D; Shapiro J; Troon S; Yip D; Mainwaring P; Zigeuner R; Loidl W; Greil RF; Schmidinger M; De Grève J; Rottey S; Vermorken J; Gil T; Gennigens C; Roumeguere T; Barrios C; Mathias C; Assi H; Hotte S; Karakiewicz P; Knox J; Spadafora S; Wood L; Zalewski P; Mackensie M; Bjarnason G; Lalancette A; Chan A; Higgins B; North S; Soulieres D; Asselah J; Sperlich C; Miller W; Yadav S; El-Maraghi R; Godoy J; Prausová J; Katolicka J; Petruzelka L; Kiss I; Lapela M; Miller K; Bergmann L; Beck J; Jäger E; Kindler M; Overkamp F; Wirth M; Hölzer W; Gschwend J; Stenzl A; Gauler T; Niederwieser D; Marschner N; Lück A; Tessen H; Eichelberg C; Steiner T; Goebell P; Kettner E; Bakhshandeh-Bath A; Wilhelm M; Schmitz S; Jacob A; Bierer S; Kube U; Staehler M; Engel E; Frambach M; Schellenberger U; Albers P; Simon J; Gleissler M; Klotz T; Repp R, 2012, 'An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy', European Journal of Cancer, vol. 48, pp. 324 - 332, http://dx.doi.org/10.1016/j.ejca.2011.06.054

Saleh OA; Birnbaum AD; Tessler HH; Goldstein DA, 2012, 'Behçet uveitis in the American midwest', Ocular Immunology and Inflammation, vol. 20, pp. 12 - 17, http://dx.doi.org/10.3109/09273948.2011.630550

Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G, 2012, 'Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.', Clin Cancer Res, vol. 18, pp. 196 - 206, http://dx.doi.org/10.1158/1078-0432.CCR-11-1759

Wang X; Crowe PJ; Goldstein D; Yang JL, 2012, 'STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers', International Journal of Oncology, vol. 41, pp. 1181 - 1191, http://dx.doi.org/10.3892/ijo.2012.1568

Cameron BA; Bennett B; Li H; Boyle F; deSouza P; Wilcken N; Friedlander M; Goldstein D; Lloyd AR, 2012, 'Post-cancer fatigue is not associated with immune activation or altered cytokine production', Annals of Oncology, vol. 23, pp. 2890 - 2895, http://dx.doi.org/10.1093/annonc/mds108

Demetri GD; Garrett C; Sch offski P; Shah M; Verweij J; Leyvraz S; Hurwitz HI; Lopez Pousa A; Le Cesne A; Goldstein D; Paz-Ares L; Blay J; McArthur G; Xu Q; Huang X; Harmon CS; Tassell V; Cohen DP; Casali P, 2012, 'Complete Longitudinal Analyses of the Randomized,Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure', Clinical Cancer Research, vol. 18, pp. 3170 - 3179, http://dx.doi.org/10.1158/1078-0432.CCR-11-3005

Bennett BK; Park SB; Lin CS-Y; Friedlander M; Kiernan MC; Goldstein D, 2012, 'Impact of Oxaliplatin-induced Neuropathy: A Patient Perspective', Supportive Care in Cancer, vol. 20, pp. 2959 - 2967, http://dx.doi.org/10.1007/s00520-012-1428-5

Goldstein D; Spry N; Cummins MM; Brown C; Van Hazel GA; Carroll SL; Selva Nayagam S; Borg M; Ackland S; Wratten C; Shapiro J; Porter L; Hruby G; Horvath LG; Bydder S; Underhill C; Harvey JE; Gebski V, 2012, 'The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer', British Journal of Cancer, vol. 106, pp. 61 - 69, http://dx.doi.org/10.1038/bjc.2011.526

Goldstein D; Bennett BK; Webber K; Boyle F; De Souza P; Wilcken NRC; Scott E; Toppler R; Murie P; O''Malley L; Mccourt J; Friedlander M; Hickie IB; Lloyd AR, 2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, vol. 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148

Ngan SY; Burmeister B; Fisher R; Solomon M; Goldstein D; Joseph D; Ackland S; Schache D; McClure B; McLachlan S; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J, 2012, 'Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04', Journal of Clinical Oncology, vol. 30, pp. 3827 - 3833, http://dx.doi.org/10.1200/JCO.2012.42.9597

Butow P; Lobb EA; Jefford M; Goldstein D; Eisenbruch M; Girgis A; King MT; Sze M; Aldridge L; Schofield P, 2012, 'A bridge between cultures: Interpreters' perspectives of consultations with migrant oncology patients', Supportive Care in Cancer, vol. 20, pp. 235 - 244, http://dx.doi.org/10.1007/s00520-010-1046-z

Dumont AG; Rink L; Godwin AK; Miettinen M; Joensuu H; Strosberg JR; Gronchi A; Corless CL; Goldstein D; Rubin BP; Maki RG; Lazar AJ; Lev D; Trent JC; von Mehren M, 2012, 'A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients.', Annals of Oncology, vol. 23, pp. 1335 - 1340, http://dx.doi.org/10.1093/annonc/mdr442

Mitchison D; Butow PN; Sze M; Aldridge L; Hui R; Vardy JL; Eisenbruch M; Iedema R; Goldstein D, 2012, 'Prognostic Communication Preferences of Migrant Patients and their Relatives', Psycho-oncology, vol. 21, pp. 496 - 504, http://dx.doi.org/10.1002/pon.1923

Butow PN; Philips F; Schweder J; White K; Underhill C; Goldstein D, 2012, 'Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review', Supportive Care in Cancer, vol. 20, pp. 1 - 22, http://dx.doi.org/10.1007/s00520-011-1270-1

Ngan S; Fisher R; Burmeister B; Mackay J; McLachlan S; Beresford J; McClure B; Goldstein D; Joseph D; Solomon M, 2012, 'Long-term Quality of Life in Patients Treated in TROG 01.04: A Randomized Trial Comparing Short Course and Long Course Preoperative Radiation Therapy for Rectal Cancer', International Journal of Radiation Oncology*Biology*Physics, vol. 84, pp. S143 - S144, http://dx.doi.org/10.1016/j.ijrobp.2012.07.371

Dooks P; McQuestion M; Goldstein D; Molassiotis A, 2012, 'Experiences of patients with laryngectomies as they reintegrate into their community.', Support Care Cancer, vol. 20, pp. 489 - 498, http://dx.doi.org/10.1007/s00520-011-1101-4

Huang SH; O'Sullivan B; Weinreb I; Perez-Ordonez B; Irish J; Waldron J; Gullane P; Gilbert R; Brown D; Cummings B; Kim J; Freeman J; Witterick I; Goldstein D, 2012, 'Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease.', Head Neck, vol. 34, pp. 913 - 922, http://dx.doi.org/10.1002/hed.21854

Erovic BM; Harris L; Jamali M; Goldstein DP; Irish JC; Asa SL; Mete O, 2012, 'Biomarkers of parathyroid carcinoma.', Endocr Pathol, vol. 23, pp. 221 - 231, http://dx.doi.org/10.1007/s12022-012-9222-y

Huang S; O'Sullivan B; Xu W; Zhao H; Chen D; Chan K; Kim J; Bayley A; Goldstein D; Waldron J, 2012, 'Temporal Regression of Cervical Lymph Node in N2-N3 Head-and-Neck Cancer Treated with Primary Radiation Therapy ± Chemotherapy: Stratified by HPV Status', International Journal of Radiation Oncology*Biology*Physics, vol. 84, pp. S205 - S205, http://dx.doi.org/10.1016/j.ijrobp.2012.07.532

Harris L; Goldstein D; Hofer S; Gilbert R, 2012, 'Impact of vasopressors on outcomes in head and neck free tissue transfer.', Microsurgery, vol. 32, pp. 15 - 19, http://dx.doi.org/10.1002/micr.20961

Ross G; Yla-Kotola TM; Goldstein D; Zhong T; Gilbert R; Irish J; Gullane PJ; Hofer SOP; Neligan PC, 2012, 'Second free flaps in head and neck reconstruction.', J Plast Reconstr Aesthet Surg, vol. 65, pp. 1165 - 1168, http://dx.doi.org/10.1016/j.bjps.2012.03.035

Sawka AM; Straus S; Gafni A; Meiyappan S; David D; Rodin G; Brierley JD; Tsang RW; Thabane L; Rotstein L; Ezzat S; Goldstein DP, 2012, 'Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study.', Support Care Cancer, vol. 20, pp. 641 - 645, http://dx.doi.org/10.1007/s00520-011-1302-x

Minkovich L; Mccluskey S; Djaiani G; Goldstein D, 2012, 'High prevalence of significant hypophosphatemia in patient undergoing reconstructive surgery for head and neck cancers', European Journal of Anaesthesiology, vol. 29, pp. 185 - 185, http://dx.doi.org/10.1097/00003643-201206001-00614

Gilbert RW; Goldstein DP; Guillemaud JP; Patel RS; Higgins KM; Enepekides DJ, 2012, 'Vertical partial laryngectomy with temporoparietal free flap reconstruction for recurrent laryngeal squamous cell carcinoma: technique and long-term outcomes.', Arch Otolaryngol Head Neck Surg, vol. 138, pp. 484 - 491, http://dx.doi.org/10.1001/archoto.2012.410

Erovic BM; Kim D; Cassol C; Goldstein DP; Irish JC; Asa SL; Mete O, 2012, 'Prognostic and predictive markers in medullary thyroid carcinoma.', Endocr Pathol, vol. 23, pp. 232 - 242, http://dx.doi.org/10.1007/s12022-012-9225-8

Bachar G; Goldstein DP; Barker E; Lea J; O'Sullivan B; Brown DH; Gullane PJ; Gilbert RW; Xu W; Su J; Irish JC, 2012, 'Squamous cell carcinoma of the buccal mucosa: outcomes of treatment in the modern era.', Laryngoscope, vol. 122, pp. 1552 - 1557, http://dx.doi.org/10.1002/lary.23296

Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis', The Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470-2045(11)70212-1

Saraiya NV; Patel SS; Goldstein DA, 2011, 'A report of high intraocular pressure with the dexamethasone intravitreal implant', Archives of Ophthalmology, vol. 129, pp. 1638 - 1639, http://dx.doi.org/10.1001/archophthalmol.2011.355

Oltra EZ; Morris C; Birnbaum AD; Tessler HH; Goldstein DA, 2011, 'Chronic anterior uveitis in common variable immunodeficiency', Ocular Immunology and Inflammation, vol. 19, pp. 448 - 449, http://dx.doi.org/10.3109/09273948.2011.625136

SALEH O; GOLDSTEIN DA, 2011, 'Managing Birdshot Chorioretinitis in Clinical Practice', Retinal Physician, vol. 8, pp. 22 - 28, http://dx.doi.org/10.1097/01.rp.0000407522.86803.1b

Reis PP; Waldron L; Perez-Ordonez B; Pintilie M; Galloni NN; Xuan Y; Cervigne NK; Warner GC; Makitie AA; Simpson C; Goldstein D; Brown D; Gilbert R; Gullane P; Irish J; Jurisica I; Kamel-Reid S, 2011, 'A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.', BMC Cancer, vol. 11, pp. 437, http://dx.doi.org/10.1186/1471-2407-11-437

Li SY; Birnbaum AD; Tessler HH; Goldstein DA, 2011, 'Posterior syphilitic uveitis: Clinical characteristics, co-infection with HIV, response to treatment', Japanese Journal of Ophthalmology, vol. 55, pp. 486 - 494, http://dx.doi.org/10.1007/s10384-011-0053-z

Le-Nguyen XT; Lee TKM; Do DV; Sepah YJ; Nguyen QD; Rao NA; Vasconcelos-Santos DV; Goldstein DA, 2011, 'Diagnostic and therapeutic challenges', Retina, vol. 31, pp. 1732 - 1739, http://dx.doi.org/10.1097/IAE.0b013e31820f4825

Peng J; Shi D; Goodman KA; Goldstein D; Xiao C; Guan Z; Cai S, 2011, 'Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29', Radiation Oncology, vol. 6, http://dx.doi.org/10.1186/1748-717X-6-93

Butow PN; Goldstein D; Bell ML; Sze M; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J; Ashgari R; Hui R; Eisenbruch M, 2011, 'Interpretation in consultations with immigrant patients with cancer: How accurate is it?', Journal of Clinical Oncology, vol. 29, pp. 2801 - 2807, http://dx.doi.org/10.1200/JCO.2010.34.3335

Patel KH; Birnbaum AD; Tessler HH; Goldstein DA, 2011, 'Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center', Retina, vol. 31, pp. 1387 - 1391, http://dx.doi.org/10.1097/IAE.0b013e3182069a8f

Jayaprakash Patil A; Edward DP; Wong M; Ravichandran P; Goldstein DA, 2011, 'The role of perivascular melanophage infiltrates in the conjunctiva in sympathetic ophthalmia', Ocular Immunology and Inflammation, vol. 19, pp. 186 - 191, http://dx.doi.org/10.3109/09273948.2010.538122

Webber K; Mok K; Bennett BK; Juraskova I; Goldstein D; Friedlander M; Lloyd AR; FOLCAN study group , 2011, 'Cancer-related fatigue and sexual functioning in women with early breast cancer: Is there a link?', J Clin Oncol, vol. 29, pp. 9072, http://www.ncbi.nlm.nih.gov/pubmed/28021533

Goldstein D; Lee C; Tracey E; Cook-Yarborough C; Lord S, 2011, 'Validating innovation: A population-based study of gastrointestinal stromal tumors (GIST) to estimate the survival benefit of imatinib.', J Clin Oncol, vol. 29, pp. 10060, http://www.ncbi.nlm.nih.gov/pubmed/28021288

Hammel P; Huguet F; Van Laethem J; Goldstein D; Glimelius B; Moore MJ; Chibaudel B; Bonnetain F; Louvet C, 2011, 'Randomized multicenter phase III study in patients with locally advanced adenocarcinoma of the pancreas: Gemcitabine with or without chemoradiotherapy and with or without erlotinib—LAP 07 study.', Journal of Clinical Oncology, vol. 29, pp. e14619 - e14619, http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e14619

Saraiya NV; Goldstein DA, 2011, 'Dexamethasone for ocular inflammation', Expert Opinion on Pharmacotherapy, vol. 12, pp. 1127 - 1131, http://dx.doi.org/10.1517/14656566.2011.571209

Choi DE; Birnbaum AD; Oh F; Tessler HH; Goldstein DA, 2011, 'Pediatric uveitis secondary to probable, presumed, and biopsy-proven sarcoidosis', Journal of Pediatric Ophthalmology and Strabismus, vol. 48, pp. 157 - 162, http://dx.doi.org/10.3928/01913913-20100518-01

Birnbaum AD; Jiang Y; Tessler HH; Goldstein DA, 2011, 'Elevation of intraocular pressure in patients with uveitis treated with topical difluprednate', Archives of Ophthalmology, vol. 129, pp. 667 - 668, http://dx.doi.org/10.1001/archophthalmol.2011.82

Arun SJ; Xu Z; Fiala-Beer E; Phillips P; Goldstein D; Biankin A; Pirola R; Wilson JS; Apte MV, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-LB-395

Yang JL; DasGupta R; Hopkins A; Luk F; Goldstein D; Crowe P, 2011, 'Significance of IGF-1R and Its signaling pathways in human sarcoma', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-4416

Rush RB; Goldstein DA; Callanan DG; Meghpara B; Feuer WJ; Davis JL, 2011, 'Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonidecontaining device', American Journal of Ophthalmology, vol. 151, pp. 630 - 636, http://dx.doi.org/10.1016/j.ajo.2010.10.005

Birnbaum AD; Oh FS; Chakrabarti A; Tessler HH; Goldstein DA, 2011, 'Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis', Archives of Ophthalmology, vol. 129, pp. 409 - 413, http://dx.doi.org/10.1001/archophthalmol.2011.52

Sen HN; Sangave AA; Goldstein DA; Suhler EB; Cunningham D; Vitale S; Nussenblatt RB, 2011, 'A standardized grading system for scleritis', Ophthalmology, vol. 118, pp. 768 - 771, http://dx.doi.org/10.1016/j.ophtha.2010.08.027

Goldstein D; Gainford MC; Brown C; Tebbutt N; Ackland SP; Van Hazel G; Jefford M; Abdi E; Selva-Nayagam S; Gebski V; Miller D; Shannon J, 2011, 'Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, vol. 67, pp. 519 - 525, http://dx.doi.org/10.1007/s00280-010-1351-8

Birnbaum AD; Little DM; Tessler HH; Goldstein DA, 2011, 'Etiologies of chronic anterior uveitis at a tertiary referral center over 35 years', Ocular Immunology and Inflammation, vol. 19, pp. 19 - 25, http://dx.doi.org/10.3109/09273948.2010.519852

Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Jeffrey GM; Tebbutt NC; Buck M; Lowenthal RM; Boland A; Gebski V; Zalcberg J; Simes RJ, 2011, 'Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis', European Journal of Cancer, vol. 47, pp. 1826 - 1836, http://dx.doi.org/10.1016/j.ejca.2011.04.024

Gupta S; Blair MP; Lin AY; David O; Tessler HH; Goldstein DA, 2011, 'Cutaneous melanoma metastatic to the vitreous cavity', Retinal Cases and Brief Reports, vol. 5, pp. 197 - 200, http://dx.doi.org/10.1097/ICB.0b013e3182235354

Hoang QV; Simon DM; Goldstein DA, 2011, 'Approach to recurrent CMV disease and antiviral resistance', Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 249, pp. 149, http://dx.doi.org/10.1007/s00417-010-1411-0

Goldstein D; Gainford M; Brown C; Tebbutt N; Ackland S; Van Hazel GA; Jefford M; Abdi E; Gebski V; Miller D; Shannon JF, 2011, 'Fixed dose rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, vol. 16, pp. 519 - 519

Wirth A; Grigg A; Wolf M; Goldstein D; Johnson C; Davis S; Dutu G; Kypreos P; Smith C; Kneebone A; Herzberg M; Joseph D; Catalano J; Roos DE; Stone J; Reynolds J, 2011, 'Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group', Leukemia and Lymphoma, vol. 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155

Park SB; Goldstein D; Lin CS-Y; Krishnan AV; Friedlander M; Kiernan MC, 2011, 'Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, vol. 29, pp. e553 - e554e, http://dx.doi.org/10.1200/JCO.2011.34.8227

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Long-term neuropathy after Oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, vol. 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Dose effects of Oxaliplatin on persistent and transient na+ conductances and the development of neurotoxicity', PLoS One, vol. 6, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0018469

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, vol. 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002

Webber K; Cooper A; Kleiven H; Yip D; Goldstein D, 2011, 'Management of metastatic renal cell carcinoma in the era of targeted therapies', Internal Medicine Journal, vol. 41, pp. 594 - 605, http://dx.doi.org/10.1111/j.1445-5994.2011.02540.x

Webber K; Mok K; Bennett BK; Lloyd AR; Friedlander M; Juraskova I; Goldstein D, 2011, 'If I Am in the Mood, I Enjoy It: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer', Oncologist, vol. 16, pp. 1333 - 1344, http://dx.doi.org/10.1634/theoncologist.2011-0100

Sjoquist KM; Goldstein D; Bester L; Bester L, 2011, 'A serious complication of selected internal radiation therapy: case report and literature review', Oncologist, vol. 15, pp. 830 - 835, http://dx.doi.org/10.1634/theoncologist.2010-0074

Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge L; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis', Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470

Tebbutt N; murphy F; Zannino D; Wilson D; Cummins MM; Abdi E; Strickland A; Lowenthal RM; Marx G; Karapetis C; Shannon JF; Goldstein D; Nayagam SS; Blum R; Chantrill L; Simes RJ; Price T, 2011, 'Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab', Annals of Oncology, vol. 22, pp. 1834 - 1838, http://dx.doi.org/10.1093/annonc/mdq702

Zhi J; Major P; Chen E; Burns I; Robinson B; McKendrick J; Rittweger K; Abt M; Goldstein D, 2011, 'A multi-centre, randomised, open-lable study to assess the steady state paramacokinetics of Bevacizumab given with either Xeloda or FOLFOX-4 in patient with metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, vol. 68, pp. 1199 - 1206, http://dx.doi.org/10.1007/s00280-011-1606-z

Goldstein D; Butow P; Sze M; Mikhail M; Eisenbruch M, 2011, 'Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters', Patient Education and Counseling, vol. 84, pp. 398 - 405, http://dx.doi.org/10.1016/j.pec.2011.01.035

Leighl N; Shepherd H; Butow PN; clarke SJ; Mcjannett M; Beale P; Wilken N; Moore M; Chen E; Goldstein D; Horvath LG; Knox J; Krzyzanowska M; Oza AM; Feld R; Hedley D; Xu W; Tattersall MH, 2011, 'Supporting treatment decision-making in advanced cancer: a randomized trial of a decision aid for patients considering chemotherapy in advanced colorectal cancer', Journal of Clinical Oncology, vol. 29, pp. 2077 - 2084, http://dx.doi.org/10.1200/JCO.2010.32.0754

Alexander AJ; de Almeida JR; Shrime MG; Goldstein DP; Gilbert RW, 2011, 'Novel outpatient approach to lower lip reanimation using a palmaris longus tendon sling.', J Otolaryngol Head Neck Surg, vol. 40, pp. 481 - 488, https://www.ncbi.nlm.nih.gov/pubmed/22420436

Eskander A; Freeman J; Rotstein L; Higgins K; Enepekides D; Gilbert R; Brown D; Gullane P; Irish J; Sawka AM; Goldstein DP, 2011, 'Response rates for mailout survey-driven studies in patients waiting for thyroid surgery.', J Otolaryngol Head Neck Surg, vol. 40, pp. 462 - 467, https://www.ncbi.nlm.nih.gov/pubmed/22420433

Bachar G; Hod R; Goldstein DP; Irish JC; Gullane PJ; Brown D; Gilbert RW; Hadar T; Feinmesser R; Shpitzer T, 2011, 'Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors.', Oral Oncol, vol. 47, pp. 45 - 50, http://dx.doi.org/10.1016/j.oraloncology.2010.11.003

Habbous S; Chu KP; Shao Hui H; Xu W; Cheng L; Tse A; Goldstein DP; Waldron J; O'Sullivan B; Liu G, 2011, 'Comparing Epidemiologic Survey Data To Abstracted Data From A Head and Neck Cancer (HNC) Radiation Oncology Administrative Database', International Journal of Radiation Oncology*Biology*Physics, vol. 81, pp. S501 - S502, http://dx.doi.org/10.1016/j.ijrobp.2011.06.1024

Chan AK; Huang S; Le LW; Goldstein DP; Chan K; Dawson LA; Kim J; O'Sullivan B; Cummings B; Hope AJ, 2011, 'Postoperative IMRT following Surgery for Oral Cavity Squamous Cell Carcinoma: Patterns of Failure', International Journal of Radiation Oncology*Biology*Physics, vol. 81, pp. S105 - S105, http://dx.doi.org/10.1016/j.ijrobp.2011.06.214

O'Sullivan B; Huang SH; Perez-Ordonez B; Weinreb I; Xu W; Cheng L; Kim J; Chen E; Goldstein D; Waldron J, 2011, '8500 ORAL Impact of Smoking Pack-years on Anatomic Disease Outcomes for HPV-related Oropharyngeal Cancer Treated With Radiotherapy With or Without Chemotherapy', European Journal of Cancer, vol. 47, pp. S543 - S543, http://dx.doi.org/10.1016/s0959-8049(11)72142-6

Ganly I; Goldstein D; Patel S; Lee N; Gullane P; Shah J, 2011, 'Long Term Regional Control and Survival in Patients with “Low Risk” Early Stage Oral Tongue Cancer Managed by Partial Glossectomy and Neck Dissection without Postoperative Radiation: The Importance of Depth of Invasion', International Journal of Radiation Oncology*Biology*Physics, vol. 81, pp. S105 - S106, http://dx.doi.org/10.1016/j.ijrobp.2011.06.215

Sawka AM; Straus S; Gafni A; Meiyappan S; O'Brien MA; Brierley JD; Tsang RW; Rotstein L; Thabane L; Rodin G; George SR; Goldstein DP, 2011, 'A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment.', Patient Educ Couns, vol. 84, pp. e24 - e27, http://dx.doi.org/10.1016/j.pec.2010.07.038

Sawka AM; Straus S; Gafni A; Brierley JD; Tsang RW; Rotstein L; Ezzat S; Thabane L; Rodin G; Meiyappan S; David D; Goldstein DP, 2011, 'How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?', Clin Endocrinol (Oxf), vol. 74, pp. 419 - 423, http://dx.doi.org/10.1111/j.1365-2265.2010.03966.x

Huang SH; Goldstein D; Weinreb I; Perez-Ordonez B; Fung S; Irish J; Waldron J; Kim J; Cummings B; O'SuIlivan B, 2011, 'PATTERN OF FAILURE AND HiSTOPATHOLOGICAL FEATURES IN PATIENTS WITH POSITIVE POSTRADIATION PLANNED NECK DISSECTION', Radiotherapy and Oncology, vol. 98, pp. S31 - S31, http://dx.doi.org/10.1016/s0167-8140(11)70078-0

Johnston ML; Waldron JN; Huang SSH; Atenafu E; Chan K; Cummings BJ; Goldstein D; Perez-Ordonez B; O'Sullivan B; Kim J, 2011, 'Salivary Duct Carcinoma: Treatment, Outcomes and Clinico-pathological Review', International Journal of Radiation Oncology*Biology*Physics, vol. 81, pp. S526 - S526, http://dx.doi.org/10.1016/j.ijrobp.2011.06.813

Lee C; Cooper RM; Goldstein D, 2011, 'Management of a patient with tracheomalacia and supraglottic obstruction after thyroid surgery.', Can J Anaesth, vol. 58, pp. 1029 - 1033, http://dx.doi.org/10.1007/s12630-011-9570-y

Li SY; Birnbaum AD; Goldstein DA, 2010, 'Optic neuritis associated with adalimumab in the treatment of uveitis', Ocular Immunology and Inflammation, vol. 18, pp. 475 - 481, http://dx.doi.org/10.3109/09273948.2010.495814

Gupta S; Blair MP; Lin AY; David O; Tessler HH; Goldstein DA, 2010, 'CUTANEOUS MELANOMA METASTATIC TO THE VITREOUS CAVITY', RETINAL Cases & Brief Reports, vol. Publish Ahead of Print, http://dx.doi.org/10.1097/icb.0b013e3181e1a753

Birnbaum AD; Tessler HH; Goldstein DA, 2010, 'Sympathetic ophthalmia in operation Iraqi freedom', American Journal of Ophthalmology, vol. 150, pp. 758 - 759, http://dx.doi.org/10.1016/j.ajo.2010.07.017

Sawka AM; Straus S; Brierley JD; Tsang RW; Rotstein L; Rodin G; Gafni A; Ezzat S; Thabane L; Thorpe KE; Goldstein DP, 2010, 'Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.', Trials, vol. 11, pp. 81, http://dx.doi.org/10.1186/1745-6215-11-81

Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; Van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP; Forgeson G; Cunningham D; Saunders MP; Stockler MR; Chua Y; Zalcberg JR; Simes RJ; Price TJ; Price T; Coates A; O'Connell D; Brown C; Hague W; France A; Hicks S; James R; Masson R; O'Connell R; Pike R; Shoulder J; Stevens L; Tunney V; Vachan B; Wong N; Ackland S; Moylan E; Strickland A; Abdi E; Ransom D; Lowenthal R; Marx G; Nayagam SS; Shannon J; Goldstein D; Karapetis C; Blum R; Eek R; Ward R; Pavlakis N; Wilcken N; Burns I; Wyld D; Underhill C; Claringbold P; Liauw W; Clingan P; Jefford M; Horvath L; McKendrick J; Chong G; Boyce A; Cassidy J; Kirsten F; Clarke S; Guo Y; Innes-Rowe J; Smith A; Williams J; Tournier E; Maliepaard S; Vitullo E; Humm G; Nguyen V; Midolo P; Chorlton C; McDonald L; Oliver L; Sjursen AM; Inglis C; Marafioti T; McCourt J; Howard J; Richards A; Provis A; Rundle A; Whatman A; Emmett L; Raymond B; Byrne S; Withers E; Campbell J; Hodgkins C; Szwajcer M; Parker S; Welby S; Page F; Corker M; Wykes R; Goss C; Whitney S, 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, vol. 28, pp. 3191 - 3198, http://dx.doi.org/10.1200/JCO.2009.27.7723

Webber K; Goldstein D; Bennett BK; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Lloyd AR, 2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, vol. 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047

Ngan S; Fisher R; Goldstein D; Solomon M; Burmeister B; Ackland SP; Joseph DJ; McClure B; McLachlan S; Mackay J, 2010, 'A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS).', Journal of Clinical Oncology, vol. 28, pp. 3509 - 3509, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3509

Bernstein LJ; Gan HK; Abdul Razak AR; Tirona KM; Ringash J; O'Sullivan B; Waldron JN; Hope AJ; Goldstein DP; Siu LL, 2010, 'Cognitive functioning pre- and postradiotherapy (RT), chemoradiotherapy (CRT), or bioradiotherapy (BRT) in patients with locally advanced squamous cell cancer of the head and neck (LA-SCCHN).', Journal of Clinical Oncology, vol. 28, pp. e19629 - e19629, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.e19629

Tebbutt NC; Kotasek D; Burris HA; Schwartzberg LS; Hurwitz H; Stephenson J; Adewoye H; Sun Y; Ye Y; Goldstein D, 2010, 'Motesanib with or without panitumumab (pmab) plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer (mCRC).', Journal of Clinical Oncology, vol. 28, pp. 3538 - 3538, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3538

Klumpen H; Eechoute K; Hertzberg MS; Schwarer AA; Goldstein D; Hughes TP; Liddle C; Mathijssen R; Schellens JH; Gurney H, 2010, 'Pharmacogenetic factors predicting the need for a higher dose of imatinib.', Journal of Clinical Oncology, vol. 28, pp. 3098 - 3098, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3098

Birnbaum AD; Blair MP; Tessler HH; Goldstein DA, 2010, 'Subretinal fluid in acute posterior multifocal placoid pigment epitheliopathy', Retina, vol. 30, pp. 810 - 814, http://dx.doi.org/10.1097/IAE.0b013e3181c596f8

Meghpara B; Sulkowski G; Kesen MR; Tessler HH; Goldstein DA, 2010, 'Long-term follow-up of acute retinal necrosis', Retina, vol. 30, pp. 795 - 800, http://dx.doi.org/10.1097/IAE.0b013e3181c7013c

Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S, 2010, 'Low prevalence of human papillomavirus in oral cavity carcinomas.', Head Neck Oncol, vol. 2, pp. 6, http://dx.doi.org/10.1186/1758-3284-2-6

Birnbaum AD; Huang W; Sahin O; Tessler HH; Goldstein DA, 2010, 'Ocular sarcoidosis misdiagnosed as primary intraocular lymphoma', Retina, vol. 30, pp. 310 - 316, http://dx.doi.org/10.1097/IAE.0b013e3181b773fc

Hoang QV; Simon DM; Kumar GN; Oh F; Goldstein DA, 2010, 'Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV', Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, pp. 737 - 740, http://dx.doi.org/10.1007/s00417-009-1283-3

Chua YJ; Michael M; Zalcberg JR; Hicks RJ; Goldstein D; Liauw W; Price T, 2010, 'Antitumor effect of somatostatin analogs in neuroendocrine tumors', Journal of Clinical Oncology, vol. 28, http://dx.doi.org/10.1200/JCO.2009.26.0612

Lovell MR; Forder PM; Stockler MR; Butow P; Briganti EM; Chye R; Goldstein D; Boyle FM, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain', Journal of Pain and Symptom Management, vol. 40, pp. 49 - 59, http://dx.doi.org/10.1016/j.jpainsymman.2009.12.013

Kapur R; Birnbaum AD; Goldstein DA; Tessler HH; Shapiro MJ; Ulanski LJ; Blair MP, 2010, 'Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection', Retina, vol. 30, pp. 140 - 145, http://dx.doi.org/10.1097/IAE.0b013e3181b32f06

Birnbaum AD; Oh F; Sahin O; Little DM; Tessler HH; Goldstein DA, 2010, 'Chlorambucil and malignancy', Ophthalmology, vol. 117, http://dx.doi.org/10.1016/j.ophtha.2010.03.023

Xu ZH; Vonlaufen A; Phillips PA; Fiala-Beer E; Zhang X; Yang L; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer metastasis', American Journal of Pathology, vol. 177, pp. 2585 - 2596, http://dx.doi.org/10.2353/ajpath.2010.090899

Goldstein D; Ackland S; Van Hazel GA; Jefford M; Shannon JF; Gainford M; Brown C; Abdi E; Miller D; Gebski V; Tebbutt N, 2010, 'Optimising the benefit: a phase II trial of Gemcitabine in fixed dose rate infusion combined with Cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology

Goldstein D; Harris C; Harris C, 2010, 'Tamoxifen use in retroperitoneal fibrosis, case report and review of the literature', Internal Medicine Journal, vol. 40, pp. e5 - e7

Goldstein D; Gill A; Chou A; Vilain R; Clarkson A; Lui M; Jin R; Tobias VH; Samral J; Smith C; Sioson L; Parker N; Smith R; Sywak M; Wyatt S; Robinson B; Eckstein R; Benn D; Clifton-bligh R, 2010, 'Immunohistochemistry for SDHB divides gastrointestinal stromal tumours (GISTs) into two distinct types', American Journal of Surgical Pathology, vol. 34, pp. 636 - 644, http://dx.doi.org/10.1097/PAS.0b013e3181d6150d

Rossleigh MA; Goldstein D, 2010, 'Treatment of Fluorouracil-Refractory Patients with Liver Metastases from Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, vol. 27, pp. 4089 - 4095, http://dx.doi.org/10.1200/JCO.2008.20.8116

Goldstein D; Butow PN; Boyle F; Stockler M; Lovell M; Chye R; Forder P; Briganti E, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain', Journal of Pain and Symptom Management, vol. 49, pp. 49 - 59, http://dx.doi.org/10.1016/j.jpainsymman.2009.12.013

Butow PN; Sze M; Dugal-beri P; Mikhail M; Eisenbruch M; Jefford M; Schofield P; Girgis A; king M; Goldstein D, 2010, 'From inside the bubble: Migrants' perceptions of communication with the cancer tea', Supportive Care in Cancer, vol. 19, pp. 281 - 290, http://dx.doi.org/10.1007/s00520-010-0817-x

Wolf M; Kneebone AB; Goldstein D; Joseph D; Wirth A; Grigg A; Johnson C; Davis S, 2010, 'Risk and Response Adapted Therapy for Early Stage Hodgkin Lymphoma: A Prospective Multi-Centre Study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group', Leukemia and Lymphoma, vol. 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155

Goldstein D; Underhill CR; Olver IN; Kosczwara ; Kay F; Franca M, 2010, 'Reaching Further with Online Education? The Development of an Effective Online Program in Palliative Oncology', Journal of Cancer Education, vol. 25, pp. 317 - 323, http://dx.doi.org/10.1007/s13187-009-0037-6

Blinman P; Duric V; Nowak A; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler M, 2010, 'Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?', European Journal of Cancer, vol. 46, pp. 1800 - 1807, http://dx.doi.org/10.1016/j.ejca.2009.12.032

Neoptolemos J; stocken D; bassi C; Goldstein D, 2010, 'Adjuvant chemotherapy with flurouracil plus folinic acid vs gemcitabine following pancreatic cancer resection:a randomsied trial JAMA 2010', JAMA - Journal of the American Medical Association, vol. 304, pp. 1073 - 1081, http://dx.doi.org/10.1001/jama.2010.1275

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2010, '5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity', Clinical Neurophysiology, vol. 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.025

Eskander A; Ghazarian D; Bray P; Dawson LA; Goldstein DP, 2010, 'Squamous cell carcinoma arising in a proliferating pilar (trichilemmal) cyst with nodal and distant metastases.', J Otolaryngol Head Neck Surg, vol. 39, pp. E63 - E67, https://www.ncbi.nlm.nih.gov/pubmed/20828506

Guillemaud JP; Patel RS; Goldstein DP; Higgins KM; Enepekides DJ, 2010, 'Prognostic impact of intraoperative microscopic cut-through on frozen section in oral cavity squamous cell carcinoma.', J Otolaryngol Head Neck Surg, vol. 39, pp. 370 - 377, https://www.ncbi.nlm.nih.gov/pubmed/20643001

Shah MD; Goldstein DP; McCluskey SA; Miles BA; Hofer SO; Brown DH; Irish JC; Gullane PJ; Gilbert RW, 2010, 'Blood transfusion prediction in patients undergoing major head and neck surgery with free-flap reconstruction.', Arch Otolaryngol Head Neck Surg, vol. 136, pp. 1199 - 1204, http://dx.doi.org/10.1001/archoto.2010.202

Haykal S; Al Habeeb AS; Goldstein DP; Murray CA; Ghazarian D, 2010, 'Infundibular carcinoma of the skin: a distinct morphological and immunohistochemical entity.', J Clin Pathol, vol. 63, pp. 455 - 462, http://dx.doi.org/10.1136/jcp.2009.074419

Miles BA; Goldstein DP; Gilbert RW; Gullane PJ, 2010, 'Mandible reconstruction.', Curr Opin Otolaryngol Head Neck Surg, vol. 18, pp. 317 - 322, http://dx.doi.org/10.1097/MOO.0b013e32833aaf7e

Lea J; Bachar G; Sawka AM; Lakra DC; Gilbert RW; Irish JC; Brown DH; Gullane PJ; Goldstein DP, 2010, 'Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis.', Head Neck, vol. 32, pp. 184 - 190, http://dx.doi.org/10.1002/hed.21163

Patel RS; McCluskey SA; Goldstein DP; Minkovich L; Irish JC; Brown DH; Gullane PJ; Lipa JE; Gilbert RW, 2010, 'Clinicopathologic and therapeutic risk factors for perioperative complications and prolonged hospital stay in free flap reconstruction of the head and neck.', Head Neck, vol. 32, pp. 1345 - 1353, http://dx.doi.org/10.1002/hed.21331

de Almeida JR; Alexander AJ; Shrime MG; Gilbert RW; Goldstein DP, 2010, 'Development and preliminary validation of the lip reanimation outcomes questionnaire.', Otolaryngol Head Neck Surg, vol. 143, pp. 361 - 366, http://dx.doi.org/10.1016/j.otohns.2010.05.015

Huang S; Goldstein D; Weinreb I; Perez-Ordonez B; Fung S; Irish J; Waldron J; Kim J; Cummings B; O'Sullivan B, 2010, 'Positive Postradiotherapy Planned Neck Dissection is Strongly Associated with Increased Distant Metastasis Rather Than Regional Relapse', International Journal of Radiation Oncology*Biology*Physics, vol. 78, pp. S454 - S455, http://dx.doi.org/10.1016/j.ijrobp.2010.07.1067

Shrime MG; Gullane PJ; Dawson L; Kim J; Gilbert RW; Irish JC; Brown DH; Goldstein DP, 2010, 'The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity.', Arch Otolaryngol Head Neck Surg, vol. 136, pp. 225 - 228, http://dx.doi.org/10.1001/archoto.2010.22

Patel RS; Goldstein DP; Guillemaud J; Bruch GA; Brown D; Gilbert RW; Gullane PJ; Higgins KM; Irish J; Enepekides DJ, 2010, 'Impact of positive frozen section microscopic tumor cut-through revised to negative on oral carcinoma control and survival rates.', Head Neck, vol. 32, pp. 1444 - 1451, http://dx.doi.org/10.1002/hed.21334

Patel RS; Goldstein DP; Brown D; Irish J; Gullane PJ; Gilbert RW, 2010, 'Circumferential pharyngeal reconstruction: history, critical analysis of techniques, and current therapeutic recommendations.', Head Neck, vol. 32, pp. 109 - 120, http://dx.doi.org/10.1002/hed.21169

van Driel AA; Mureau MAM; Goldstein DP; Gilbert RW; Irish JC; Gullane PJ; Neligan PC; Hofer SOP, 2010, 'Aesthetic and oncologic outcome after microsurgical reconstruction of complex scalp and forehead defects after malignant tumor resection: an algorithm for treatment.', Plast Reconstr Surg, vol. 126, pp. 460 - 470, http://dx.doi.org/10.1097/PRS.0b013e3181de2260

Harris C; Goldstein D, 2010, 'Tamoxifen use in retroperitoneal fibrosis.', Intern Med J, vol. 40, pp. e5 - e7, http://dx.doi.org/10.1111/j.1445-5994.2010.02373.x

Goldstein DP; Eskander A; Chepeha DB; Ringash J; Irish J; Davis AM, 2010, 'Response rates for mailout survey-driven studies in patients with head and neck cancer.', Head Neck, vol. 32, pp. 1585 - 1591, http://dx.doi.org/10.1002/hed.21363

Sawka AM; Ibrahim-Zada I; Galacgac P; Tsang RW; Brierley JD; Ezzat S; Goldstein DP, 2010, 'Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.', Thyroid, vol. 20, pp. 1129 - 1138, http://dx.doi.org/10.1089/thy.2010.0055

Bachar GY; Goh C; Goldstein DP; O'Sullivan B; Irish JC, 2010, 'Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy.', Eur Arch Otorhinolaryngol, vol. 267, pp. 295 - 301, http://dx.doi.org/10.1007/s00405-009-1070-0

Xu Z; Phillips PA; Vonlaufen A; Fiala-Beer E; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Normal Pancreatic Stellate Cells Facilitate Pancreatic Cancer Progression, Exhibit Transendothelial Migration and Accompany Cancer Cells to Distant Metastatic Sites', PANCREAS, vol. 38, pp. 1062 - 1062, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271225300403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong M; Janowicz M; Tessler HH; Goldstein DA, 2009, 'High-resolution optical coherence tomography of presumed sarcoid retinal granulomas', Retina, vol. 29, pp. 1545 - 1546, http://dx.doi.org/10.1097/IAE.0b013e3181bd2ffc

Fontanilla FA; Edward DP; Wong M; Tessler HH; Eagle RC; Goldstein DA, 2009, 'Juvenile xanthogranuloma masquerading as melanoma', Journal of AAPOS, vol. 13, pp. 515 - 518, http://dx.doi.org/10.1016/j.jaapos.2009.06.010

Novakovic D; Patel RS; Goldstein DP; Gullane PJ, 2009, 'Salvage of failed free flaps used in head and neck reconstruction.', Head Neck Oncol, vol. 1, pp. 33, http://dx.doi.org/10.1186/1758-3284-1-33

Kesen MR; Edward DP; Rao NA; Sugar J; Tessler HH; Goldstein DA, 2009, 'Atypical infectious nodular scleritis', Archives of Ophthalmology, vol. 127, pp. 1079 - 1080, http://dx.doi.org/10.1001/archophthalmol.2009.197

Channa R; Khurana RN; Speicher MA; Shah SM; Do D; Quan DN; Levinson R; Goldstein DA, 2009, 'Diagnostic and therapeutic challenges', Retina, vol. 29, pp. 1045 - 1051, http://dx.doi.org/10.1097/IAE.0b013e3181a3b886

Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, vol. 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.18s.lba4505

Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, vol. 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.18_suppl.lba4505

Goldstein DA, 2009, 'Uncovering the risks of immunosuppressive therapy in patients with uveitis', Archives of Ophthalmology, vol. 127, pp. 799 - 800, http://dx.doi.org/10.1001/archophthalmol.2009.124

Wong M; Goldstein DA; Tessler HH, 2009, 'Presumed Fuchs Heterochromic Iridocyclitis and Posner-Schlossman Syndrome: Comparison of Cytomegalovirus-Positive and -Negative Eyes', American Journal of Ophthalmology, vol. 147, pp. 1106 - 1107, http://dx.doi.org/10.1016/j.ajo.2009.02.025

Oh FS; Goldstein DA; Tessler HH, 2009, 'Etiologies of Pediatric Uveitis', Contemporary Ophthalmology, vol. 8, pp. 1 - 7, http://dx.doi.org/10.1097/01.cop.0000351855.10266.10

Goldstein D; van Hazel G; Selva-Nayagam S; Ackland S; Shapiro J; Carroll S; Cummins M; Brown C; Simes RJ; Spry N, 2009, 'GOFURTGO trial (GFG): An AGITG multicenter phase II study of fixed dose rate gemcitabine-oxaliplatin (Gem-Ox) integrated with concomitant 5FU and 3-D conformal radiotherapy (5FU-3DRT) for the treatment of locally advanced pancreatic cancer (LAPC).', J Clin Oncol, vol. 27, pp. 4616, http://www.ncbi.nlm.nih.gov/pubmed/27964183

Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, vol. 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.lba4505

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', CANCER RESEARCH, vol. 69, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phillips P; Chow MW; Vonlaufen A; Xu Z; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression.', CANCER RESEARCH, vol. 69, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Huang SH; Hwang D; Lockwood G; Goldstein DP; O'Sullivan B, 2009, 'Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies.', Cancer, vol. 115, pp. 1489 - 1497, http://dx.doi.org/10.1002/cncr.24161

Lee CK; Hadley A; Desilva K; Smith G; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis.', World J Surg Oncol, vol. 7, pp. 8, http://dx.doi.org/10.1186/1477-7819-7-8

Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2009, 'WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online)

Smith JA; Mackensen F; Sen HN; Leigh JF; Watkins AS; Pyatetsky D; Tessler HH; Nussenblatt RB; Rosenbaum JT; Reed GF; Vitale S; Smith JR; Goldstein DA, 2009, 'Epidemiology and Course of Disease in Childhood Uveitis', Ophthalmology, vol. 116, http://dx.doi.org/10.1016/j.ophtha.2009.05.002

Goldstein DA; Mis AA; Oh FS; Deschenes JG, 2009, 'Persistent pupillary dilation in herpes simplex uveitis', Canadian Journal of Ophthalmology, vol. 44, pp. 314 - 316, http://dx.doi.org/10.3129/i09-018

Mahajan VB; Gehrs KM; Goldstein DA; Fischer DH; Lopez JS; Folk JC, 2009, 'Management of Sympathetic Ophthalmia with the Fluocinolone Acetonide Implant', Ophthalmology, vol. 116, http://dx.doi.org/10.1016/j.ophtha.2008.10.024

Galor A; Davis JL; Flynn HW; Feuer WJ; Dubovy SR; Setlur V; Kesen MR; Goldstein DA; Tessler HH; Ganelis IB; Jabs DA; Thorne JE, 2009, 'Sympathetic Ophthalmia: Incidence of Ocular Complications and Vision Loss in the Sympathizing Eye', American Journal of Ophthalmology, vol. 148, http://dx.doi.org/10.1016/j.ajo.2009.05.033

Goldstein DA; Godfrey DG; Hall A; Callanan DG; Jaffe GJ; Pearson PA; Usner DW; Comstock TL, 2009, 'In reply', Archives of Ophthalmology, vol. 127, pp. 116, http://dx.doi.org/10.1001/archophthalmol.2008.555

Goldstein D; Van Hazel GA; Pavlakis N, 2009, 'Treatment of 5-Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, vol. 27, pp. 4085 - 4095

Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, vol. 45, pp. 393 - 399

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced Lhermitte’s phenomenon as a manifestation of severe generalized nerve dysfunction', Oncology, vol. 77, pp. 342 - 348, http://dx.doi.org/10.1159/000265940

Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, vol. 27, pp. 1243 - 1249, http://dx.doi.org/10.1200/JCO.2008.19.3425

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, vol. 132, pp. 2712 - 2723, http://dx.doi.org/10.1093/brain/awp219

Tan TH; Hemmings C; Stafford-bell M; Robson S; Goldstein D; Yip D, 2009, 'The successful management of two pregnancies with wild type metastatic gastrointestinal stromal tumors', Asia-Pacific Journal of Clinical Oncology, vol. 5, pp. 187 - 192, http://dx.doi.org/10.1111/j.1743-7563.2009.01225.x

Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, vol. 45, pp. 393 - 399, http://dx.doi.org/10.1016/j.ejca.2008.09.029

Underhill CR; Bartel R; Goldstein D; Snodgrass H; Begbie S; Yates P; White K; Jong K; Grogan P, 2009, 'Mapping oncology services in regional and rural Australia', Australian Journal of Rural Health, vol. 17, pp. 321 - 329, http://dx.doi.org/10.1111/j.1440-1584.2009.01106.x

Pranavan G; Goldstein D; Yip D, 2009, 'Response of Carney`s triad-related metastatic gastrointestinal stromal tumor to sunitinib', Asia-Pacific Journal of Clinical Oncology, vol. 4, pp. 170 - 174, http://dx.doi.org/10.1111/j.1743-7563.2008.00182.x

Chua W; Goldstein D; Dhillon H; Mitchell P; Clarke SJ; Iacopetta BJ; Lee CK; Michael M, 2009, 'Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer', British Journal of Cancer, vol. 101, pp. 998 - 1004, http://dx.doi.org/10.1038/sj.bjc.6605239

Torda AJ, 2009, 'Response', Journal of Bioethical Inquiry, vol. 6, pp. 257 - 258, http://dx.doi.org/10.1007/s11673-009-9158-1

Steer C; Marx GM; Singhal N; Mcjannett M; Prowse R; Goldstein D, 2009, 'Cancer in the older adult: a tale of two disciplines', Journal of Internal Medicine, vol. 39, pp. 771 - 775, http://dx.doi.org/10.1111/j.1445-5994.2009.02056.x

Lee CK; Hadley A; Desilva K; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis', World Journal of Surgical Oncology, vol. 7, pp. 1 - 4, http://dx.doi.org/10.1186/1477-7819-7-8

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'S1820 Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', Gastroenterology, vol. 136, pp. A - 277, http://dx.doi.org/10.1016/s0016-5085(09)61262-2

Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP, 2009, 'Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.', Thyroid, vol. 19, pp. 451 - 457, http://dx.doi.org/10.1089/thy.2008.0392

Sawka AM; Goldstein DP; Brierley JD; Tsang RW; Rotstein L; Ezzat S; Straus S; George SR; Abbey S; Rodin G; O'Brien MA; Gafni A; Thabane L; Goguen J; Naeem A; Magalhaes L, 2009, 'The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.', PLoS One, vol. 4, pp. e4191, http://dx.doi.org/10.1371/journal.pone.0004191

Patel RS; Guillemaud J; Goldstein DP; Brown D; Gilbert RW; Gullane PJ, 2009, 'P2.50. Prognostic implication and necessity for post-surgical adjuvant therapy in microscopic cut-through of oral carcinoma', Oral Oncology Supplement, vol. 3, pp. 177 - 178, http://dx.doi.org/10.1016/j.oos.2009.06.453

Parmar PS; Goldstein DP, 2009, 'The submental island flap in head and neck reconstruction.', Curr Opin Otolaryngol Head Neck Surg, vol. 17, pp. 263 - 266, http://dx.doi.org/10.1097/MOO.0b013e32832cee83

Weinreb I; Goldstein D; Irish J; Perez-Ordonez B, 2009, 'Expression patterns of Trk-A, Trk-B, GRP78, and p75NRT in olfactory neuroblastoma.', Hum Pathol, vol. 40, pp. 1330 - 1335, http://dx.doi.org/10.1016/j.humpath.2009.02.001

Hod R; Irish J; Goldstein D; Brown D; Bachar G; Shpitzer T, 2009, 'O60. Cancer of the tongue: Comparing outcome in patients with no known risk factors with those with high risk factors', Oral Oncology Supplement, vol. 3, pp. 76 - 76, http://dx.doi.org/10.1016/j.oos.2009.06.145

Sommer L; Sommer DD; Goldstein DP; Irish JC, 2009, 'Patient perception of risk factors in head and neck cancer.', Head Neck, vol. 31, pp. 355 - 360, http://dx.doi.org/10.1002/hed.20970

Goldstein D; Bachar G; Lea J; White J; Gilbert RW; Brown DH, 2009, 'O55. Outcomes in patients with tongue cancer treated at the Princess Margaret from 1994 to 2004', Oral Oncology Supplement, vol. 3, pp. 74 - 74, http://dx.doi.org/10.1016/j.oos.2009.06.140

Lea J; Goldstein D; Yehuda M; Moukarbel R; Gilbert R; Brown D, 2009, 'O53. Squamous cell carcinoma of the floor of mouth: Outcomes and prognostic indicators', Oral Oncology Supplement, vol. 3, pp. 74 - 74, http://dx.doi.org/10.1016/j.oos.2009.06.138

Shrime MG; Bachar G; Lea J; Volling C; Ma C; Gullane PJ; Gilbert RW; Irish JC; Brown DH; Goldstein DP, 2009, 'Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity.', Head Neck, vol. 31, pp. 1482 - 1488, http://dx.doi.org/10.1002/hed.21114

Patel RS; Makitie AA; Goldstein DP; Gullane PJ; Brown D; Irish J; Gilbert RW, 2009, 'Morbidity and functional outcomes following gastro-omental free flap reconstruction of circumferential pharyngeal defects.', Head Neck, vol. 31, pp. 655 - 663, http://dx.doi.org/10.1002/hed.21016

Shrime MG; Ma C; Gullane PJ; Gilbert RW; Irish JC; Brown DH; Goldstein DP, 2009, 'Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity.', Head Neck, vol. 31, pp. 1129 - 1136, http://dx.doi.org/10.1002/hed.21073

Irish J; Sandhu N; Simpson C; Wood R; Gilbert R; Gullane P; Brown D; Goldstein D; Devins G; Barker E, 2009, 'Quality of life in patients with maxillectomy prostheses.', Head Neck, vol. 31, pp. 813 - 821, http://dx.doi.org/10.1002/hed.21042

Alvaro F; Young A; Goldstein D; Thomas D; McJannett M; Dillon R, 2008, 'Clinical oncological society of Australia: Adolescent and young adult cancer forum', Cancer Forum, vol. 32, pp. 116 - 119

Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, vol. 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596

Blinman PL; Duric VM; Nowak AK; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler MR, 2008, 'Patients’ preferences for adjuvant chemotherapy (ACT) in early colon cancer (ECC): What makes it worthwhile?', Journal of Clinical Oncology, vol. 26, pp. 4050 - 4050, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.4050

Kesen MR; Edward DP; Ulanski LJ; Tessler HH; Goldstein DA, 2008, 'Pulmonary metastasis masquerading as anterior uveitis', Archives of Ophthalmology, vol. 126, pp. 572 - 574, http://dx.doi.org/10.1001/archopht.126.4.572

Lin P; Bhullar SS; Tessler HH; Goldstein DA, 2008, 'Immunologic Markers as Potential Predictors of Systemic Autoimmune Disease in Patients with Idiopathic Scleritis', American Journal of Ophthalmology, vol. 145, http://dx.doi.org/10.1016/j.ajo.2007.09.024

Vonlaufen A; Phillips PA; Xu ZH; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Lending a helping hand: Role of pancreatic stellate in pancreatic cancer', Cancer Research, vol. 68, pp. 7707 - 7710

Shepherd LM; Goldstein D; Olver IN; Parle MD, 2008, 'Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?', Australian Health Review, vol. 32, pp. 423 - 438, http://dx.doi.org/10.1071/AH080423

Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 15, pp. 3081 - 3094, http://dx.doi.org/10.2174/092986708786848569

Spry N; Macleod C; Borg M; Ngan SY; Millar J; Graham PH; Zissiadis Y; Kneebone AB; Carroll SL; Davies T; Reece W; Iacopetta BJ; Goldstein D; Harvey JE, 2008, '3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: Factors influencing outcome', International Journal of Radiation Oncology and Biology Physics, vol. 70, pp. 1438 - 1446, http://dx.doi.org/10.1016/j.ijrobp.2007.08.070

Underhill CR; Goldstein D; Gorbounova VA; Biakhov MY, 2008, 'Randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', Oncology, vol. 73, pp. 9 - 20, http://dx.doi.org/10.1159/000120626

Lin CS-Y; Krishnan A; Goldstein D; Friedlander M; Kiernan M, 2008, '457: Sensory nerve excitability in cancer patients treated with oxaliplatin', Journal of Clinical Neuroscience, vol. 15, pp. 362 - 362, http://dx.doi.org/10.1016/j.jocn.2007.07.067

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, vol. 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044

Butow PN; Eisenbruch M; Goldstein D; Duggal-Beri P; Jefford M; Schofield P; Girgis A; King M, 2007, 'Unmet needs in Chinese, Greek and arabic speaking cancer patients in Australia', PSYCHO-ONCOLOGY, vol. 16, pp. S77 - S78, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249687400142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Underhill C, 2007, 'Regional cancer services in Australia: Some evidence of improvement but a long way to go', Cancer Forum, vol. 31, pp. 67 - 69

Wilcken NR; Goldstein D; Nowak AK; Beale PJ; Jefford M; Dhillon H; O'Connell R; Heritier S; Simes RJ; Stockler M, 2007, 'A placebo-controlled trial of Sertraline's effects on symptoms, well-being and survival in advanced cancer: The ZEST Trial', Journal of Clinical Oncology, vol. 25, pp. 9002 - 9002, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.9002

Leighl NB; Shepherd H; Butow P; Clarke SJ; McJannett M; Beale P; Wilcken N; Moore MJ; Chen EX; Tattersall MH; Goldstein D, 2007, 'When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer', Journal of Clinical Oncology, vol. 25, pp. 6509 - 6509, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.6509

Schwartzberg LS; Hurwitz H; Stephenson J; Kotasek D; Goldstein D; Tebbutt N; McGreivy J; Sun Y; Yang L; Burris H, 2007, 'Safety and pharmacokinetics (PK) of AMG 706 with panitumumab plus FOLFIRI or FOLFOX for the treatment of patients (pts) with metastatic colorectal cancer (mCRC)', Journal of Clinical Oncology, vol. 25, pp. 4081 - 4081, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4081

Goldstein D; Shannon J; Brown C; Tebbutt N; Ackland S; Van Hazel G; Abdi E; Jefford M; Gainford MC; Adams K, 2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', Journal of Clinical Oncology, vol. 25, pp. 15015 - 15015, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15015

Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ, 2007, 'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial', Lancet Oncology, vol. 8, pp. 603 - 612, http://dx.doi.org/10.1016/S1470-2045(07)70148-1

Goldstein DA; Tessler HH, 2007, 'Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.', American journal of ophthalmology, vol. 144, http://dx.doi.org/10.1016/j.ajo.2007.08.014

Birnbaum AD; Tessler HH; Schultz KL; Farber MD; Gao W; Lin P; Oh F; Goldstein DA, 2007, 'Epidemiologic Relationship Between Fuchs Heterochromic Iridocyclitis and the United States Rubella Vaccination Program', American Journal of Ophthalmology, vol. 144, http://dx.doi.org/10.1016/j.ajo.2007.05.026

Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, vol. 34, pp. 126 - 135

Yang JL; Qu XJ; Hayes V; Brenner PC; Russell PJ; Goldstein D, 2007, 'Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha', British Journal of Urology, vol. 99, pp. 1539 - 1545, http://dx.doi.org/10.1111/j.1464-410X.2007.06778.x

Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander ML, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, vol. 6, pp. 578 - 582, http://dx.doi.org/10.3816/CCC.2007.n.025

Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, vol. 34, pp. 126 - 135, http://dx.doi.org/10.1016/j.jpainsymman.2006.10.014

Goldstein D; Spry N; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Australia EL, 2006, 'Combined modality therapy for pancreatic carcinoma: An Australian Pancreatic Cancer Group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI 5FU) and 3D conformal radiotherapy (RT)-Final outcomes.', J Clin Oncol, vol. 24, pp. 4104, http://www.ncbi.nlm.nih.gov/pubmed/27953934

Stockler MR; Heritier S; Nowak AK; Goldstein D; Turner J; Jefford M; Glasgow A; Abdi E; Beale PJ; Carter C, 2006, 'The time taken to complete quality of life questionnaires in an advanced cancer trial', Journal of Clinical Oncology, vol. 24, pp. 8592 - 8592, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.8592

Tebbutt N; Gebski V; Strickland A; Gibbs D; Walpole E; Ganju V; Goldstein D; Munro S; Harrod M; Van Hazel G, 2006, 'Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer', Journal of Clinical Oncology, vol. 24, pp. 4067 - 4067, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4067

Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2006, 'Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online), vol. 3

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, vol. 36, pp. 367 - 377

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, vol. 12, pp. 4481 - 4484, http://dx.doi.org/10.1158/1078-0432.CCR-06-0694

Barlow-Stewart K; Yeo SS; Meiser B; Goldstein D; Tucker K; Eisenbruch M, 2006, 'Towards cultural competence in cancer genetic counselling and genetics education: lessons learned from Chinese-Australians', Genetics in Medicine, vol. 8, pp. 24 - 32, http://dx.doi.org/10.1097/01.gim.0000195884.86201.a0

Grimison PS; T Chin M; Harrison ML; Goldstein D, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, vol. 6, http://dx.doi.org/10.1186/1471-2407-6-117

Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, vol. 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240

Underhill CR; Goldstein D; Grogan PB, 2006, 'Inequity in rural cancer survival in Australia is not an insurmountable problem', Medical Journal of Australia, vol. 6, pp. 479 - 480

Dalton L; Luxford K; Boyle F; Goldstein D; Underhill CR; Yates P, 2006, 'An Educational Workshop Program for Rural Practitioners to Encourage Best practice for Delivery of Systemic Adjuvant Therapy', Journal of Cancer Education, vol. 21, pp. 35 - 39, http://dx.doi.org/10.1207/s15430154jce2101_12

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, vol. 36, pp. 367 - 377, http://dx.doi.org/10.1111/j.1445-5994.2006.01077.x

Mitchell P; Goldstein D; Beale P; Friedlander ML; Zalcberg J; White S; Thomson JA; Clarke S; Michael M, 2006, 'Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity', Clinical Colorectal Cancer, vol. 6, pp. 146 - 151, http://dx.doi.org/10.3816/CCC.2006.n.032

Mok KW; Goldstein D, 2006, 'Hypersensitivity reactions to oxaliplatin: Can patients be rechallenged?', Asia-Pacific Journal of Clinical Oncology, vol. 2, pp. 175 - 179, http://dx.doi.org/10.1111/j.1743-7563.2006.00066.x

Shepherd LM; Goldstein D; Whitford H; Thewes B; Brummell V; Hicks M, 2006, 'The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study', Journal of Pain and Symptom Management, vol. 32, pp. 453 - 461, http://dx.doi.org/10.1016/j.jpainsymman.2006.05.018

Goldstein D; Ackland S; Bell DR; Olver IN; Davis ID; Rosenthal M; Toner GC; Pinel MC; Byrne M, 2006, 'Phase II study of vinflunine in patients with metastatic renal cell carcinoma', Investigational New Drugs, vol. 24, pp. 429 - 434, http://dx.doi.org/10.1007/s10637-006-6437-0

Yip D; Karapetis C; Strickland C; Steer C; Goldstein D, 2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, vol. 4, http://dx.doi.org/10.1002/14651858.CD011044.pub2

Van Glabbeke M; Verweij J; Casali PG; Le Cesne A; Hohenberger P; Ray-Coquard I; Schlemmer M; Van Oosterom AT; Goldstein D; Sciot R; Hogendoorn PCW; Brown M; Bertulli R; Judson IR, 2005, 'Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group Study', Journal of Clinical Oncology, vol. 23, pp. 5795 - 5804, http://dx.doi.org/10.1200/JCO.2005.11.601

Birnbaum AD; Tessler HH; Goldstein DA, 2005, 'A case of hypopyon uveitis nonresponsive to steroid therapy and a review of anterior segment masquerade syndromes in childhood', Journal of Pediatric Ophthalmology and Strabismus, vol. 42, pp. 372 - 377

Schultz KL; Birnbaum AD; Goldstein DA, 2005, 'Ocular disease in pregnancy', Current Opinion in Ophthalmology, vol. 16, pp. 308 - 314, http://dx.doi.org/10.1097/01.icu.0000179803.42218.cc

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-α promotes the anti-proliferative effect of gefitinib (ZD1839) on human colon cancer cell lines', Oncology, vol. 69, pp. 224 - 238, http://dx.doi.org/10.1159/000088070

Burmeister B; Smithers M; Gebski V; Denham J; Devitt P; Ackland S; Findlay M; Dhillon H; Stockler M; Coates A; Matthews J; Simes J; Beller E; Fitzgerald L; Gray E; Dodds H; Marks P; Hayden P; Erratt A; Monro C; Pike R; Walpole E; Gotley D; Thomson D; Harvey J; Martin I; Burmeister E; Jamieson G; Borg M; Yeoh E; Olver I; Caruso D; Game P; Joseph D; Spry N; Minchin D; Cameron F; Faulkner K; Einhorn S; Dewar J; Gillies J; Johnson C; Kilmurray J; Neely M; Carmody M; Mackintosh J; Millar J; O'Brien P; Schwartz M; Smith R; Woods S; Nathanson L; O'Loughlin B; Grimes D; Cheuk R; Dickie G; Keller J; Archer S; Bayliss E; Gray B; Trotter J; Ransom D; Shepherd J; Stone C; Thompson I; Guiney M; Henderson M; Thomas R; Kian M; Ngan S; Rischin D; Walcher V; Zalcberg J; North J; Costello S; Perez D; Whitely D; Wyllie A; Avramovic J; Donnolly P; Fon P; Collins M; McIntosh R; Melville P; Bell R; Kirrof G; Harris I; McLennan R; Monro W; Aroney R; Falconer K; Cullingford G; Davidson A; Randell C; Berry M; Delaney G; Moylan E; Burns D; Goldstein D; Zissiadis M, 2005, 'Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial', Lancet Oncology, vol. 6, pp. 659 - 668, http://dx.doi.org/10.1016/S1470-2045(05)70288-6

Grimison P; Goldstein D; Yeo B, 2005, 'Editor's quiz: GI snapshot. An unusual abdominal mass', Gut, vol. 54, http://dx.doi.org/10.1136/gut.2004.051342

Grimison P; Goldstein D; Schneeweiss J; Murray N, 2005, 'Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms', Internal Medicine Journal, vol. 35, pp. 136 - 137, http://dx.doi.org/10.1111/j.1445-5994.2004.00757.x

Glabbeke M; Verweij J; Casali P; Le Cesne A; Hohenberger P; Ray-Coquard I; Goldstein D; Schlemmer M; Van Oosterom AT; Sciot R; Hogendoorn P; Brown M; Bertulli R; Judson I, 2005, 'Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A Eurpoean Organisation for Research and Treatment of Cancer etc.', Journal of Clinical Oncology, vol. 23, pp. 5795 - 5804

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines', Cancer Letters, vol. 225, pp. 61 - 74, http://dx.doi.org/10.1016/j.canlet.2004.11.041

Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, vol. 32, pp. 51 - 60, http://dx.doi.org/10.1002/mus.20340

Meiser B; Yeo SS; Barlow-Stewart K; Goldstein D; Tucker K; Eisenbruch M, 2005, 'Understanding community beliefs of Chinese-Australians about cancer: Initial insights using an ethnographic approach', Psycho - Oncology, vol. 14, pp. 174 - 186, http://dx.doi.org/10.1002/pon.831

Thewes B; Meiser B; Taylor AJ; Phillips KA; Pendlebury S; Capp A; Dalley D; Goldstein D; Baber R; Friedlander ML, 2005, 'Fertility - and Menoapuse-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer', Journal of Clinical Oncology, vol. 23, pp. 5155 - 5165, http://dx.doi.org/10.1200/JCO.2005.07.773

Goldstein D; Tan BS; Rossleigh MA; Haindl W; Walker BM; Dixon J, 2005, 'Gastrointestinal Stromal Tumours: Correlation of 18F-FDG Gamma Camera-Based Coincidence Positron Emission tomography with CT for the Assessment of Treatment Response - An AGITG Study', Oncology, vol. 69, pp. 326 - 332, http://dx.doi.org/10.1159/000089765

Yip D; Goldstein D, 2005, 'Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer', Cancer Treatment Reviews, vol. 31, pp. 236 - 241, http://dx.doi.org/10.1016/j.ctrv.2005.03.003

Goldstein D, 2005, 'The role of chemotherapy in the treatment of pancreatic carcinoma', Australian Prescriber, vol. 28, pp. 42 - 44

Goldstein D; Mitchell P; Friedlander ML; Michael M; Beale P; Zalcberg JR; White S; Clarke SJ, 2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, vol. 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426

Goldstein D; Grimpen F; Yip D; McArthur G; Waring P; Loughrey M; Beshay V; Chong G, 2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, vol. 6, pp. 724 - 727, http://dx.doi.org/10.1016/S1470-2045(05)70321-1

Ngan SY; Fisher R; Burmeister B; Mackay J; Goldstein D; Kneebone AB; Schache D; Joseph D; McKendrick J; Long T; McClure B; Rischin D, 2005, 'Promising results of a cooperative group phase II trial of preoperative chemoradiation For locally advanced rectal cancer (TROG 9801)', Diseases of the Colon and Rectum, vol. 48, pp. 1389 - 1396, http://dx.doi.org/10.1007/s10350-005-0032-x

Goldstein D; Taylor JL; Marx G, 2005, 'Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience', Internal Medicine Journal, vol. 35, pp. 34 - 38, http://dx.doi.org/10.1111/j.1445-5994.2004.00749.x

Moore MJ; Goldstein D; Hamm J; Figer A; Hecht J; Gallinger S; Au H; Ding K; Christy-Bittel J; Parulekar W, 2005, 'Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]', Journal of Clinical Oncology, vol. 23, pp. 1 - 1, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.1

Goldstein D; van Hazel G; Pavlakis N; Olver I, 2005, 'Selective Internal Radiation Therapy (SIRT) plus systemic chemotherapy with Irinotecan. A phase I dose escalation study', Journal of Clinical Oncology, vol. 23, pp. 3701 - 3701, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3701

Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC)', Journal of Clinical Oncology, vol. 23, pp. 3581 - 3581, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3581

Rafferty MA; Goldstein DP; Brown DH; Irish JC, 2005, 'The sternomastoid branch of the occipital artery: a surgical landmark for the spinal accessory nerve in selective neck dissections.', Otolaryngol Head Neck Surg, vol. 133, pp. 874 - 876, http://dx.doi.org/10.1016/j.otohns.2005.08.004

Brown RF; Butow PN; Sharrock MA; Henman M; Boyle F; Goldstein D; Tattersall MHN, 2004, 'Education and role modelling for clinical decisions with female cancer patients', Health Expectations, vol. 7, pp. 303 - 316, http://dx.doi.org/10.1111/j.1369-7625.2004.00294.x

Hughes BGM; Yip D; Chao M; Gibbs P; Carroll S; Goldstein D; Burmeister B; Karapetis C, 2004, 'Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience', ANZ Journal of Surgery, vol. 74, pp. 951 - 956, http://dx.doi.org/10.1111/j.1445-1433.2004.03218.x

Hughes B; Yip D; Goldstein D; Waring P; Beshay V; Chong G, 2004, 'Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report', BMC Cancer, vol. 4, http://dx.doi.org/10.1186/1471-2407-4-74

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N; Eli Lilly Australia , 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, vol. 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N, 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy', Journal of Clinical Oncology, vol. 22, pp. 4100 - 4100, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4100

Goldstein DA; Tessler HH; Franzco DS; Franzco AK, 2004, 'Re: Mitomycin-induced punctal stenosis [4] (multiple letters)', American Journal of Ophthalmology, vol. 137, pp. 593, http://dx.doi.org/10.1016/j.ajo.2003.11.055

Jong KE; Smith DP; Yu XQ; O Connell DL; Goldstein D; Armstrong BK, 2004, 'Remoteness of residence and survival from cancer in New South Wales', Medical Journal of Australia, vol. 180, pp. 618 - 622

Apte MV; Wilson JS; Park S; Phillips PA; Santucci N; Goldstein D; Ramm GA; Buchler M; Friess H; Mccarroll JA; Merrett ND; Pirola RC, 2004, 'Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells', Pancreas, vol. 29, pp. 179 - 187, http://dx.doi.org/10.1097/00006676-200410000-00002

Qu XJ; Yang JL; Russell PJ; Goldstein D, 2004, 'Change in epidermal growth factor receptor expression in human bladdercancer cell lines following interferon-alpha treatment', Journal of Urology, vol. 172, pp. 733 - 738, http://dx.doi.org/10.1097/01.ju.0000130751.83953.55

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha', Gut, vol. 53, pp. 123 - 129, http://dx.doi.org/10.1136/gut.53.1.123

Daly EB; Chen GW; Sun L; Friedlander ML; Goldstein D; Beer D; Chesterman CN; Hogg PJ, 2004, 'Blood level of phosphoglycerate kinase does not correlate with presenceor extent of tumor', International Journal of Biological Markers, vol. 19, pp. 170 - 172

Robotin M; Law MG; Milliken ST; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, vol. 5, pp. 377 - 384, http://dx.doi.org/10.1111/j.1468-1293.2004.00238.x

Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, vol. 40, pp. 1689 - 1695, http://dx.doi.org/10.1016/j.ejca.2004.03.021

Hagerty RG; Butow PN; Ellis PA; Lobb EA; Pendlebury S; Leighl N; Goldstein D; Lo SK; Tattersall MH, 2004, 'Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting', Journal of Clinical Oncology, vol. 22, pp. 1721 - 1730, http://dx.doi.org/10.1200/JCO.2004.04.095

Goldstein D; Apte MV; Carroll SL; Keogh G, 2004, 'Modern management of pancreatic cancer', Internal Medicine Journal, vol. 34, pp. 475 - 481, http://dx.doi.org/10.1111/j.1444-0903.2004.00658.x

Loi S; Goldstein D; Clezy KR; Milliken ST; Hoy JF; Chipman M, 2004, 'Castleman`s disease and HIV infection in Australia', HIV Medicine, vol. 5, pp. 157 - 162, http://dx.doi.org/10.1111/j.1468-1293.2004.00204.x

Ngan SYK; Goldstein D; Solomon M; Zalcberg J; Meagher AP; Ward RL, 2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, vol. 73, pp. 660 - 661, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x

Eisenbruch IM; Yeo SS; Meiser B; Goldstein D; Tucker K; Barlow-Stewart K, 2003, 'Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, vol. 59, pp. 235 - 248, http://dx.doi.org/10.1016/j.socscimed.2003.10.016

Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, vol. 71, pp. 399 - 403, http://dx.doi.org/10.1002/jmv.10500

Shannon JF; Mackenzie-Wood AR; Wood G; Goldstein D, 2003, 'Cicatricial pemphigoid in non-Hodgkin`s lymphoma', Internal Medicine Journal, vol. 33, pp. 396 - 397, http://dx.doi.org/10.1046/j.1445-5994.2003.t01-1-00430.x

Ngan SY; Fisher R; Burmeister B; Rischin D; Mackay J; Kneebone A; Joseph D; McKendrick J; Goldstein D; McClure B; Lim Joon D, 2003, 'Delayed relapse following preoperative chemoradiation and surgery for rectal cancer', International Journal of Radiation Oncology*Biology*Physics, vol. 57, pp. S220 - S220, http://dx.doi.org/10.1016/s0360-3016(03)01035-6

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, vol. 32, pp. 158 - 162, http://dx.doi.org/10.1046/j.1444-0903.2001.00184.x

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'Alpha-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, vol. 32, pp. 158 - 162

Harrison ML; Goldstein D, 2002, 'Prolonged survival in a patient with an occult small-cell lung cancer and a solitary brain metastasis at diagnosis', Internal Medicine Journal, vol. 32, pp. 621 - 622, http://dx.doi.org/10.1046/j.1445-5994.2002.00285.x

Goldstein D; Thewes B; Butow P, 2002, 'Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia', Internal Medicine Journal, vol. 32, pp. 289 - 296, http://dx.doi.org/10.1046/j.1445-5994.2002.00230.x

Marx GM; Boyce A; Goldstein D, 2002, 'Elevated alpha-foetoprotein and hepatic metastases - it`s not always what it seems!', Annals of Oncology, vol. 13, pp. 167 - 169, http://dx.doi.org/10.1093/annonc/mdf015

Goldstein D; Margo J, 2001, 'Cancer in the bush - Optimising clinical services', Cancer Forum, vol. 25, pp. 121 - 125

Eisenbruch IM; Barlow-Stewart K; Tucker K; Steel ZP; Goldstein D; Meiser B, 2001, 'Cultural aspects of cancer genetics: setting a research agenda', Journal of Medical Genetics, vol. 38, pp. 425 - 429

Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson GD; Davis I, 2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, vol. 32, pp. 89 - 94, http://dx.doi.org/10.1016/S0169-5002(00)00207-5

Ngan S; Burmeister B; Fisher R; Rischin D; Schache D; Kneebone A; Mackay J; Joseph D; Bell A; Goldstein D, 2001, 'Early Toxicity from Preoperative Radiotherapy with Continuous Infusion 5-Fluorouracil for Resectable Adenocarcinoma of the Rectum: A Phase II Trial for the Trans-Tasman Radiation', International Journal of Radiation Oncology and Biology Physics, vol. 50, pp. 883 - 887, http://dx.doi.org/10.1016/S0360-3016(01)01536-X

Carnahan MC; Goldstein DA, 2000, 'Ocular complications of topical, peri-ocular, and systemic corticosteroids', Current Opinion in Ophthalmology, vol. 11, pp. 478 - 483, http://dx.doi.org/10.1097/00055735-200012000-00016

Herz H; Cooke B; Goldstein D, 2000, 'Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature', Annals of Oncology, vol. 11, pp. 1343 - 1347, http://dx.doi.org/10.1023/A:1008387800525

Skolnick CA; Fiscella RG; Tessler HH; Goldstein DA, 2000, 'Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis', American Journal of Ophthalmology, vol. 129, pp. 363 - 366, http://dx.doi.org/10.1016/S0002-9394(99)00350-5

Garcia-Valenzuela E; Tessler HH; Carnahan M; Ryan JJ; Goldstein DA, 2000, 'Multiple recurrences of exudative retinal detachment in a patient with Vogt-Koyanagi-Harada disease', Retina, vol. 20, pp. 672 - 674, http://dx.doi.org/10.1097/00006982-200006000-00017

Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; Mackay JR; Joseph DJ; Bell A; Goldstein D, 2000, 'A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A multi-center trial for the Trans-Tasman Radiation Oncology Group', International Journal of Radiation Oncology*Biology*Physics, vol. 48, pp. 119 - 120, http://dx.doi.org/10.1016/s0360-3016(00)80035-8

Huang X; Butow PN; Meiser B; Goldstein D, 1999, 'Attitudes and information needs of Chinese migrant cancer patients and their relatives', Australian and New Zealand Journal of Medicine, vol. 29, pp. 207 - 213, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00685.x

Bishop JF; Dewar J; Toner GC; Smith J; Tattersall MHN; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J; Canetta R, 1999, 'Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer', Journal of Clinical Oncology, vol. 17, pp. 2355 - 2364, http://dx.doi.org/10.1200/jco.1999.17.8.2355

Carnahan MC; Goldstein DA, 1999, 'The use of immunosuppressive drugs in uveitis.', Developments in ophthalmology, vol. 31, pp. 132 - 159

Davis AJ; Goldstein D; Milliken S, 1998, 'Long term follow-up of CEOP in the treatment of HIV related non- Hodgkin's lymphoma (NHL)', Australian and New Zealand Journal of Medicine, vol. 28, pp. 28 - 32, http://dx.doi.org/10.1111/j.1445-5994.1998.tb04455.x

Newell ME; Milliken ST; Goldstein D; Lewis CR; Boyle MJ; Dolan G; Ryan S; Cooper DA; boyle , 1998, 'A phase 2 study of liposomal doxorubicin in the treatment of AIDS-related Kaposi¿s sarcoma', Australian and New Zealand Journal of Medicine, vol. 28, pp. 777 - 783, http://dx.doi.org/10.1111/j.1445-5994.1998.tb01553.x

Goldstein D; Hertzog P; Tomkinson E; Couldwell D; Mccarville S; Parrish S; Cunningham PH; Newell ME; Owens M; Cooper DA, 1998, 'Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification', Journal of Infectious Diseases, vol. 178, pp. 856 - 861, http://dx.doi.org/10.1086/515343

Bishop JF; Dewar J; Toner GC; Tattersall MH; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first-line treatment for metastatic breast cancer', ONCOLOGY, vol. 11, pp. 19 - 23

Goldstein D; Wolley I; Collett J, 1997, 'Diffuse alveolar damage following a singel adminstration of a cyclophosphamide containing chemotherapy regimen.', Australian and New Zealand Journal of Medicine, pp. 605 - 606

Goldstein D; Bishop J; Dewar J; Tattersall MH; Smith JS; Olver IN; Ackland S; Kennedy I; Toner GC; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first line treatment for metastatic breast cancer.', Oncology, pp. 17 - 19

Joshua D; Penny R; Matthews JP; Laidlawcr ; Gibson K; Bradstock KF; Wolf M; Goldstein D, 1997, 'Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive comBination chemotherapy with or without interferon in patients with myeloma', British Journal of Haematology, pp. 38 - 45

Goldstein D; Douglas JR; Penny R; Matthews JP; Laidlaw CR; Gibson K; Bradstock KF; Wolf M, 1997, 'Australian leukaemia study group myeloma II: A randomised trial of intensive combination chemotherapy with or without interferon in patients with myeloma.', British Journal Haematology, vol. 97, pp. 38 - 45, http://dx.doi.org/10.1046/j.1365-2141.1997.9942643.x

Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness', Annals of Oncology, vol. 8, pp. 871 - 875, http://dx.doi.org/10.1023/A:1008261413274

Goldstein D; Pillay P; Hayman J; Leydman M, 1997, 'Association of hypercalcaemia, PTHrP expression and disease progression in a woman with primary squamous cell carcinoma of the breast.', Pathologe, vol. 29, pp. 317 - 319, http://dx.doi.org/10.1080/00313029700169195

Goldstein D; Butow P; Tattersall MH, 1997, 'Communication with cancer patients in culturally diverse Societies.', Annals of the New York Academy of Sciences, vol. 809, pp. 317 - 329

Stricker P; Pryor K; Nicholson T; Goldstein D; Golovsky D; Ferguson R; Nash P; Ehsman S; Rumma J; Mammen G; Penny R, 1996, 'Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer', Urology, vol. 48, pp. 957 - 962, http://dx.doi.org/10.1016/S0090-4295(96)00375-5

Millar JL; Goldstein D; Gelmon KA, 1996, '5.14 HIV and Kaposi's sarcoma', Medical Journal of Australia, vol. 164, pp. 539 - 542, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122167.x

Boyle MJ; Goldstein DA; Frazer IH; Sculley TB, 1996, 'How HIV promotes malignancies', Medical Journal of Australia, vol. 164, pp. 230 - 232, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94147.x

Newell M; Goldstein D; Milliken S; Lewis C; Hoy J; Thomson B; Cooper D, 1996, 'Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma', Annals of Oncology, vol. 7, pp. 1029 - 1036, http://dx.doi.org/10.1093/oxfordjournals.annonc.a010495

Millward MJ; Bishop JF; Friedlander M; Levi JA; Goldstein D; Olver IN; Smith JG; Toner GC; Rischin D; Bell DR, 1996, 'Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer', Journal of Clinical Oncology, vol. 14, pp. 142 - 148, http://dx.doi.org/10.1200/JCO.1996.14.1.142

Morton J; Taylor K; Bunce I; Eliadis P; Rentoul A; Moore D; Kelly C; Wright S; Bashford J; Rodwell R; Rooney K; Mulligan S; Firkin F; Dodds A; Parkin J; Lowenthal R; Kimber R; Frost T; Grigg A; Goldstein D; Stone J; Lee N, 1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, vol. 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x

Goldstein D, 1996, 'HIV associated malignancies', Hematology Reviews and Communications, vol. 9, pp. 275 - 283

Dear AE; Goldstein D; Hayman JA, 1996, 'Malignant pulmonary lymphoid disease: Case reports illustrating anatomical pattern of disease as a prognostic marker', Pathology, vol. 28, pp. 20 - 24, http://dx.doi.org/10.1080/00313029600169443

Goebel F; Goldstein D; Goos M; Jablonowski H; Stewart JS, 1996, 'Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi`s sarcoma', British Journal of Cancer, vol. 73, pp. 989 - 994, http://dx.doi.org/10.1038/bjc.1996.193

Goldstein DA; Tessler HH, 1996, 'Irrigating the Capsular Bag', Journal of Cataract and Refractive Surgery, vol. 22, pp. 1003 - 1003, http://dx.doi.org/10.1016/s0886-3350(96)80109-x

Nirenberg A; Meikle GR; Goldstein D; Meikle RG, 1995, 'Metastatic carcinoma infiltrating lung mimicking BOOP', Australasian Radiology, vol. 39, pp. 405 - 407, http://dx.doi.org/10.1111/j.1440-1673.1995.tb00323.x

Pryor K; Goddard JD; Goldstein D; Stricker PD; Russell PJ; Golovsky D; Penny R, 1995, 'Bacillus Calmette-Guerein (BCG) enhances mobocyte-and lymphocyte-mediated bladder tumour cell killilng', British Journal of Cancer, vol. 71, pp. 801 - 807, http://dx.doi.org/10.1038/bjc.1995.155

Dear A; Goldstein D; Salem H, 1995, 'pulmonary chronic lymphocytic leukaemia: difficulty in establishing a tissue diagnosis', European Journal of Haematology, vol. 54, pp. 130 - 133, http://dx.doi.org/10.1111/j.1600-0609.1995.tb01783.x

FRIEDLANDER M; LEWIS C; GOLDSTEIN D, 1994, 'UNTITLED', MEDICAL JOURNAL OF AUSTRALIA, vol. 161, pp. 638 - 638, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PT68600027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA, 1994, 'Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine', Patient Education and Counseling, vol. 24, pp. 261 - 266, http://dx.doi.org/10.1016/0738-3991(94)90069-8

Tindall B; Forde S; Goldsten D; Ross MW; Cooper DA, 1994, 'Sexual dysfunction in advanced HIV disease', AIDS Care, vol. 6, pp. 105 - 107, http://dx.doi.org/10.1080/09540129408258030

Kaldor J; Elford J; Grulich A; Goldstein D, 1994, 'HIV AIDS and cancer', Cancer Forum, vol. 18, pp. 3 - 11

Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, vol. 161, pp. 638 - 639, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127659.x

D G; E T; D C; H G; M N; P H; M O; S M; S P; D H; D C, 1994, 'PHASE I A/B TRIAL OF IMIQUIMOD, AN ORAL INTERFERON INDUCER IN ASYMPTOMATIC HTV POSITIVE INDIVIDUALS', AIDS, vol. 8, pp. S14 - S14, http://dx.doi.org/10.1097/00002030-199411004-00054

GOLDSTEIN D; MILLIKEN S NM; LEWIS C; HOY J; THOMSON B; DOLAN G; RYAN S; SARR A; COOPER DA, 1994, 'FILGRASTIM (r-metHuG-CSF, Amgen), CEOP AND ANTIRETROVIRAL THERAPY IN HIV- RELATED NON-HODGKINS LYMPHOMA (NHL)', AIDS, vol. 8, pp. S46 - S46, http://dx.doi.org/10.1097/00002030-199411004-00179

Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, vol. 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020

Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand journal of medicine, vol. 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x

Nolten WE; Goldstein D; Lindstrom M; Mckenna MV; Carlson IH; Trump DL; Schiller J; Borden EC; Ehrlich EN, 1993, 'Effects of Cytokines on the Pituitary–Adrenal Axis in Cancer Patients', Journal of Interferon Research, vol. 13, pp. 349 - 357, http://dx.doi.org/10.1089/jir.1993.13.349

Gibson DFC; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC, 1993, 'Human recombinant interferon-βSER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse', Breast Cancer Research and Treatment, vol. 25, pp. 141 - 150, http://dx.doi.org/10.1007/BF00662139

GOLDSTEIN D; KAUFMANN M, 1992, 'NOVEL APPROACHES TO THE MANAGEMENT OF GYNECOLOGIC MALIGNANCIES - CHAIRMENS PREFACE - PROCEEDINGS OF A SATELLITE SYMPOSIUM HELD IN CAIRNS, AUSTRALIA, ON 22 SEPTEMBER 1991', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 2, pp. 1 - 1, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992KF21500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smalley RV; Goldstein D; Bulkowski D; Hannon C; Buchler D; Knudsen C; Tuttle RL, 1992, 'A phase II study of crisnatol mesylate in patients with ovarian carcinoma', Investigational New Drugs, vol. 10, pp. 107 - 112, http://dx.doi.org/10.1007/BF00873127

Greiner JW; Guadagni F; Goldstein D; Smalley RV; Borden EC; Simpson JF; Molinolo A; Schlom J, 1992, 'Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells', Journal of Clinical Oncology, vol. 10, pp. 735 - 746, http://dx.doi.org/10.1200/JCO.1992.10.5.735

Witt PL; Goldstein D; Storer BE; Grossberg SE; Flashner M; Colby CB; Borden EC, 1992, 'Absence of Biological Effects of Orally Administered Interferon-βser', Journal of Interferon Research, vol. 12, pp. 411 - 413, http://dx.doi.org/10.1089/jir.1992.12.411

Greiner JW; Guadagni F; Borden EC; Ritts RE; Goldstein D; LoBuglio AF; Schlom J, 1992, 'EVIDENCE THAT RECOMBINANT INTERFERONS CAN ENHANCE THE SENSITIVITY OF THE DETECTION OF SERUM TAG-72 AND CEA IN PATIENTS DIAGNOSED WITH ADENOCARCINOMA', Journal of Immunotherapy, vol. 11, pp. 126 - 126, http://dx.doi.org/10.1097/00002371-199202000-00021

Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J, 1991, 'Evidence for the Elevation of Serum Carcinoembryonic Antigen and Tumor-associated Glycoprotein-72 Levels in Patients Administered Interferons', Cancer Research, vol. 51, pp. 4155 - 4163

Goldstein D; Lewis C, 1991, 'Advances in drug delivery and targeting', Current Opinion in Oncology, vol. 3, pp. 1096 - 1104, http://dx.doi.org/10.1097/00001622-199112000-00019

Sosman JA; Hank JA; Moore KH; Borchert A; Schell K; Kohler PC; Goldstein D; Bechhofer R; Storer B; Albertini MR; Leung PE; Levitt D; Sondel PM, 1991, 'Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinom', Cancer Investigation, vol. 9, pp. 35 - 48, http://dx.doi.org/10.3109/07357909109032798

Goldstein D; O'Leary M; Mitchen J; Borden EC; Wilding G, 1991, 'Effects of interferon βser and transforming growth factor β on prostatic cell lines', Journal of Urology, vol. 146, pp. 1173 - 1177, http://dx.doi.org/10.1016/S0022-5347(17)38034-5

Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC, 1990, 'Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-α2', Breast Cancer Research and Treatment, vol. 15, pp. 95 - 101, http://dx.doi.org/10.1007/BF01810781

Goldstein D; Cheuvart B; Trump DL; Shiraki M; Comis RL; Tormey DC; Harris JE; Borden EC, 1990, 'Phase II trial of carboplatin in soft-tissue sarcoma', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 13, pp. 420 - 423, http://dx.doi.org/10.1097/00000421-199010000-00011

Laszlo J; Goldstein D; Gockerman J; Hood L; Huang AT; Triozzi P; Sedwick WD; Koren H; Ellinwood EH; Tso CY, 1990, 'Phase I studies of recombinant interferon-gamma.', J Biol Response Mod, vol. 9, pp. 185 - 193, https://www.ncbi.nlm.nih.gov/pubmed/2160521

Goldstein D; Sosman JA; Hank JA; Weil-Hillman G; Moore KH; Borchert A; Bechhofer R; Storer B; Kohler PC; Levitt D, 1989, 'Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity.', Cancer Res, vol. 49, pp. 6832 - 6839, https://www.ncbi.nlm.nih.gov/pubmed/2819723

Goldstein D; Sielaff KM; Stores BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC, 1989, 'Human biologic response modification by interferon in the absence of measurable serum concentrations: A comparative trial of subcutaneous and intravenous interferon-β serine', Journal of the National Cancer Institute, vol. 81, pp. 1061 - 1068, http://dx.doi.org/10.1093/jnci/81.14.1061

Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW, 1989, 'Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells', Journal of the National Cancer Institute, vol. 81, pp. 502 - 512, http://dx.doi.org/10.1093/jnci/81.7.502

Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC, 1989, 'Effects of Type I and II Interferons on Cultured Human Breast Cells: Interaction with Estrogen Receptors and with Tamoxifen', Cancer Research, vol. 49, pp. 2698 - 2702

Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z, 1989, 'Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy', Oncology (Switzerland), vol. 46, pp. 105 - 108, http://dx.doi.org/10.1159/000226695

Goldstein D; Laszlo J, 1988, 'The role of interferon in cancer therapy: A current perspective', CA: A Cancer Journal for Clinicians, vol. 38, pp. 258 - 277, http://dx.doi.org/10.3322/canjclin.38.5.258

Laszlo J; Goldstein D, 1988, 'The doctor's dilemma (the nurse's Waterloo)', Cancer Investigation, vol. 6, pp. 361 - 363, http://dx.doi.org/10.3109/07357908809080660

Triozzi PL; Goldstein D; Laszlo J, 1988, 'Contributions of benzodiazepines to cancer therapy.', Cancer Invest, vol. 6, pp. 103 - 111, http://dx.doi.org/10.3109/07357908809077033

Goldstein D; Kelly R; Ralston M; Penny R; Hayes J, 1987, 'Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma', Medical Oncology and Tumor Pharmacotherapy, vol. 4, pp. 101 - 105, http://dx.doi.org/10.1007/BF02934947

Goldstein D; Gockerman J; Tso CY; Hood LE, 1987, 'Effects of 7-Interferon on the Endocrine System: Results from a Phase I Study', Cancer Research, vol. 47, pp. 6397 - 6401

Geczy CL; Ryan J; Walsh J; Goldstein D, 1986, 'Lymphokine‐induced monocyte procoagulant activity is depressed in patients with advanced malignancies', International Journal of Cancer, vol. 37, pp. 677 - 682, http://dx.doi.org/10.1002/ijc.2910370506

Goldstein D; Laszlo J, 1986, 'Interferon Therapy in Cancer: From Imaginon to Interferon', Cancer Research, vol. 46, pp. 4315 - 4329

Laszlo J; Goldstein D; Vugrin D; Hood L; Tso CY, 1986, 'Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.', J Biol Response Mod, vol. 5, pp. 294 - 299, https://www.ncbi.nlm.nih.gov/pubmed/3734845

Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 'Bringing the pancreas patient back to the bench: Ex vivo culture of intact human patient derived pancreatic tumour tissue', , http://dx.doi.org/10.1101/2020.07.30.223925

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Pancreatic cancer-related diabetes: Do pancreatic stellate cell and cancer cell derived exosomes play a role?', in Pancreratology, presented at European Pancreatic Club

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'I. Pancreatic Stellate Cell and Cancer Cell Derived Exosomes Impair Beta Cell Function: Implications for Pancreatic Cancer Related Diabetes', in Gastroenterology, Elsevier, Chicago, USA, presented at Digestive Disease Week, Chicago, USA, 02 May 2020, http://dx.doi.org/10.1016/S0016-5085(20)31245-2

Flukes S; Cracchiolo J; Geer E; Goldstein D; De Almeida J; Tabar V; Cohen MA, 2020, 'Quality from the Patient’s Perspective: Implementation of an Established Patient-Reported Outcome Platform in a Multidisciplinary Skull Base Tumor Clinic', in 30th Annual Meeting North American Skull Base Society, Georg Thieme Verlag KG, presented at 30th Annual Meeting North American Skull Base Society, 07 February 2020 - 09 February 2020, http://dx.doi.org/10.1055/s-0040-1702409

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, 'PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Austin, TX, pp. S221 - S221, presented at Crohn's and Colitis Congress, Austin, TX, 23 January 2020 - 25 January 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349500565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mekapogu A; Xu Z; Pothula S; Perera C; Pang T; Hosen Z; Janetka J; Damalanka V; Mahoney M; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Inhibition of both the ligand and receptor of the hepatocyte growth factor/c-MET pathway, in combination with chemotherapy, retards progression of PanIN lesions in KPC mice', in Pancreatology, Elsevier BV, pp. S39 - S40, http://dx.doi.org/10.1016/j.pan.2020.07.049

Xu Z; Pang T; Pothula S; Mekapogu A; Perera C; Murakami T; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'Inhibition of Hepatocyte Growth Factor (HGF) Signaling Pathway in Combination With Chemotherapy Reduces Tumour Burden in an Orthotopic Model of Advanced Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1551 - 1551, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000505712800617&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee B; Shapiro J; Thomson B; Ananda S; Lipton L; McLachlan S-A; Wong R; Cooray P; Burge M; Clarke K; Pattison S; Nikfarjam M; Tebbutt N; Harris M; Croagh D; Goldstein D; Nagrial A; Zielinski R; Roy A; Chee CE; Putoczki T; Hollande F; Hofmann O; Vissers J; Grimmond S; Gibbs P, 2019, 'How can digital health be used to improve outcomes in pancreatic ductal adenocarcinoma (PDAC)? Examining the potential of the PURPLE translational pancreatic cancer platform', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 73 - 74, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Z; Pang T; Pothula S; Mekapogu A; Perera C; Murakami T; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'Inhibition of hepatocyte growth factor signaling pathway in combination with chemotherapy reduces tumor burden in an orthotopic model of advanced pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 37 - 38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hayes SA; Martin A; Yip S; Howell VM; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Simes J; Goldstein D; Pavlakis N, 2019, 'Abstract 4531: SWATH-MS profiling identifies prognostic factors for progression-free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)', in Cancer Chemistry, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-4531

Hayes SA; Martin A; Yip S; Howell VM; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Simes J; Goldstein D; Pavlakis N, 2019, 'SWATH-MS profiling identifies prognostic factors for progression- free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Atlanta, GA, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-4531

Ziai H; Yao C; Leon A; Torti D; Pugh T; Aldape K; Xu W; Yu M; Weinreb I; Perez-Ordonez B; Witterick I; Vescan A; Monteiro E; Goldstein D; Ringash J; Bayley A; Zadeh G; Gentili F; De Almeida J, 2019, 'Regional Recurrences, Hyams Grade, and Methylation Immune Score Analysis in Esthesioneuroblastoma', in 29th Annual Meeting North American Skull Base Society, Georg Thieme Verlag KG, presented at 29th Annual Meeting North American Skull Base Society, 15 February 2019 - 17 February 2019, http://dx.doi.org/10.1055/s-0039-1679438

Kuo J; Bampton D; Lemech CR; Brown MP; Stanley A; Chojnowski G; Hammond E; Dredge K; Goldstein D, 2018, 'Preliminary results from a Phase Ib study of pixatimod (PG545) in combination with nivolumab in patients with advanced solid tumours with an expansion cohort in patients with metastatic pancreatic cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Dublin, IRELAND, pp. E18 - E19, presented at 30th EORTC-NCI-AACR Symposium, Dublin, IRELAND, 13 November 2018 - 16 November 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461258600037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu F; Quinn CM; Porwal M; O'Neill S; Goldstein D, 2018, 'Can health service utilisation by gastrointestinal cancer patients be assessed using data from a Biobank?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 95 - 95, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Z; Buckley BJ; Pothula S; Pang T; Goldstein D; Pirola RC; Wilson JS; Kelso MJ; Ranson M; Apte MV, 2018, 'Amiloride Analogues as Inhibitors of Human Urokinase Plasminogen Activator and Anti-Pancreatic Cancer Agents', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1434 - 1434, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449304600277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kokkinos J; Sharbeen G; Mccarroll J; Akerman A; Youkhana J; Goldstein D; Phillips P, 2018, 'beta III-Tubulin is a brake for external cell-death signaling and chemosensitivity in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 19 - 19, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pang T; Xu Z; Pothula S; Yang MH; Becker T; Goldstein D; Heeschen C; Pirola R; Wilson J; Apte MV, 2018, 'WORLD-FIRST IDENTIFICATION OF CIRCULATING PANCREATIC STELLATE CELLS IN METASTATIC PANCREATIC CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S114 - S114, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, Washington, DC, 02 June 2018 - 05 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011100327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Z; Pothula S; Pang T; Mekapogu A; Goldstein D; Pirola R; Wilson J; Apte M, 2018, 'Inhbition of hepatocyte growth factor (HGF) signalling pathway in combination with chemotherapy reduces tumour buden in an orthotopic pancreatic cancer model', Sydney, presented at Avner Cancer Symposium, Sydney

Wilson J; Pang T; Xu Z; Mekapogu A; Pothula S; Goldstein D; Pirola R; Wilson J; Apte M, 2018, 'Establishment of a noval adjuvant model of orthotopic pancreatic cancer: effects of HGF-cMET inhibition on disease progression', Sydney, presented at Avner Cancer Symposium, Sydney

McCrary JM; Goldstein D; Battaglini E; Barry B; Sandler C; Murray J; Park S, 2017, 'The Effects of Exercise Training on Neurophysiology, Symptoms, and Function in Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 130 - 131, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bekaii-Saab T; Goldstein D; Li CP; Okusaka T; O'Neil B; Reni M; Tabernero J; Qin S; Van Cutsem E; Borodyansky L; Li CJ, 2017, 'CanStem111P trial: A phase III study of napabucasin plus nab-paclitaxel (nab-PTX) with gemcitabine (gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC)', in Annals of Oncology, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. iii136, presented at ESMO 19th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, 28 June 2017 - 01 July 2017, http://dx.doi.org/10.1093/annonc/mdx261.379

Clifford B; Barry B; Simar D; Goldstein D, 2017, 'Exercise Induced Analgesia in Survivors of Cancer', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, Denver, CO, pp. 163 - 163, presented at Annual Meeting of the American-College-of-Sports-Medicine (ACSM), Denver, CO, 30 May 2017 - 03 June 2017, http://dx.doi.org/10.1249/01.mss.0000517274.66389.d8

Apte M; Xu Z; Pothula S; Goldstein D; Pirola R; Wilson JS, 2016, 'Stromal remodeling in pancreatic cancer', in Pancreatology, Elsevier, Sendai, pp. S28 - S28, presented at International Association of Pancreatology, Sendai, -

Wang X; Yeo RX; Crowe P; Goldstein D; Hogg P; Dilda P; Yang JL, 2015, 'Synergistic effect of targeting EGFR and metabolism in sarcoma cell lines', in Synergistic effect of targeting EGFR and metabolism in sarcoma cell lines, 2015 Annual Sarcoma Conference, Brisbane, Australia, presented at 2015 Annual Sarcoma Conference, Brisbane, Australia, 17 October 2015 - 18 October 2015

Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, San Diego, Pancreas 44(8):1407, pp. 1407 - 1408, presented at American Pancreatic Association, San Diego, Pancreas 44(8):1407, - , http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000233&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', in Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach, International Association of Pancreatology, Shanghai, Pancreatology, presented at International Association of Pancreatology, Shanghai, Pancreatology, -

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', in Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach, European Pancreatic Club, Toledo, Pancreatology 15(3):S17, presented at European Pancreatic Club, Toledo, Pancreatology 15(3):S17, -

Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600356&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Youkhana J; Mccarroll J; Sharbeen G; Erkan M; Liu J; Goldstein D; Phillips PA, 2014, 'Heat shock protein 47 is a potential therapeutic target for the depletion of cancer-promoting stromal cells in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 7 - 7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shannon J; Goldstein D; Wong N; Chichen S; Sjoquist K; O'Connell R; Grimison P; McLachlan S; Tebbutt NC; Lipton L; Vasey P; Cronk M; Varma SC; Jefford M; Segelov E; Abdi E; Ng S; Karapetis C; Gebski V; Zalcberg J, 2014, 'A MULTI-CENTRE, PHASE II, OPEN-LABEL, SINGLE ARM STUDY OF PANITUMUMAB, CISPLATIN AND GEMCITABINE IN BILIARY TRACT CANCER: PRIMARY RESULTS OF THE AGITG TACTIC STUDY', in Annals of Oncology, Oxford University Press (OUP), Madrid, Spain, pp. 1 - 1, presented at 39th ESMO Congress (ESMO 2014), Madrid, Spain, 26 September 2014 - 30 September 2014, http://dx.doi.org/10.1093/annonc/mdu334.106

Webber K; Bennett BK; Goldstein D; Lloyd AR, 2014, 'Genetic associations of fatigue and other symptom domains after breast cancer treatment: Results from a prospective cohort study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Chicago, IL, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9537

Davis ID; Long A; Martin A; Espinoza D; Yip S; Kichenadasse G; Thompson JF; Harrison ML; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro JD; Stockler MR, 2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium, San Francisco, CA, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438

Yip S; Pavlakis N; Harvie R; Martin A; Jovanovic L; Hudson A; Thompson JF; Nelson C; Long A; Steer C; Harrison ML; Kannourakis G; Goldstein D; Kichenadasse G; Lowenthal RM; Stockler MR; Davis ID, 2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium, San Francisco, CA, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428

Chua YJ; Karapetis CS; Gebski V; O'Connell R; Begbie S; Nott LM; Cronk MF; Underhill C; Abdi EA; Van Hagen T; Wong N; Hall M; Ferraro DA; Sjoquist KM; Santos C; Mackey JR; Goldstein D, 2014, 'Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 16 January 2014 - 18 January 2014, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.228

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2014, 'Hepatocyte Growth Factor (HGF) inhibition may be a superior therapeutic approach than gemcitabine in pancreatic cancer', in Hepatocyte Growth Factor (HGF) inhibition may be a superior therapeutic approach than gemcitabine in pancreatic cancer, Australasian Pancreatic Club and the Australian Health and Medical Research Congress, Melbourne, presented at Australasian Pancreatic Club and the Australian Health and Medical Research Congress, Melbourne, -

Pothula S; Patel M; Xu Z; Lee A; Goldstein D; Pirola R; Apte M; Wilson JS, 2014, 'The role of hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: anti-angiogenic implications in pancreatic cancer', in The role of hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: anti-angiogenic implications in pancreatic cancer, International Association of Pancreatology and European Pancreatic Club, Southampton, Pancreatology 14(3):S9, presented at International Association of Pancreatology and European Pancreatic Club, Southampton, Pancreatology 14(3):S9, -

Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; McCarroll J; Youkhana J; Teo J; McCarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Teo J; Boyer C; Liu J; Sharbeen G; Erlich R; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D, 2013, 'Therapeutic Potential of Angiogenesis Inhibitors for Gastric Cancer', in Annals of Oncology, OXFORD UNIV PRESS, Sendai, JAPAN, pp. ix8, presented at 11th Annual Meeting of the Japanese-Society-of-Medical-Oncology, Sendai, JAPAN, 29 August 2013 - 31 August 2013, http://dx.doi.org/10.1093/annonc/mdt437.1

Beesley VL; Janda M; Wockner LF; O'Rourke P; Gooden H; Goldstein D; Merrett ND; Wyld DK; Neale RE, 2013, 'PANCREATIC CANCER PATIENT'S MODERATE OR HIGH UNMET SUPPORTIVE CARE NEEDS OVER TIME AND RISK FACTORS OF FUTURE UNMET NEEDS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 105 - 105, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scott A; Goldstein D; Grennan K, 2013, 'IS SECOND LINE CHEMOTHERAPY IN PANCREATIC CANCER ONE LINE TOO MANY?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 150 - 150, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pothula S; Xu Z; Arun S; Goldstein D; Biankin A; Pirola R; Wilson J; Apte M, 2013, 'Hepatocyte Growth Factor Inhibition: A Therapeutic Approach Superior to Gemcitabine in Pancreatic Cancer?', in Pancreas, Lippincott Williams & Wilkins, Miami, pp. 1377 - 1377, presented at American Pancreatic Association, Miami, 31 October 2013 - 02 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000330468400188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; Mccarroll J; Youkhana J; Teo J; Mccarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-tubulin is a novel therapeutic target for the treatment of pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 12 - 12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bennett B; Webber K; Goldstein D; Lloyd A, 2013, 'What do patients really mean when they complain of fatigue after treatment? Reliable identification of post cancer fatigue', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Amsterdam, NETHERLANDS, pp. S283 - S283, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, NETHERLANDS, 27 September 2013 - 01 October 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843602060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butow PN; Sze M; Eisenbruch M; Bell M; Aldridge L; Vardy JL; Hui R; Boyle F; Liauw WS; Goldstein D, 2013, 'Should culture affect practice? Prognostic discussions with immigrants', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419602272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601380&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vickers MM; Tu D; Lee C; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H-J; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2013, 'Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Racadot S; Hammel P; Chibaudel B; Goldstein D; Spry N; Van Laethem J; Van Houtte P; Glimelius B; Gubanski M; Huguet F, 2012, 'Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, Boston, MA, pp. S322 - S322, presented at 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Boston, MA, 28 October 2012 - 31 October 2012, http://dx.doi.org/10.1016/j.ijrobp.2012.07.845

Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 June 2012 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802389&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chua YJ; Karapetis CS; Underhill C; Nott LM; Goldstein D; Cronk MF; Gebski V; Wong N; Sjoquist KM; Biankin AV, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 June 2012 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803706&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken N; Wyld D; Beale PJ; Jefford M; Glasgow AL; Abdi EA; Glare PA; Stockler MR, 2012, 'Usefulness of medical oncologists' estimates of survival time in people with advanced cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 June 2012 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803861&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Habbous S; Chu KP; Waldron J; Harland L; Delfa AL; Su S; Xu W; Hui A; Huang S-H; Goldstein D; O'Sullivan B; Liu G, 2012, 'Abstract 666: The effect of comorbidity, smoking and alcohol on survival of head and neck cancer anatomic subsites: A retrospective analysis of 4689 patients', in Epidemiology, American Association for Cancer Research, presented at Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL, http://dx.doi.org/10.1158/1538-7445.am2012-666

Youkhana J; Liu J; Kiriella N; Yang L; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte MV; Phillips PA, 2011, 'Heat Shock Proteins 27 and 47 Inhibit Platelet-Derived Growth Factor (PDGF)-Induced Pancreatic Stellate Cell Proliferation: Implication in Pancreatic Cancer Progression', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1365 - 1366, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296398000273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Stockholm, SWEDEN, pp. S436 - S436, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71792-0

Bennett BK; Goldstein D; Friedlander M; Park SB; Kiernan MG, 2011, 'Oxaliplatin-induced Neurotoxicity - Comparing Four Methods of Assessment', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Stockholm, SWEDEN, pp. S234 - S234, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71114-5

Arun SJ; Xu Z; Fiala-Beer E; Yang L; Phillips P; Goldstein D; Biankin A; Pirola R; Wilson JS; Apte MV, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', in Journal of Gastroenterology and Hepatology, Wiley, pp. 20 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Youkhana J; Liu J; Kiriella N; Yang S; Xu Z; Biankin AV; Goldstein D; Wilson JS; Apte MV; Phillips P, 2011, 'Heat shock proteins 27 and 47 inhibit platelet-derived growth factor (PDGF)-induced pancreatic stellate cell proliferation: implication in pancreatic cancer progression', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. 19 - 19, presented at Australian Gastroenterology Week, Brisbane Australia, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Fiala-Beer E; Xu Z; Phillips P; Yang L; Goldstein D; Pirola R; Wilson J; Apte M, 2010, 'Role of Pancreatic Stellate Cells in Pancreatic Cancer: The Urokinase Plasminogen Activator System', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1320 - 1320, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fiala-Beer E; Xu Z; Phillips PA; Yang L; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer: the urokinase plasminogen system', in Journal of Gastroenterology and Hepatology, Wiley, pp. A75 - A75, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Lee C; Hui Y; Shah B; Yip D; McArthur GA, 2010, 'Development of a nomogram to predict overall survival in patients with locally advanced or metastatic gastrointestinal stromal tumor receiving first-line treatment with imatinib', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.10054

Yang JL; Zahorowska B; Kasim Y; Goldstein D; Crowe P, 2010, 'Abstract 1655: Mechanism of the synergistic antiproliferative effect of gefitinib and interferon-alpha in sarcoma cell lines', in Experimental and Molecular Therapeutics, American Association for Cancer Research, presented at Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC, http://dx.doi.org/10.1158/1538-7445.am10-1655

Webber K; Goldstein D; Bennett BK; Boyle F; De Souza PL; Wilken N; Friedlander M; Lloyd AR, 2010, 'Late fatigue after adjuvant therapy for early breast cancer is largely unrelated to cancer or its treatment: 5 year follow-up of a prospective cohort study', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 53 - 60, presented at ., -

Aldridge L; McGrane J; Butow PN; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Yates P; Connell S; Duggal-beri P; Sze M; Lobb E; Goldstein D, 2010, 'Unmet needs in Chinese (Mandarin and Cantonese), Greek, and Arabic-speaking cancer survivors in Australia', in Psycho-oncology, John Wiley & Sons, New York, pp. 1810 - 1813

Bennett BK; Goldstein D; De Souza PL; Wilken N; Friedlander M; Hickie IB; Scott E; Rogers N; Lloyd AR, 2010, 'What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study', in Journal of Clinical Oncology, American Society of Clinical Oncology, United States, pp. 93s, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.605

Phillips PA; Yang L; Vonlaufen A; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', in Journal of Gastroenterology and Hepatology, Wiley, pp. A334 - A334, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phillips PA; Chow E; Kaplan W; Cowley M; Vonlaufen A; Yang L; Goldstein D; Pirola R; Wilson J; Apte MV, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A333 - A334, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200303&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Chicago, IL, pp. A277 - A277, presented at Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, Chicago, IL, 30 May 2009 - 04 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275277201376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Z; Phillips PA; Vonlaufen A; Fiala-Beer E; Yang L; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Pancreatic stellate cells (stromal cells) migrate with pancreatic cancer cells to distant metastatic sites', in Journal of Gastroenterology and Hepatology, Wiley, pp. A334 - A335, presented at AGW, - , http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2008, 'Early detection of oxaliplatin-induced neurotoxicity: Getting it before it hurts', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.15015

Xu ZH; Vonlaufen A; Yang L; Phillips PA; Fiala-Beer E; Biankin AV; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Pancreatic stellate cells stimulate angiogenesis in pancreatic cancer and accompany pancreatic cancer cells to distant metastatic sites', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 502 - 503, presented at Pancreas, http://dx.doi.org/10.1097/01.MPA.0000335420.28357.d3

Bennett BK; Goldstein D; Friedlander ML; Boyle F; De Souza PL; Wilken N; Hickie IB; Scott E; Lloyd AR, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer', in Psycho - Oncology, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S36 - S37, presented at Psycho-Oncology 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Underhill CR; Goldstein D; Gorbunova VA; Biakhov MY; Bazin IS; Melemed A; Hossain A; Granov DA, 2006, 'A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Istanbul, TURKEY, pp. 118 - 118, presented at 31st Congress of the European-Society-for-Medical-Oncology, Istanbul, TURKEY, 29 September 2006 - 03 October 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248078900349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Spry N; Harvey J; MacLeod C; Borg M; Ngan S; Millar J; Graham P; Delaney G; Reece W; Goldstein D, 2006, 'Concurrent infusional 5-fluorouracil and 'protocol specific' 3D conformal radiotherapy is effective and safe in combination with 'sandwich' gemcitabine in the management of locally advanced pancreatic cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 21 - 21, presented at Satellite Symposium on New Horizons for Gastric Cancer held in conjunction with the 8th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, 29 June 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Joshi SB; Vonlaufen A; Xu Z; Daniel B; Qu CF; Kumar RK; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2006, 'Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 472 - 473, - , http://dx.doi.org/10.1097/00006676-200611000-00123

Joshi SB; Qu CF; Phillips PA; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2005, 'Epithelial-stromal interactions in pancreatic cancer: do pancreatic cancer cells actively recruit host stromal cells for their own benefit?', in The Peter McCallum Institute (ed.), 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, pp. 21 - 21, presented at 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, 14 November 2005 - 16 November 2005

Au HJ; Goldstein D; Ding K; Parulekar W; Gallinger S; Moore M, 2005, 'DOES EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR (EGFRI) SKIN TOXICITY AFFECT QOL? RESULTS FROM A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP (NCIC-CTG) RCT', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. 2135 - 2135, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000520235700429&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Spry N; Van Hazel GA; Underhill CR; Kotasek D; Harvey JE; Links MJ; Shapiro J; Iacopetta BJ, 2005, 'Combined modality therapy for pancreatic carcinoma: An australian pancreatic cancer group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI5FI)and 3D conformal radiotherapy (RT)-final outcomesAbstract No: 4101', in Bhave AB (ed.), Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 203s - 203s, presented at 42nd Annual Meeting of the Amercian Society of Clinical Oncology, Atlanta, Georgia USA, 02 June 2005 - 06 June 2005

Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Orlando, FL, pp. 266S - 266S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando, FL, 13 May 2005 - 17 May 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326601475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Van Hazel GA; Underhill CR; Kotasek D; Harvey JE; Links MR; Shapiro J; Iacopetta BJ; Spry N; Lilly E, 2004, '', in Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India

Evans VE; Vockler C; Magnay J; Friedlander N; Lewis CR; Goldstein D; Walsh BR; Holden BA; Willcox MD, 2000, 'Lacryglobin in human tears, a potential marker for cancer metastasis', in Australian and New Zealand Journal of Ophthalmology, Blackwell Science Asia, South Carlton, Australia, pp. 36 - 36, presented at Australasian Ophthalmic and Visual Sciences Meeting 2000, Sydney

Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results', in Seminars in Oncology

Goldstein D; Milliken ST; Chipman M; Lebon J; Lewis CR; Cooper DA, 1997, 'Dox-SL maintenance therapy after response in AIDS-related Kaposis Sarcoma.', in J. AIDS and Human Retrovirology, J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology

Goldstein D; Padigliene A; Law MG; Kaldor JM; Mijch AM; Hoy JF, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness.', in J. AIDS and Human Retrovirology, J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology

Goldstein D; Davis A; Milliken ST, 1997, 'Long term follow-up of CEOP in the treatment of HIV related NHL.', in J. AIDS and Human Retrovirology, J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology

Goldstein D; Cooper DA, 1993, 'Current status of clinical trials in HIV disease in Australia', in Journal of Acquired Immune Deficiency Syndromes, pp. S68 - S71

Lim HJ; Wang X; Goldstein ; Crowe , 2015, 'Targeting the PI3K/PTEN/AKT/mTOR pathway in sarcoma cell lines', in Anticancer Research, Lorne, Victoria, Australia, Vol. 36, pp. 5765 - 5771, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015, http://dx.doi.org/10.21873/anticanres.11160

Wang X; Goldstein ; Crowe ; Yang , 2014, 'Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines', in Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines, The 105th Annual Meeting of the American Association for Cancer Research 2014, San Diego, CA, PA, presented at The 105th Annual Meeting of the American Association for Cancer Research 2014, San Diego, CA, PA, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-172

Wang X; Goldstein D; Crowe P; Yang J, 2013, 'Mechanisms of gefitinib alone and in combination therapy in soft tissue sarcoma cell lines', in MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH, Boston, MA, US, Vol. 12, presented at Molecular Targets and Cancer Therapeutics 2013, Boston, MA, US, 19 October 2013 - 23 October 2013, http://dx.doi.org/10.1158/1535-7163.TARG-13-A113

Wang X; Goldstein D; Crowe P; Yang J, 2013, 'STAT3 inhibitor S3I-201 suppresses human osteosarcoma cell growth', in STAT3 inhibitor S3I-201 suppresses human osteosarcoma cell growth, 25th Lorne Cancer Conference 2013, Lorne, Victoria, Australia, presented at 25th Lorne Cancer Conference 2013, Lorne, Victoria, Australia, 14 February 2013 - 16 February 2013

Wang X; Goldstein D; Crowe P; Yang J, 2012, 'Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors', in Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors, The 103rd Annual Meeting of AACR 2012, presented at The 103rd Annual Meeting of AACR 2012, 31 March 2012 - 04 April 2012

Wang X; Goldstein D; Crowe P; Yang J, 2012, 'STAT3-targeted therapy on human soft tissue sarcomas', in STAT3-targeted therapy on human soft tissue sarcomas, 24th Lorne Cancer Conference 2012, Lorne, Victoria, Australia, presented at 24th Lorne Cancer Conference 2012, Lorne, Victoria, Australia, 09 February 2012 - 11 February 2012

Best M; Butow P; Jacobs C; Juraskova I; Savard J; Meiser B; Goldstein D; Ballinger M; Bartley N; Napier C; Davies G; Thomas D; Tucker K; Schlub T; Newson AJ, 2020, 'Advanced cancer patient preferences for receiving molecular profiling results', in Psycho-Oncology, WILEY, Vol. 29, pp. 1533 - 1539, http://dx.doi.org/10.1002/pon.5446

Butow P; Davies G; Napier C; Thomas DM; Bartley N; Goldstein D; Ballinger ML; Juraskova I; Schlub TE; Tucker K; Meiser B; Young M-A, 2020, 'Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368301063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Battaglini E; Goldstein D; Park S, 2020, 'Determining the impact of chemotherapy-induced peripheral neuropathy: A survey of cancer survivors.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368308496&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Timmins H; Li T; Kiernan M; Harrison M; Trinh T; Battaglini E; Goldstein D; Park S, 2020, 'Dose modification: Does it affect follow-up outcomes in taxane-induced neuropathy?', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 480 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Battaglini E; Goldstein D; Park S, 2020, 'Chemotherapy-induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-term Quality of Life', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 548 - 548, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Li T; Timmins H; McCrary J; Trinh T; Friedlander M; Horvath L; Kiernan M; Goldstein D; Park S, 2020, 'Patient reported outcome scores used in chemotherapy-induced peripheral neuropathy: Defining minimal important differences', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 481 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mizrahi D; Trinh T; Au K; Timmins HC; Li T; McCrary JM; Friedlander M; Grimison P; Park SB; Goldstein D, 2019, 'Does physical activity participation associate with the degree of chemotherapy-induced peripheral neuropathy after neurotoxic treatment?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 179 - 179, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400288&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thavaneswaran S; Napier C; Goldstein D; Meiser B; Butow P; Thomas DM; Ballinger ML; Best M, 2019, 'Medical oncologists' experience with returning molecular tumor profiling to patients.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2019 - 04 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487345804031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Akerman A; McCarroll J; Boyer C; Holst J; Youkhana J; Davis TP; Goldstein D; Erkan M; Phillips PA, 2018, 'Metabolically Reprograming Pancreatic Stellate Cells Using a Novel Nanomedicine for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 47, pp. 1422 - 1422, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449304600230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kokkinos J; Sharbeen G; McCarroll J; Boyer C; Akerman A; Youkhana J; Davis TP; Goldstein D; Phillips PA, 2018, 'beta III-Tubulin is a Brake for External Cell-Death Signaling and Regulates TRAIL Sensitivity in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Miami Beach, Florida, Vol. 47, pp. 1401 - 1401, presented at 49th Annual Meeting of the American Pancreatic Association, Miami Beach, Florida, 31 October 2018 - 03 November 2018, http://dx.doi.org/10.1097/MPA.0000000000001177

Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, WILEY, Vol. 13, pp. 66 - 66, presented at COSA's 44th Annual Scientific Meeting, 13 November 2017 - 15 November 2017, http://dx.doi.org/10.1111/ajco.12798

Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in Immunotherapy: Molecules and Mountains, Sydney, presented at COSA's 44th Annual Scientif Meeting, Sydney, http://dx.doi.org/10.1111/ajco.12798

Timmins HC; Li T; Kiernan MC; Horvath LG; Harrison M; Grimison P; Cox KM; Boyle FM; Goldstein D; Park SB, 2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, Sitges, SPAIN, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, Sitges, SPAIN, 08 July 2017 - 12 July 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wang X; Yeo R; Crowe P; Goldstein D; Hogg R; Dilda P; Yang JL, 2016, 'Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Munich, GERMANY, Vol. 69, pp. S37 - S38, presented at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Munich, GERMANY, 29 November 2016 - 02 December 2016, http://dx.doi.org/10.1016/S0959-8049(16)32693-4

McCrary JM; Park S; Goldstein D, 2016, 'CLINICIAN AND NURSE REPORTING HABITS FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 129 - 129, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McCrary JM; Park S; Goldstein D, 2016, 'A SYSTEMATIC REVIEW AND DELPHI SURVEY OF ASSESSMENT STRATEGIES FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 128 - 128, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yip S; Harvie R; Martin AJ; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Burnell MJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Strickland A; Zalcberg JR; Simes J; Goldstein D; Pavlakis N, 2016, 'Evaluation of circulating VEGF based biomarkers in INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 34, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.64

McNamara MG; Bridgewater JA; Lopes A; Wasan H; Malka D; Jensen HR; Okusaka T; Knox JJ; Wagner AD; Cunningham D; Shannon J; Goldstein D; Moehler MH; Bekaii-Saab TS; Valle JW, 2016, 'Systemic therapy in elderly patients with advanced biliary tract cancer: Sub-analysis of ABC-02 and 10 other prospective studies.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 34, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.382

Tempero MA; Cardin DB; Goldstein D; O'Reilly EM; Philip AP; Riess H; Macarulla T; Yung L; Li M; Lu BD; Biankin A, 2016, 'APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 34, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.tps473

Farrar MA; KAndula T; Murray J; Goldstein D; Krishnan A; PArk S, 2016, 'Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?', in Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?, ANZAN Biennial Clinical Neurophysiology Workshop, presented at ANZAN Biennial Clinical Neurophysiology Workshop, http://dx.doi.org/10.1016/j.clinph.2015.11.029

Sharbeen G; McCarroll J; Liu J; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta III-Tubulin Regulates Sensitivity to Nab-Paclitaxel (Abraxane (R)) in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1415, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; McCarroll J; Limbri L; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta IVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1414, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritchie GE; Fernando M; Goldstein D, 2015, 'RITUXIMAB TO TREAT GEMCITABINE INDUCED HEMOLYTIC URAEMIC SYNDROME IN THREE PATIENTS WITH PANCREATIC ADNENOCARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 11, pp. 63 - 63, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pavlakis N; Sjoquist KM; Tsobanis E; Martin AJ; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Kim JW; Yip S; Simes J; Zalcberg JR; Goldstein D, 2015, 'INTEGRATE: A randomized, phase II, double-blind, placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC): A study by the Australasian Gastrointestinal Trials Group (AGITG)-Final overall and subgroup results', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4003

Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4153

Barbour A; O'Rourke N; Chandrasegaram MD; Chua YJ; Kench J; Samra JS; Pavlakis N; Haghighi KS; Yip S; Fawcett J; Donoghoe M; Walker K; Burge ME; Gananadha S; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4115

Chan D; Goldstein D; Sjoquist KM; Pavlakis N, 2015, 'Antiangiogenic agents (AAs) in metastatic oesophago-gastric cancer (mOGC): A systematic review and meta-analysis', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15111

Kunzmann V; Ramanathan RK; Goldstein D; Penenberg DN; Ferrara S; Lu BD; Von Hoff DD, 2015, 'Reduction in primary pancreatic and metastatic tumor burden in the phase III MPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15299

Stein A; Arnold D; Bechstein WO; Bridgewater JA; Goldstein D; Jensen LH; Kasper S; Kluempen HJ; Kunzmann V; Lindig U; Lohse AW; Nashan B; Primrose JN; Markus R; Shannon JA; Sinn M; Karl-Heinz W; Wege H, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1): A randomized, multidisciplinary, multinational phase III trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4140

Wege H; Arnold D; Bechstein WO; Bridgewater J; Goldstein D; Jensen LH; Kasper S; Klumpen HJ; Kunzmann V; Lindig U; Lohse AW; Nashan B; Primrose J; Rentsch M; Shannon J; Sinn M; Weiss KH; Stein A, 2015, 'ADJUVANT CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN COMPARED TO OBSERVATION AFTER CURATIVE INTENT RESECTION OF CHOLANGIOCARCINOMA AND MUSCLE INVASIVE GALLBLADDER CARCINOMA (ACTICCA-1) - A RANDOMIZED, MULTIDISCIPLINARY, MULTINATIONAL PHASE III TRIAL', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vienna, AUSTRIA, Vol. 62, pp. S845 - S846, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)31489-6

Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HTT; Goldstein D; Davis TP; Kavallaris M; Mccarroll J, 2015, 'Erratum: Effective Delivery of siRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers (Molecular Pharmaceutics (2013) 10: 6 (2435−2444) DOI: 10.1021/mp400049e)', in Molecular Pharmaceutics, Vol. 12, pp. 1004, http://dx.doi.org/10.1021/acs.molpharmaceut.5b00092

Barbour A; O'Rourke N; Samra JS; Haghighi KS; Kench J; Mitchell J; Pavlakis N; Burge ME; Fawcett J; Gananadha S; Harris M; Aghmesheh M; Chua YJ; Joubert WL; Chan MMK; Chandrasegaram MD; Yip S; Simes J; Gebski V; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 33, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 15 January 2015 - 17 January 2015, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.387

Wang X; Goldstein D; Crowe P; Yang JL, 2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vienna, AUSTRIA, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, Vienna, AUSTRIA, http://dx.doi.org/10.1016/S0959-8049(16)31921-9

Zilliacus E; Meiser B; Taouk M; Watts K; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Goldstein D, 2013, 'WORKING WITH PATIENTS FROM CULTURALLY AND LINGUISTICALLY DIVERSE BACKGROUNDS: PERSPECTIVES OF ONCOLOGY HEALTH PROFESSIONALS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 9, pp. 130 - 130, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Webber K; Girgis A; Kaye B; Bonaventura BA; Boyle FM; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2013, 'The unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners (GPs)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Chicago, IL, Vol. 31, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Webber K; Girgis A; Bennett BK; Bonaventura T; Boyle F; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2012, 'CURRENT CARE AND NEEDS OF ADULT CANCER SURVIVORS - A CROSS-SECTIONAL SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 8, pp. 356 - 357, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400419&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Sze M; Bell M; King M; Jefford M; Eisenbruch M; Girgis A; Vaccaro L; Butow PN, 2012, 'Disparities in quality-of-life outcomes in immigrant cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 30, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 June 2012 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802650&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sze M; Butow PN; King M; Goldstein D; Jefford M; Girgis A; Eisenbruch M; Bell M; Vaccaro L; Dong R; Asghari M; Tattersall MH; Hui R, 2011, 'Cancer in a country not your own: Illness perceptions and distress in immigrant versus native-born cancer patients', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 81 - 81

Aldridge L; McGrane J; Butow PN; Goldstein D; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Duggal-beri P; Sze M; Lobb E; Grayson NM; Faraji S, 2009, 'Unmet needs in Chinese, Greek, and Arabic-speaking cancer patients in New South Wales', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 221 - 221

Butow PN; Lobb E; Schofield PR; Jefford M; Goldstein D; King M; Eisenbruch M; Girgis A; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse backgrounds – the interpreters’ perceptions of roles, challenges, and support needs', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 207 - 207

Aldridge L; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M; Lobb E; Grayson NM; Faraji S, 2009, 'Unmet needs in Chinese, Greek, Arabic, and English-speaking cancer patients in New South Wales', in Psycho-oncology, John Wiley & Sons, New York, pp. 117 - 117

Butow PN; Lobb EA; Schofield PR; Goldstein D; Eisenbruch M; Girgis A; Jefford M; King M; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse (CALD) backgrounds: the interpreter perspective', in Psycho-oncology, John Wiley & Sons, New York, pp. 46 - 46

Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M; Lobb E; Aldridge L; Grayson NM; Faraji S; Threlfall T, 2008, 'Conducting research with culturally and linguistically diversre cancer patients: methodological issues', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 40 - 40

Butow PN; Girgis A; Goldstein D; Eisenbruch M; Schofield PR; Jefford M; King M; Duggal-beri P; Mikhail M; Sze M; Lobb E, 2008, 'Unmet needs in Chinese, Greek and Arabic speaking cancer patients in Australia', in Psycho-oncology, John Wiley & Sons, New York, Vol. 17, pp. S7 - S7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Butow PN; Girgis A; Goldstein D; Eisenbruch M; Schofield PR; Jefford M; King M; Duggal-beri P; Sze M; Mikhail M; Lobb E, 2008, 'Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia', in Psycho-oncology, John Wiley & Sons, New York, Vol. 17, pp. S280 - S280, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200539&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Duggal-beri P; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR, 2007, 'Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A95 - A96

Duggal-beri P; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR, 2007, 'Psychological morbidity or unmet needs of cancer patients from culturally and linguistically diverse (CALD) backgrounds', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A67 - A67

Sze M; Duggal-beri P; Butow PN; Mikhail M; Eisenbruch M; Goldstein D; Schofield PR; Jefford M; King M; Girgis A, 2007, 'Low psychological service utilisation in cancer – does it mean CALD patients cope better', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A96 - A96